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3.	
  ABSTRACT	
  	
  The	
   developing	
   limb	
   is	
   an	
   ideal	
   genetic	
   model	
   to	
   investigate	
   basic	
   developmental	
  mechanisms	
  and	
   signaling	
  networks.	
  The	
  Bone	
  Morphogenetic	
  Protein	
   (BMP)	
   signaling	
  pathway	
   has	
   been	
   associated	
   with	
   a	
   number	
   of	
   context-­‐specific	
   functions	
   during	
   limb	
  development,	
   including	
   establishment	
   of	
   the	
   limb	
   signalling	
   domains,	
   regulation	
   of	
   cell	
  proliferation	
  and	
  cell	
  death,	
  digit	
  patterning,	
  differentiation	
  of	
  the	
  endochondral	
  skeleton	
  and	
  the	
  soft	
  tissue.	
  The	
  present	
  work	
  aimed	
  at	
  providing	
  insights	
  into	
  the	
  roles	
  of	
  canonical	
  BMP	
  signaling	
  in	
   mouse	
   limb	
   bud	
   patterning	
   and	
   tissue	
   differentiation.	
   The	
   canonical	
   BMP	
   pathway	
  includes	
  numerous	
  components,	
  which	
  are	
  often	
  functionally	
  redundant.	
  Conversely,	
  the	
  non-­‐redundant	
  intracellular	
  transducer	
  SMAD4	
  is	
  essential	
  for	
  gastrulation,	
  such	
  that	
  its	
  inactivation	
  results	
  in	
  an	
  early	
  lethal	
  phenotype	
  and	
  prevents	
  the	
  analysis	
  of	
  its	
  functions	
  during	
  limb	
  development.	
  For	
  the	
  purpose	
  of	
  our	
  investigation,	
  we	
  used	
  the	
  conditional	
  inactivation	
   of	
   the	
   Smad4	
  gene	
   to	
   generate	
   time-­‐	
   and	
   space-­‐restricted	
   loss-­‐of-­‐function	
  models	
  during	
  limb	
  development.	
  This	
   approach	
   allowed	
   us	
   to	
   show	
   that	
   mesenchymal	
   SMAD4	
   is	
   dispensable	
   for	
  establishment	
  of	
  the	
  Apical	
  Ectodermal	
  Ridge	
  (AER),	
  which	
  is	
  an	
  ectodermal	
  source	
  of	
  the	
  Fibroblast	
  Growth	
  Factor	
  (FGF)	
  signalling	
  factors	
  that	
  contribute	
  to	
  proximo-­‐distal	
  (P-­‐D)	
  limb	
  axis	
  extension.	
  However,	
  mesenchymal	
  SMAD4	
  contributes	
  to	
  the	
  establishment	
  of	
  the	
  SHH/GREM1/AER-­‐FGFs	
  feedback	
  loop	
  that	
  controls	
  limb	
  outgrowth	
  and	
  patterning.	
  Most	
   importantly,	
   we	
   observed	
   a	
   discrete	
   temporal	
   requirement	
   of	
   SMAD4	
   for	
   the	
  specification	
  of	
  digit	
  primordia	
  during	
  a	
  developmental	
  period,	
  when	
  high	
  BMP	
  activity	
  is	
  essential	
   to	
   initiate	
   chondrogenesis.	
   Specific	
   inactivation	
   of	
   SMAD4	
   in	
   the	
   limb	
  mesenchyme	
   at	
   this	
   stage	
   is	
   sufficient	
   to	
   inhibit	
   the	
   initiation	
   of	
   mesenchymal	
  condensations,	
   which	
   represent	
   the	
   first	
   structures	
   committed	
   to	
   endochondral	
   bone	
  formation.	
   In	
   fact,	
   the	
   Smad4	
   deficiency	
   results	
   in	
   the	
   absence	
   of	
   any	
   limb	
   skeletal	
  elements.	
  Molecular	
  evidence	
   indicates	
   that	
   the	
  discrete	
  pattern	
  of	
  genes	
   that	
  normally	
  specify	
  the	
  chondrogenic	
  fate	
  is	
  replaced	
  by	
  wide-­‐spread	
  up-­‐regulation	
  of	
  genes	
  relevant	
  to	
  tendon	
  and	
  joint	
  development	
  in	
  Smad4	
  deficient	
  limb	
  bud,	
  but	
  no	
  ectopic	
  tendons	
  or	
  joints	
  are	
  formed.	
  These	
  observations	
  suggest	
  a	
  role	
  for	
  SMAD4	
  in	
  cell	
  fate	
  restriction	
  and	
  differentiation	
  of	
  lateral	
  plate	
  mesoderm-­‐derived	
  tissues	
  in	
  the	
  limb.	
  To	
   further	
   analyze	
   the	
   rapid	
   changes	
   in	
   BMP	
   activity	
   during	
   limb	
   development,	
   we	
  sought	
  to	
  generate	
  a	
  mouse	
  model	
  which	
  senses	
  BMP	
  activity	
   in	
  a	
  specific	
  and	
  dynamic	
  fashion.	
   For	
   the	
   purpose	
   of	
   this	
   project,	
   I	
   have	
   established	
   the	
   aggregation	
   chimera	
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technique	
  to	
  allow	
  for	
  the	
  rapid	
  investigation	
  of	
  cis-­‐regulatory	
  elements	
  in	
  the	
  context	
  of	
  the	
  Gt(ROSA)26Sor	
  locus.	
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4.	
  INTRODUCTION	
  
	
  	
  Parts	
  of	
  this	
  introduction	
  were	
  used	
  to	
  write	
  a	
  review:	
  Emanuele	
   Pignatti,	
   Rolf	
   Zeller,	
   Aimée	
   Zuniga.	
   To	
   BMP	
   or	
   not	
   to	
   BMP	
   during	
  
vertebrate	
   limb	
   bud	
   development.	
   Seminars	
   in	
   Cell	
  &	
  Developmental	
   Biology,	
   2014.	
  
Submitted.	
  
	
  
	
  
Limb	
  development	
  The	
   tetrapod	
   limb	
   emerges	
   from	
   the	
   lateral	
   plate	
   mesoderm	
   as	
   a	
   pocket	
   of	
  mesenchymal	
   cells	
   wrapped	
   in	
   a	
   ectoderm	
   monolayer.	
   Three	
   limb	
   axes	
   are	
   specified	
  during	
   the	
  earliest	
  phases	
  of	
   limb	
  outgrowth.	
  The	
  proximo-­‐distal	
   (P-­‐D)	
  axis	
  defines	
   the	
  axis	
  running	
  from	
  the	
  flank	
  of	
  the	
  embryo	
  to	
  the	
  tip	
  of	
  the	
  limb	
  bud;	
  the	
  antero-­‐posterior	
  (A-­‐P)	
  axis	
  goes	
  from	
  the	
  1st	
  digit	
  (the	
  thumb	
  in	
  humans)	
  to	
  the	
  5th	
  digit	
  (the	
  pinkie);	
  the	
  dorso-­‐ventral	
  (D-­‐V)	
  axis	
  defines	
  the	
  prospective	
  back	
  and	
  the	
  palm	
  of	
  the	
  hand	
  (Fig.	
  1a).	
  Limb	
   patterning	
   and	
   outgrowth	
   are	
   regulated	
   by	
   two	
   signaling	
   centers:	
   the	
   Apical	
  Ectodermal	
  Ridge	
  (AER),	
  an	
  ectodermal	
  structure	
  of	
  the	
  limb	
  bud	
  running	
  along	
  the	
  D-­‐V	
  interface	
  (Fernandez-­‐Teran	
  and	
  Ros,	
  2008;	
  Saunders,	
  1948);	
  and	
  the	
  Zone	
  of	
  Polarizing	
  Activity	
  (ZPA),	
  composed	
  of	
  a	
  group	
  of	
  mesenchymal	
  cells	
   located	
   in	
   the	
  posterior	
   limb	
  bud	
  mesenchyme	
  (Saunders,	
  1968;	
  Zwilling,	
  1956).	
  The	
  instructive	
  role	
  of	
  the	
  AER	
  along	
  the	
  P-­‐D	
  axis	
  is	
  mediated	
  by	
  FGFs	
  (Niswander	
  et	
  al.,	
  1993),	
  and	
  the	
  A-­‐P	
  patterning	
  activity	
  of	
  the	
  ZPA	
  is	
  mediated	
  by	
  the	
  expression	
  of	
  the	
  Sonic	
  Hedgehog	
  (SHH)	
  morphogen	
  (Fig.	
  3B;	
  Riddle	
  et	
  al.,	
  1993).	
  
	
  
	
  
	
  
Fig.	
   1	
   Limb	
   bud	
   axes.	
   a)	
  Micrograph	
  of	
   a	
  mouse	
  embryo	
  at	
  gestational	
  day	
  10.5.	
  The	
  enlarged	
  inset	
  shows	
  the	
  forelimb	
  bud	
  which	
  arises	
  from	
  the	
  flank	
  of	
  the	
  embryo	
  at	
  the	
  level	
  of	
  the	
  heart.	
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Two	
  axes	
  (proximal-­‐to-­‐distal	
  and	
  anterior-­‐to-­‐posterior)	
  are	
  indicated.	
  The	
  green	
  line	
  denotes	
  the	
  apical	
  ectodermal	
  ridge	
  (AER).	
  b)	
  Schematic	
  of	
  the	
  skeleton	
  of	
  a	
  human	
  arm.	
  In	
  blue,	
  the	
  proximal	
  structures	
  of	
   the	
   limb,	
   the	
   stylopod,	
   is	
   here	
   indicated	
   as	
   the	
  humerus.	
  The	
  middle	
   elements	
   are	
  indicated	
  in	
  purple.	
  The	
  zeugopod,	
  i.e.	
  the	
  radius	
  (anterior),	
  and	
  the	
  ulna	
  (posterior)	
  are	
  showed.	
  The	
  distal	
  elements	
  depicted	
  in	
  yellow	
  are	
  the	
  carpals,	
  metacarpals	
  and	
  phalanges,	
  which	
  are	
  the	
  skeletal	
  elements	
  of	
  the	
  autopod	
  domain.	
  Clavicle	
  and	
  scapula	
  do	
  not	
  originate	
  from	
  the	
  limb	
  bud.	
  (adapted	
  from	
  Zeller	
  et	
  al.,	
  2009).	
  
	
  
	
  
Limb	
  bud	
  outcrop	
  from	
  the	
  embryo	
  flank	
  and	
  specification	
  of	
  the	
  axes	
  Limb	
  budding	
  from	
  the	
  flank	
  mesenchyme	
  occurs	
  at	
  precise	
  levels	
  and	
  is	
  controlled	
  by	
  the	
  Hox	
  gene	
  expression	
  code	
  along	
  the	
  primary	
  body	
  axis	
  (Burke	
  et	
  al.,	
  1995;	
  Molven	
  et	
  al.,	
  1990).	
   In	
  the	
  mouse,	
   forelimbs	
  are	
  formed	
  at	
  around	
  8.75	
  days	
  post	
  coitum	
  (E8.75),	
  whereas	
  hindlimb	
  development	
  is	
  delayed	
  by	
  about	
  16	
  hours	
  (see	
  e.g.	
  Saito	
  et	
  al.,	
  2002).	
  The	
  early	
  limb	
  bud	
  is	
  characterized	
  by	
  a	
  positive	
  epithelial/mesenchymal	
  (e-­‐m)	
  feedback	
  loop	
  that	
  is	
  fundamental	
  to	
  initiate	
  limb	
  outgrowth	
  and	
  for	
  the	
  establishment	
  of	
  the	
  AER.	
  
Fgf10,	
  which	
   is	
   strongly	
   expressed	
   in	
   the	
   limb	
  mesenchyme,	
   triggers	
   the	
   expression	
   of	
  
Wnt3	
   in	
   the	
   ectoderm,	
   which	
   in	
   turn	
   up-­‐regulates	
   Fgf8	
   in	
   the	
   ventral	
   ectoderm	
   in	
   a	
  domain	
  destined	
  to	
  form	
  the	
  AER	
  (Kawakami	
  et	
  al.,	
  2001).	
  Inactivation	
  of	
  Fgf10	
  results	
  in	
  limb	
   agenesis	
   (Min	
   et	
   al.,	
   1998).	
   Conversely,	
   ectopic	
   expression	
   of	
   FGF	
   ligands	
   in	
   the	
  embryonic	
   flank	
   mesenchyme	
   results	
   in	
   localized	
   budding	
   and	
   formation	
   of	
   limb	
  structures	
   (Cohn	
   et	
   al.,	
   1995;	
   Crossley	
   et	
   al.,	
   1996;	
   Ohuchi	
   et	
   al.,	
   1997;	
   Ohuchi	
   et	
   al.,	
  1995).	
  Conditional	
  inactivation	
  of	
  Wnt3	
  before	
  the	
  AER	
  is	
  established	
  results	
  in	
  a	
  variety	
  of	
  phenotypes,	
  ranging	
  from	
  completely	
  normal	
  limb	
  skeletal	
  structures	
  to	
  limb	
  agenesis.	
  In	
  agreement,	
   the	
  expression	
  and	
  maintenance	
  of	
  Fgf8	
   are	
  affected	
   to	
  a	
  variable	
  extent	
  (Barrow	
  et	
  al.,	
  2003).	
  In	
  contrast,	
  inactivation	
  of	
  Fgf8	
  in	
  the	
  ectoderm	
  results	
  in	
  the	
  loss	
  of	
   proximal	
   limb	
   skeletal	
   elements	
   (Lewandoski	
   et	
   al.,	
   2000).	
   This	
   relatively	
   mild	
  phenotype,	
  which	
  is	
  an	
  effect	
  of	
  a	
  patterning	
  defect,	
  is	
  likely	
  due	
  to	
  the	
  compensation	
  of	
  the	
  Fgf8	
  deficiency	
   by	
   other	
   FGF	
   ligands	
   (FGF4,	
   FGF9,	
   FGF17),	
  which	
   are	
   expressed	
   at	
  later	
  stages	
  by	
  the	
  AER	
  (Moon	
  and	
  Capecchi,	
  2000).	
  	
  
	
  
Specification	
  of	
  the	
  D-­‐V	
  axis	
  and	
  formation	
  of	
  the	
  AER	
  The	
  D-­‐V	
  axis	
  is	
  specified	
  during	
  initiation	
  of	
  limb	
  outgrowth	
  by	
  factors	
  expressed	
  by	
  the	
  ectoderm.	
   En1,	
   expressed	
   by	
   the	
   ventral	
   ectoderm,	
   restricts	
  Wnt7a	
   expression	
   to	
   the	
  dorsal	
  ectoderm.	
  Wnt7a	
  in	
  turn	
  up-­‐regulates	
  and	
  co-­‐localizes	
  with	
  the	
  LIM-­‐homeodomain	
  transcription	
  factor	
  Lmx1b	
  (see	
  e.g.	
  Loomis	
  et	
  al.,	
  1998).	
  Inactivation	
  of	
  WNT7a	
  or	
  LMX1b	
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produces	
   bi-­‐ventral	
   limbs.	
   Conversely,	
   inactivation	
   of	
   EN1	
   results	
   in	
   bi-­‐dorsal	
   limbs	
  (Cygan	
  et	
  al.,	
  1997;	
  Dreyer	
  et	
  al.,	
  1998;	
  Parr	
  and	
  McMahon,	
  1995).	
  During	
   embryonic	
   day	
   9	
   (E9)	
   in	
   mouse	
   embryos,	
   the	
   ectodermal	
   cells	
   at	
   the	
   distal-­‐dorso-­‐ventral	
   interface	
   form	
  a	
  partially	
   stratified	
   epithelium	
   in	
  mouse	
   limb	
  buds	
  and	
  a	
  pseudostratified	
  epithelium	
  in	
  the	
  chick,	
  the	
  AER	
  (reviewed	
  by	
  Fernandez-­‐Teran	
  and	
  Ros,	
  2008).	
   Ectopic	
   AERs	
   can	
   be	
   induced	
   by	
   juxtaposition	
   of	
   embryonic	
   tissues	
  with	
   dorsal	
  and	
   ventral	
   identities,	
   stressing	
   the	
   importance	
   of	
   early	
   D-­‐V	
   axis	
   specification	
   for	
   AER	
  positioning	
   and	
   formation	
   (Tanaka	
   et	
   al.,	
   1997).	
   Expression	
   of	
   Fgf8	
   hallmarks	
   AER	
  induction,	
   such	
   that	
   Fgf8	
   expression	
   reveals	
   AER	
   morphology	
   and	
   intensity	
   of	
   FGF	
  signalling	
  (see	
  e.g.,	
  Benazet	
  and	
  Zeller,	
  2013;	
  Lewandoski	
  et	
  al.,	
  2000).	
  	
  	
  
Specification	
  of	
  the	
  P-­‐D	
  axis	
  The	
   P-­‐D	
   axis	
   is	
   specified	
   during	
   the	
   earliest	
   phases	
   of	
   limb	
   outgrowth	
   and	
   its	
  polarization	
   is	
   traceable	
   with	
   specific	
   molecular	
   markers.	
   Meis1	
   and	
   Meis2	
  mark	
   the	
  proximal	
   limb	
  bud	
  mesenchyme	
  correspondent	
   to	
   the	
  prospective	
   stylopod	
   (the	
   region	
  defined	
   by	
   the	
   humerus	
   in	
   the	
   forelimb),	
   Hoxa11	
   is	
   expressed	
   by	
   the	
   prospective	
  zeugopod	
  (radius	
  and	
  ulna)	
  and	
  Hoxa13	
  marks	
  the	
  distal	
   limb	
  domain	
  corresponding	
  to	
  the	
  autopod	
  which	
  gives	
  rise	
   to	
  carpals,	
  metacarpals	
  and	
  phalanges	
  (Fig.	
  1b,	
   for	
  review	
  see	
  Zeller	
  et	
  al.,	
  2009).	
  A	
  gradient	
  of	
  retinoic	
  acid	
  (RA)	
  seems	
  to	
  originate	
  from	
  the	
  lateral	
  plate	
  mesoderm	
  and	
  RA	
  production	
   is	
   controlled	
  by	
   the	
  enzyme	
  Retinaldehyde	
  Dehydrogenase	
  2	
   (RALDH2).	
  This	
  RA	
   gradient	
   seems	
   responsible	
   for	
   specification	
   of	
   proximal	
   limb	
   identity,	
   but	
   the	
  involvement	
   of	
   RA	
   is	
   still	
   debated	
   due	
   to	
   conflicting	
   evidence	
   (Zhao	
   et	
   al.,	
   2009).	
  Mercader	
   and	
   colleagues	
   performed	
   gain-­‐of-­‐function	
   studies	
   to	
   demonstrate	
   that	
   RA	
  induces	
   Meis1	
   and	
   Meis2	
   in	
   the	
   proximal	
   limb	
   while	
   FGF8	
   from	
   the	
   AER	
   inhibits	
  expression	
   of	
   these	
   markers	
   in	
   the	
   distal	
   mesenchyme	
   (Mercader	
   et	
   al.,	
   2000).	
   In	
  addition,	
  ectopic	
  expression	
  of	
  retinoic	
  acid	
  and	
  MEIS1	
  in	
  the	
  distal	
   limb	
  induces	
  distal-­‐to-­‐proximal	
   transformations	
   (Mercader	
   et	
   al.,	
   2000;	
   Rosello-­‐Diez	
   and	
   Torres,	
   2011).	
  More	
   recent	
   evidence	
   from	
   loss-­‐of-­‐function	
   studies	
   show	
   that	
   expression	
   of	
  Meis1	
  and	
  
Meis2	
  is	
  independent	
  of	
  RALDH2	
  (Cunningham	
  et	
  al.,	
  2013).	
  In	
  addition,	
  limb	
  inactivation	
  of	
  Meis1	
  alone	
  results	
   in	
  no	
  P-­‐D	
  axis	
  defects	
  (Hisa	
  et	
  al.,	
  2004).	
  Aldh1a2,	
  which	
  encodes	
  RALDH2,	
   is	
   necessary	
   to	
   initiate	
   limb	
   bud	
   outgrowth	
   but	
   dispensable	
   for	
   P-­‐D	
   axis	
  patterning	
  (Cunningham	
  et	
  al.,	
  2013;	
  Niederreither	
  et	
  al.,	
  1999;	
  Niederreither	
  et	
  al.,	
  2002;	
  Zhao	
  et	
  al.,	
  2009).	
  On	
  the	
  other	
  hand,	
  it	
  is	
  clear	
  that	
  FGF-­‐mediated	
  inhibition	
  of	
  proximal	
  limb	
  markers	
  is	
  exerted	
  by	
  the	
  FGF-­‐dependent	
  RA	
  degrading	
  enzyme	
  CYP26b1	
  and	
  that	
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Cyp26b1	
  inactivation	
  impairs	
  distal	
  progression	
  of	
  limb	
  development	
  (Probst	
  et	
  al.,	
  2011;	
  Yashiro	
  et	
  al.,	
  2004;	
  Zhou	
  and	
  Kochhar,	
  2004).	
  Experimental	
  manipulation	
  of	
  the	
  AER	
  in	
  chicken	
  limb	
  buds	
  together	
  with	
  conditional	
  genetic	
   inactivation	
   of	
   single	
   or	
   more	
   FGF	
   ligands	
   in	
   the	
   AER	
   of	
   mouse	
   hindlimbs	
  revealed	
   the	
   instructive	
   role	
   of	
   these	
   ectodermal	
   signalling	
   centers.	
   In	
   1948,	
   Saunders	
  experimentally	
  removed	
  the	
  AER	
  from	
  chicken	
  wing	
  buds	
  at	
  several	
  progressively	
   later	
  stages	
  of	
  development,	
  which	
  resulted	
  in	
  loss	
  of	
  progressively	
  more	
  distal	
  wing	
  skeletal	
  structures	
   (Rowe	
  and	
  Fallon,	
  1982;	
  Saunders,	
  1948).	
  These	
   results	
  were	
   interpreted	
  as	
  the	
  AER	
  influencing	
  the	
  underlying	
  mesenchyme	
  in	
  a	
  time-­‐dependent	
  manner,	
  giving	
  rise	
  to	
   the	
   ‘progress	
   zone’.	
   Indeed,	
   older	
   progress	
   zones,	
   but	
   not	
   older	
   AERs,	
   were	
   able	
   to	
  induce	
   more	
   distal	
   structures	
   when	
   grafted	
   to	
   younger	
   wing	
   buds	
   (Summerbell	
   and	
  Lewis,	
  1975).	
  FGF	
   ligands	
  were	
   found	
  to	
  mediate	
   the	
   instructive	
  role	
  of	
   the	
  AER	
  on	
  the	
  underlying	
  mesenchyme.	
   In	
  particular	
  AER-­‐FGFs	
   can	
   rescue	
   the	
  massive	
   cell	
   death	
  and	
  growth	
  arrest	
  following	
  experimental	
  removal	
  of	
  the	
  AER	
  (Fallon	
  et	
  al.,	
  1994;	
  Niswander	
  et	
  al.,	
  1993).	
  In	
  particular,	
  FGF8	
  expression	
  is	
  sufficient	
  to	
  sustain	
  the	
  formation	
  of	
  wild-­‐type	
   limb	
   structures	
   in	
   the	
   absence	
   of	
   other	
   AER-­‐FGFs	
   (Mariani	
   et	
   al.,	
   2008).	
   FGF8	
   is	
  necessary	
   only	
   during	
  AER	
   compaction	
   and	
   temporally	
   correct	
   activation	
   of	
   Shh	
   in	
   the	
  mesenchyme	
   (Lewandoski	
   et	
   al.,	
   2000).	
   FGFs	
   inactivation	
   at	
   these	
   early	
   stages	
   delays	
  activation	
   of	
   Shh	
  and	
   results	
   in	
   loss	
   of	
   the	
   femur	
   together	
  with	
  mild	
   digit	
   phenotypes.	
  FGF8	
   also	
   restrains	
   FGF4	
   expression	
   in	
   time	
   and	
   space	
   together	
   with	
   BMP	
   signaling	
  (Lewandoski	
  et	
  al.,	
  2000;	
  Selever	
  et	
  al.,	
  2004).	
  Among	
  the	
  AER-­‐FGFs,	
  FGF8	
  and	
  FGF4	
  are	
  essential	
   for	
   limb	
  bud	
   formation	
  as	
   their	
   combined	
   inactivation	
   in	
   the	
  AER	
  causes	
   limb	
  agenesis	
  as	
  a	
  consequence	
  of	
  massive	
  cell	
  death	
  (Moon	
  and	
  Capecchi,	
  2000).	
  The	
  analysis	
  of	
  AER-­‐FGFs	
  during	
  mouse	
   limb	
  bud	
  development	
   indicates	
   that	
   the	
  cell	
  survival	
   activity	
   is	
   sufficient	
   to	
   promote	
   maintenance	
   and	
   expansion	
   of	
   mesenchymal	
  progenitors	
  that	
  give	
  rise	
  to	
  the	
  P-­‐D	
  axis	
  (Mariani	
  et	
  al.,	
  2008).	
  In	
  fact,	
  lineage	
  tracing	
  of	
  wing	
   bud	
   cells	
   and	
   transplantation	
   experiments	
   revealed	
   that	
   the	
   progenitors	
   that	
  contribute	
   to	
   different	
   wing	
   compartments	
   are	
   specified	
   early	
   during	
   limb	
   bud	
  development,	
  and	
  that	
   the	
  mesenchymal	
  cells	
  under	
   the	
   influence	
  of	
  FGF	
  signals	
  by	
   the	
  AER	
  are	
  regionalized	
  in	
  a	
  manner	
  that	
  mirrors	
  the	
  prospective	
  contribution	
  to	
  P-­‐D	
  limb	
  structures	
  (Dudley	
  et	
  al.,	
  2002;	
  Pearse	
  et	
  al.,	
  2007;	
  Sato	
  et	
  al.,	
  2007;	
  Suzuki	
  et	
  al.,	
  2008;	
  Tabin	
   and	
   Wolpert,	
   2007).	
   Moreover,	
   it	
   was	
   reported	
   that	
   Gli3	
   and	
   Plzf	
   transcription	
  factors	
   interact	
   to	
   specify	
   proximal	
   limb	
   structures	
   during	
   initiation	
   of	
   limb	
   bud	
  development	
   (Barna	
   et	
   al.,	
   2005),	
   pointing	
   to	
   the	
   existence	
   of	
   a	
   transcriptional	
  mechanism	
  that	
  specifies	
  discrete	
  P-­‐D	
  domains	
  during	
   limb	
  bud	
   initiation.	
  However,	
  an	
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instructive	
  role	
  of	
  AER-­‐FGFs	
  on	
  P-­‐D	
  axis	
  development	
  is	
  still	
  debated	
  (Fernandez-­‐Teran	
  and	
  Ros,	
  2008).	
  	
  
	
  
Specification	
  of	
  the	
  A-­‐P	
  axis	
  	
  The	
  A-­‐P	
  axis	
  is	
  specified	
  by	
  the	
  mutual	
  antagonistic	
  interaction	
  of	
  Gli3	
  and	
  Hand2	
  gene	
  products	
  in	
  the	
  early	
  limb	
  bud	
  mesenchyme	
  (Galli	
  et	
  al.,	
  2010;	
  Ros	
  et	
  al.,	
  1996;	
  Tarchini	
  et	
  al.,	
  2006;	
  te	
  Welscher	
  et	
  al.,	
  2002;	
  Zuniga	
  and	
  Zeller,	
  1999).	
  Hand2	
  is	
   initially	
  expressed	
  throughout	
   the	
   early	
   limb	
   bud	
   mesenchyme	
   but	
   is	
   then	
   restricted	
   to	
   the	
   posterior	
  mesenchyme	
  by	
  Gli3	
  transcriptional	
   repressor	
   (Gli3R),	
  which	
   is	
   constitutively	
  produced	
  prior	
  to	
  activation	
  of	
  SHH	
  signaling	
  (Charite	
  et	
  al.,	
  2000;	
  te	
  Welscher	
  et	
  al.,	
  2002).	
  HAND2	
  and	
  GLI3R,	
  together	
  with	
  several	
  HOX	
  transcriptional	
  regulators	
  impact	
  on	
  the	
  limb	
  bud	
  
cis-­‐regulatory	
   module	
   that	
   restricts	
   activation	
   of	
   Shh	
   expression	
   to	
   the	
   posterior-­‐proximal	
  mesenchyme	
  (Lettice	
  et	
  al.,	
  2003;	
  Sagai	
  et	
  al.,	
  2005).	
  	
  
	
  
	
  Limb	
  bud	
  patterning	
  	
  At	
  about	
  E9.5,	
  the	
  BMP	
  antagonist	
  Grem1	
  is	
  activated	
  by	
  BMP	
  signaling	
  in	
  the	
  posterior	
  limb	
  mesenchyme	
  to	
  create	
  permissive	
  conditions	
  (low	
  BMP	
  activity,	
  see	
  Fig.	
  3B)	
  for	
  the	
  activation	
  of	
  FGF4,	
  FGF9	
  and	
  FGF17	
  in	
  the	
  AER,	
  which	
  in	
  turn	
  promote	
  the	
  expression	
  of	
  
Shh	
   in	
   the	
  underlying	
   limb	
  bud	
  mesenchyme	
  (Fig.	
  2;	
  Bastida	
  et	
  al.,	
  2009;	
  Khokha	
  et	
  al.,	
  2003;	
   Lewandoski	
   et	
   al.,	
   2000;	
   Mariani	
   et	
   al.,	
   2008;	
   Michos	
   et	
   al.,	
   2004;	
   Nissim	
   et	
   al.,	
  2006;	
   Sun	
   et	
   al.,	
   2002;	
   Zuniga	
   and	
   Zeller,	
   1999).	
  Grem1	
   encodes	
   an	
   extracellular	
   BMP	
  antagonist	
  and	
  its	
  inactivation	
  results	
  in	
  fusion	
  of	
  the	
  zeugopod	
  elements	
  and	
  reduction	
  in	
  digit	
  numbers,	
  as	
  a	
  consequence	
  of	
  impaired	
  AER	
  compaction,	
  down-­‐regulation	
  of	
  Fgf8	
  and	
  Shh	
  expression	
  and	
  massive	
  mesenchymal	
  cell	
  death	
  (Michos	
  et	
  al.,	
  2004).	
  Similarly,	
  inactivation	
   of	
   Shh	
   results	
   in	
   skeletal	
   reductions	
   that	
   result	
   in	
   the	
   loss	
   of	
   posterior	
  zeugopodal	
  elements	
  and	
  digits	
  (Chiang	
  et	
  al.,	
  2001).	
  Shh	
  activation	
  by	
  the	
  ZPA	
  requires	
  several	
   signals	
   in	
  addition	
   to	
  Hand2	
  (see	
  above),	
   such	
  as	
  Hox	
  genes	
   (Kmita	
  et	
  al.,	
  2005;	
  Knezevic	
   et	
   al.,	
   1997;	
   Tarchini	
   et	
   al.,	
   2006),	
  Bmp4	
   (Benazet	
   et	
   al.,	
   2009;	
  Michos	
   et	
   al.,	
  2004;	
  Nissim	
  et	
  al.,	
  2006),	
  Fgf8	
  (Lewandoski	
  et	
  al.,	
  2000),	
  Tbx2	
  (Nissim	
  et	
  al.,	
  2007).	
  SHH	
  behaves	
  as	
  a	
  morphogen,	
  creating	
  a	
  concentration	
  gradient	
  along	
   the	
  A-­‐P	
  axis	
   (Li	
  et	
  al.,	
  2006;	
  Zeng	
  et	
  al.,	
  2001).	
  Post-­‐translational	
  modifications	
  result	
  in	
  addition	
  of	
  cholesterol	
  and	
  palmitoyl	
  acid	
  moieties	
  to	
  SHH,	
  which	
  modulate	
  its	
  long-­‐range	
  signaling	
  properties,	
  thus	
  ensuring	
  the	
  proper	
  instruction	
  of	
  A-­‐P	
  axis	
  and	
  digit	
  patterning	
  (Chen	
  et	
  al.,	
  2004;	
  Li	
  et	
  al.,	
  2006).	
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The	
  positive	
  SHH/GREM1/AER-­‐FGF	
  feedback	
  loop	
  established	
  by	
  Grem1	
  up-­‐regulation	
  coordinates	
  limb	
  bud	
  outgrowth	
  and	
  patterning.	
  During	
  limb	
  bud	
  outgrowth	
  the	
  initially	
  posterior	
   AER-­‐Fgfs	
   and	
   Grem1	
   expression	
   domains	
   expand	
   progressively	
   anterior	
  (Michos	
   et	
   al.,	
   2004;	
  Panman	
  et	
   al.,	
   2006).	
  The	
  SHH/GREM1/AER-­‐FGF	
   feedback	
   loop	
   is	
  terminated	
  by	
  high	
  levels	
  of	
  FGF	
  signaling,	
  which	
  inhibits	
  Grem1	
  expression,	
  and	
  by	
  the	
  increasing	
   displacement	
   of	
   the	
  Grem1	
  expression	
   domain	
  with	
   respect	
   to	
   the	
   posterior	
  mesenchyme	
  as	
  a	
  consequence	
  of	
  Shh	
  descendants	
  being	
  refractory	
  to	
  Grem1	
  expression	
  (Fig.	
   3C;	
   Scherz	
   et	
   al.,	
   2007;	
   Verheyden	
   and	
   Sun,	
   2008).	
   Furthermore,	
   Tbx2	
   is	
   also	
  involved	
   in	
   active	
   termination	
  of	
  Grem1	
  expression	
   in	
   the	
  distal	
   limb	
  bud	
  mesenchyme	
  (Farin	
  et	
  al.,	
  2013).	
  Ectopic	
  expression	
  of	
  SHH	
  in	
  the	
  anterior	
  chick	
  wing	
  bud	
  mesenchyme	
  induces	
  mirror-­‐image	
  duplication	
  of	
  digits	
  (Riddle	
  et	
  al.,	
  1993).	
  In	
  the	
  wild-­‐type	
  autopod	
  primordia,	
  the	
  two	
  posterior-­‐most	
   digits	
   and	
  part	
   of	
   the	
   third	
   digit	
   are	
   derived	
   from	
  progenitors	
   that	
  belonged	
  to	
  the	
  ZPA	
  (Shh-­‐descendants),	
  while	
  anterior	
  digit	
  2	
  is	
  likely	
  specified	
  by	
  long-­‐range	
  SHH	
  signaling	
  (Harfe	
  et	
  al.,	
  2004;	
  Sagai	
  et	
  al.,	
  2005).	
  In	
  contrast,	
  the	
  anterior-­‐most	
  digit	
   1	
   (thumb)	
   is	
   specified	
   independent	
   of	
   SHH	
   (for	
   review,	
   see	
   Oberg,	
   2013).	
   The	
  instructive	
   role	
   of	
   SHH	
   provides	
   a	
   temporal	
   distinct	
   order	
   for	
   digit	
   specification	
   and	
  determination,	
  whereby	
  the	
  4th	
  digit	
   is	
  specified	
  and	
  forms	
  first,	
  while	
   the	
  thumb	
  is	
   the	
  last	
   one	
   to	
   appear	
   (Zhu	
   et	
   al.,	
   2008).	
   The	
   patterning	
   activity	
   of	
   SHH	
   signalling	
   is	
  genetically	
   linked	
   to	
   Hox	
   genes	
   (Galli	
   et	
   al.,	
   2010;	
   Tarchini	
   et	
   al.,	
   2006).	
   During	
   limb	
  development,	
  Hox	
  genes	
   are	
   activated	
   in	
   a	
   collinear	
   fashion,	
   such	
   that	
  5’Hox	
  genes	
   are	
  activated	
   later	
   than	
  3’Hox	
  genes	
  and	
   in	
   a	
  more	
   restricted	
   fashion,	
   overlapping	
  with	
   the	
  ZPA	
  in	
  the	
  posterior	
  part	
  of	
  the	
  limb	
  bud.	
  As	
  discussed	
  above,	
  5’HoxD	
  genes	
  participate	
  in	
  activating	
  Shh	
  and	
  restricting	
  its	
  expression.	
  In	
  turn,	
  Shh	
  promotes	
  the	
  anterior	
  reverse-­‐collinear	
  expansion	
  of	
  the	
  Hoxd10-­‐13	
  expression	
  domains	
  through	
  a	
  global	
  control	
  region	
  with	
   enhancer	
   activity	
   (Andrey	
  et	
   al.,	
   2013;	
   Spitz	
   et	
   al.,	
   2003;	
   Spitz	
   et	
   al.,	
   2005).	
  While	
  almost	
  all	
  HoxA	
  and	
  HoxD	
  paralogous	
  group	
  genes	
  are	
  expressed	
  in	
  developing	
  limb	
  buds,	
  only	
  the	
  posterior	
  ones	
  (located	
  at	
  the	
  5’	
  end	
  of	
  the	
  Hox	
  cluster	
  –	
  named	
  5’Hox	
  genes	
  -­‐)	
  are	
  required	
  for	
  specification	
  of	
  specific	
  limb	
  skeletal	
  structures.	
  For	
  instance,	
  compound	
  inactivation	
  of	
  Hoxa13	
   and	
  Hoxd13	
   results	
   in	
   loss	
  of	
   the	
  autopod	
   (Wellik	
  and	
  Capecchi,	
  2003).	
  In	
  contrast,	
  deletion	
  of	
  either	
  the	
  HoxA	
  or	
  HoxD	
  gene	
  clusters	
  alone	
  results	
  in	
  only	
  mild	
  autopod	
  malformations,	
  whereas	
  deletion	
  of	
  both	
  clusters	
  causes	
  forelimb	
  agenesis	
  with	
  exception	
  of	
   the	
  scapula	
  and	
   the	
  proximal-­‐most	
  part	
  of	
   the	
  humerus	
   (Kmita	
  et	
  al.,	
  2005).	
  Since	
  Hox	
  genes	
  function	
  in	
  the	
  context	
  of	
  the	
  cluster	
  the	
  instructive	
  roles	
  of	
  single	
  
Hox	
  genes	
  with	
  respect	
  to	
  the	
  formation	
  of	
  specific	
  skeletal	
  elements	
  is	
  debated	
  (Kmita	
  et	
  al.,	
   2002).	
   However,	
   misexpression	
   studies	
   and	
   genetic	
   manipulation	
   revealed	
   that	
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distalized	
   Hoxd11	
   expression	
   induces	
   polydactyly	
   and	
   increases	
   digit	
   length	
   in	
   the	
  absence	
  of	
  more	
  posterior	
  genes	
   (Goff	
  and	
  Tabin,	
  1997;	
  Kmita	
  et	
  al.,	
  2002;	
  Sheth	
  et	
  al.,	
  2012).	
  	
  
	
  
The	
  BMP	
  signaling	
  pathway	
  (see	
  Fig.	
  2)	
  BMP	
   ligands	
   were	
   first	
   identified	
   by	
   their	
   ability	
   to	
   induce	
   ectopic	
   bone	
   upon	
  subcutaneous	
   administration	
   in	
   vivo	
   (Urist,	
   1965).	
   Since,	
   a	
   wealth	
   of	
   studies	
   have	
  established	
   that	
   BMP	
   ligands	
   belong	
   to	
   the	
   TGFβ	
   superfamily	
   and	
   fulfill	
   a	
  multitude	
   of	
  functions	
   during	
   embryonic	
   and	
   postnatal	
   development,	
   homeostasis	
   and	
   disease	
   (see	
  e.g.	
  Miyazono	
  et	
  al.,	
  2010).	
  In	
  mammals,	
  twelve	
  BMP	
  ligands	
  have	
  been	
  identified,	
  which	
  can	
   form	
   homo-­‐	
   and	
   heterodimers	
   with	
   different	
   affinities	
   for	
   their	
   cognate	
   receptors	
  (reviewed	
   in	
   Butler	
   and	
   Dodd,	
   2003).	
   Upon	
   secretion	
   and	
   activation	
   by	
   cleavage,	
   the	
  extra-­‐cellular	
  BMP	
  ligands	
  can	
  be	
  sequestered	
  by	
  BMP	
  antagonists	
  to	
  prevent	
  binding	
  the	
  receptors	
   and	
   activation	
   of	
   signal	
   transduction.	
   In	
   higher	
   vertebrates,	
   twelve	
   BMP	
  antagonists	
   have	
   been	
   identified,	
   small	
   cysteine-­‐knot	
   proteins	
   with	
   striking	
   structural	
  similarities	
  to	
  BMP	
  ligands	
  (reviewed	
  by	
  Walsh	
  et	
  al.,	
  2010).	
  BMP	
  antagonists	
  modulate	
  BMP	
   activity	
   in	
   a	
   spatio-­‐temporally	
   controlled	
   manner	
   and	
   genetic	
   inactivation	
   or	
  alteration	
   of	
   their	
   expression	
   results	
   in	
   congenital	
  malformations	
   and	
   various	
   diseases	
  such	
  as	
  nephropathies,	
  fibrosis,	
  osteoarthritis	
  and	
  cancer	
  (Walsh	
  et	
  al.,	
  2010).	
  BMPs	
   activate	
   signal	
   transduction	
   by	
   interacting	
  with	
   their	
   cognate	
   serine/threonine	
  kinase	
  receptors.	
  BMP	
  ligand	
  dimers	
  interact	
  with	
  two	
  distinct	
  types	
  of	
  trans-­‐membrane	
  receptors,	
   which	
   form	
   hetero-­‐tetrameric	
   complexes	
   that	
   activate	
   intracellular	
   signal	
  transduction	
   (Marom	
   et	
   al.,	
   2011).	
   Type	
   I	
   BMP	
   receptors	
   include	
   three	
   of	
   the	
   seven	
  known	
   activin-­‐like	
   receptors	
   (ALK)	
   that	
   belong	
   to	
   the	
   TGFβ	
   superfamily:	
   BMPRIA	
   (or	
  ALK3);	
   BMPRIB	
   (or	
   ALK6)	
   and	
   ALK-­‐2.	
   Type	
   II	
   BMP	
   receptors	
   include	
   BMPRII,	
   activin	
  receptor	
   II	
   (ActRII)	
   and	
   ActRIIB	
   (Murakami	
   et	
   al.,	
   2009).	
   Upon	
   ligand	
   binding	
   and	
  receptor	
  complex	
  formation,	
  type	
  II	
  BMP	
  receptors	
  phosphorylate	
  type	
  I	
  BMP	
  receptors,	
  which	
   activate	
   their	
   cytoplasmic	
   kinase	
   activity	
   and	
   trigger	
   signal	
   transduction	
   by	
  phosphorylation	
   of	
   the	
   receptor	
   associated	
   SMAD	
   proteins	
   (R-­‐SMADs).	
   BMP	
   signal	
  transduction	
   is	
   mediated	
   by	
   association	
   of	
   phosphorylated	
   R-­‐SMADs	
   (SMAD1,	
   SMAD5	
  and	
   SMAD8)	
   with	
   the	
   common	
   SMAD	
   (co-­‐SMAD:	
   SMAD4);	
   the	
   resulting	
   complex	
  translocates	
  to	
  the	
  nucleus	
  and	
  activates	
  the	
  transcription	
  of	
  BMP	
  target	
  genes	
  (reviewed	
  in	
   Massague	
   et	
   al.,	
   2005).	
   SMAD6	
   and	
   SMAD7	
   are	
   inhibitory	
   SMAD	
   (i-­‐SMAD),	
   which	
  interfere	
  with	
  BMP	
  signaling	
  at	
  different	
  levels	
  of	
  the	
  pathway	
  (Afrakhte	
  et	
  al.,	
  1998).	
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Fig.	
   2	
   The	
   canonical	
   BMP	
   signalling	
   pathway.	
   The	
   schematic	
   illustrates	
   the	
   canonical	
  BMP	
  signalling	
  pathway	
  as	
  relevant	
  for	
  limb	
  bud	
  development,	
  from	
  establishment	
  of	
  the	
  AER	
  to	
  long	
  bone	
   formation.	
   BMP	
   homo	
   or	
   heterodimers	
   act	
   as	
   morphogenetic	
   ligands.	
   Extracellular	
  antagonists	
  modulate	
  BMP	
  activity	
  by	
  sequestering	
  BMP	
  ligands	
  and	
  blocking	
  their	
  binding	
  to	
  the	
  receptors.	
   The	
   most	
   relevant	
   BMP	
   antagonists	
   to	
   limb	
   bud	
   development	
   field	
   are	
   GREM1	
   and	
  NOGGIN,	
  with	
  essential	
  functions	
  in	
  limb	
  bud	
  outgrowth	
  and	
  patterning.	
  BMP	
  receptors	
  are	
  single-­‐transmembrane	
  glycoproteins	
  endowed	
  with	
  a	
  prevalent	
  serine-­‐threonine	
  kinase	
  activity.	
  Type	
  II	
  BMP	
  receptors	
  (BMPR2,	
  ACTR2A,	
  ACTR2B)	
  bind	
  the	
  ligands,	
  recruit	
  and	
  trans-­‐phosphorylate	
  type	
  I	
  BMP	
  receptors	
  (BMPR1A,	
  BMPR1B,	
  ALK2)	
  which	
  in	
  turn	
  activate	
  receptor	
  SMADs	
  (R-­‐SMADs)	
  in	
  the	
  cytoplasm.	
  R-­‐SMADs	
  (SMAD1,	
  -­‐5	
  and	
  -­‐8)	
  promote	
  BMP	
  signalling.	
  Inhibitory	
  SMADs	
  (i-­‐SMADs)	
  SMAD6	
   and	
   -­‐7	
   inhibit	
   BMP	
   signalling	
   at	
   different	
   levels	
   of	
   signal	
   transduction.	
   Canonical	
   BMP	
  signalling	
  transduction	
   involves	
  heteromerization	
  of	
  R-­‐SMADs	
  with	
  the	
  common,	
  non-­‐redundant	
  SMAD	
   transducer	
   SMAD4	
   (co-­‐SMAD).	
  The	
   resulting	
  heterotrimeric	
   complexes	
   translocate	
   to	
   the	
  nucleus.	
  Together	
  with	
  additional	
  co-­‐factors,	
  these	
  transcriptional	
  complexes	
  activate	
  expression	
  of	
  target	
  genes	
  (Id1	
  and	
  Msx2	
  are	
  among	
  the	
  direct	
  targets	
  of	
  the	
  BMP	
  signalling	
  pathway).	
  Genetic	
  experiments	
   provided	
   evidence	
   for	
   SMAD4-­‐independent	
   R-­‐SMAD	
   signal	
   transduction	
   during	
  endochondral	
  bone	
  formation	
  (broken	
  arrow	
  in	
  the	
  graphic).	
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The	
  intracellular	
  BMP	
  signalling	
  transducer	
  SMAD4	
  SMAD4	
   is	
   the	
  non-­‐redundant	
  mediator	
  of	
   the	
   transcriptional	
   response	
   to	
  both	
   the	
  BMP	
  and	
   TGFβ	
   signaling	
   pathways	
   (Massague	
   et	
   al.,	
   2005).	
   Genetic	
   inactivation	
   of	
   SMAD4	
  results	
   in	
   embryonic	
   lethality	
   during	
   gastrulation	
  due	
   to	
   reduced	
   epiblast	
   proliferation	
  and	
  impaired	
  mesoderm	
  formation	
  (Yang	
  et	
  al.,	
  1998a).	
  SMAD4	
  is	
  highly	
  homologous	
  to	
  the	
  mammalian	
  R-­‐SMAD	
  proteins	
  and	
  the	
  protein	
  MEDEA	
  in	
  D.	
  melanogaster	
  (Wisotzkey	
  et	
  al.,	
  1998).	
  Smad4	
  encodes	
  two	
  alternatively	
  spliced	
  protein-­‐coding	
  transcripts,	
  with	
  11	
  or	
   12	
   exons.	
   Murine	
   SMAD4	
   is	
   a	
   protein	
   with	
   551	
   amino	
   acids,	
   characterized	
   by	
   a	
   N-­‐terminal	
  MAD	
  homology	
  domain	
  1	
  (MH1)	
  and	
  a	
  C-­‐terminal	
  MH2	
  domain;	
  both	
  domains	
  are	
  evolutionary	
  highly	
  conserved	
  and	
  separated	
  by	
  a	
  central	
  linker	
  sequence.	
  The	
  MH1	
  domain	
   is	
  globular,	
  binds	
   to	
  DNA	
  and	
  several	
  SMAD	
  binding	
  elements	
   (SBE)	
  have	
  been	
  identified	
   (see	
   e.g.	
  Morikawa	
   et	
   al.,	
   2011).	
   In	
   addition,	
  MH1	
   interacts	
  with	
   other	
   DNA-­‐binding	
  proteins,	
   is	
   responsible	
   for	
  nuclear	
   translocation	
   and	
   inhibits	
  MH2	
   function	
  by	
  physical	
  interaction	
  in	
  the	
  absence	
  of	
  protein	
  phosphorylation	
  (Jones	
  and	
  Kern,	
  2000;	
  Shi	
  et	
  al.,	
  1998).	
  The	
  MH2	
  domain	
  is	
  phosphorylated	
  by	
  receptors,	
  mediates	
  oligomerization	
  with	
   R-­‐SMAD	
   proteins	
   and	
   with	
   other	
   DNA-­‐binding	
   proteins,	
   and	
   is	
   required	
   for	
  transcriptional	
   activation	
   (Massague	
   et	
   al.,	
   2005).	
  SMAD4	
   activity	
   is	
   regulated	
   through	
  phosphorylation	
   and	
   mono-­‐ubiquitination	
   of	
   the	
   linker	
   domain	
   (Dupont	
   et	
   al.,	
   2009).	
  Poly-­‐ubiquitination	
   triggers	
   proteosomal	
   degradation	
   of	
   SMAD	
   proteins	
   (Zhang	
   et	
   al.,	
  2001).	
  
	
  
	
  
BMP	
  target	
  genes	
  Few	
   direct	
   transcriptional	
   targets	
   of	
   BMP	
   signal	
   transduction	
   during	
   embryonic	
  development	
   are	
   known.	
   The	
   currently	
   best-­‐characterized	
   and	
   widely	
   expressed	
   BMP	
  signalling	
  targets	
  are	
  the	
  i-­‐SMADs,	
  together	
  with	
  the	
  Id	
  and	
  Msx	
  transcriptional	
  regulators	
  (de	
  Jong	
  et	
  al.,	
  2004;	
  Hollnagel	
  et	
  al.,	
  1999;	
  Pizette	
  and	
  Niswander,	
  1999).	
  Id	
  genes	
  (Id1-­‐4)	
  are	
   dominant	
   negative	
   helix-­‐loop-­‐helix	
   (HLH)	
   proteins	
   that	
   lack	
   a	
   basic	
   DNA-­‐binding	
  domain,	
   and	
   are	
   able	
   to	
   oligomerize	
   with	
   and	
   sequester	
   tissue-­‐specific	
   basic	
   HLH	
  transcription	
   factors	
   (e.g.	
  MyoD,	
   see	
   Lingbeck	
   et	
   al.,	
   2008).	
   Single	
   knock-­‐out	
  models	
   of	
  
Id1,	
  Id2	
  and	
  Id3	
  are	
  viable	
  and	
  exhibit	
  minor	
  defects.	
  However,	
  compound	
  inactivation	
  of	
  
Id1	
   and	
   Id3	
   results	
   in	
   premature	
   differentiation	
   of	
   neuroblasts	
   and	
   ineffective	
  compaction	
  of	
  endothelial	
  cells	
  and	
  sprouting	
  of	
  vessels	
  (Lyden	
  et	
  al.,	
  1999).	
  BMP2	
  was	
  shown	
  to	
  trigger	
  the	
  expression	
  of	
  Id1	
  and	
  Id3	
  in	
  neuroepithelial	
  cells	
  (Nakashima	
  et	
  al.,	
  2001),	
  and	
  BMP	
  antagonists	
  promote	
  formation	
  of	
  neural	
  tissue	
  in	
  X.	
  laevis	
  (Lamb	
  et	
  al.,	
  1993).	
  These	
  findings	
  are	
  consistent	
  with	
  a	
  role	
  of	
  BMP2	
  as	
  gatekeeper	
  in	
  neurogenesis,	
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with	
   Id1	
   and	
   Id3	
   as	
   transcriptional	
   targets	
   and	
   downstream	
   effectors	
   of	
   BMP	
   signal	
  transduction	
  (Nakashima	
  et	
  al.,	
  2001).	
  Furthermore,	
  defects	
  in	
  endothelium	
  exhibited	
  by	
  
Id1;Id3	
   double	
   knock-­‐out	
  mouse	
   embryos	
   resemble	
   the	
   phenotype	
   associated	
  with	
   the	
  inactivation	
  of	
  either	
  Smad1	
  or	
  Smad5	
  (Chang	
  et	
  al.,	
  1999;	
  Lechleider	
  et	
  al.,	
  2001;	
  Lyden	
  et	
  al.,	
  1999;	
  Yang	
  et	
  al.,	
  1999),	
  suggesting	
  that	
  Id	
  genes	
  respond	
  to	
  canonical	
  BMP	
  signal	
  transduction.	
  	
  In	
  addition,	
  SMAD1/5	
  BMP-­‐responsive	
  cis-­‐regulatory	
  element	
  (BRE;	
  Korchynskyi	
  and	
  ten	
   Dijke,	
   2002)	
   was	
   identified	
   in	
   the	
   Id1	
   proximal	
   promoter.	
   This	
   element	
   or	
   the	
  expression	
  of	
  Id1	
  has	
  been	
  used	
  as	
  transcriptional	
  sensor	
  of	
  BMP	
  signal	
  transduction	
   in	
  
vivo	
   (Blank	
   et	
   al.,	
   2008;	
   Monteiro	
   et	
   al.,	
   2008).	
   Msx	
   genes	
   encode	
   basic	
   HLH	
  transcriptional	
  regulators	
  and	
  Msx2	
  is	
  regulated	
  specifically	
  by	
  BMP	
  signal	
  transduction.	
  A	
  BMP	
  cis-­‐regulatory	
  element	
   is	
   located	
   in	
   the	
  Msx2	
  proximal	
  promoter	
   (Brugger	
  et	
  al.,	
  2004)	
   and	
   its	
   expression	
   has	
   been	
   used	
   to	
   sense	
   BMP	
   activity	
   during	
   limb	
   bud	
  development	
  (see	
  e.g.	
  Benazet	
  et	
  al.,	
  2009).	
  In	
  contrast,	
  Msx1	
  expression	
  is	
  also	
  regulated	
  by	
   pathways	
   other	
   than	
   BMPs	
   during	
   embryonic	
   development	
   (Medio	
   et	
   al.,	
   2012;	
  Menezes	
  et	
  al.,	
  2012;	
  Pizette	
  and	
  Niswander,	
  1999).	
  	
  
	
  
The	
  BMP	
  signalling	
  pathway	
  during	
  limb	
  bud	
  development	
  Three	
  BMP	
  ligands,	
  BMP2,	
  BMP4	
  and	
  BMP7	
  are	
  expressed	
  in	
  spatio-­‐temporally	
  restricted	
  patterns	
   in	
   the	
  mesenchyme	
  and	
  ectoderm	
   from	
   limb	
  bud	
   initiation	
  onwards	
  and	
   fulfill	
  multiple	
   roles	
   during	
   limb	
   bud	
   initiation,	
   outgrowth	
   and	
   pattern	
   and	
   formation	
   of	
   the	
  cartilage	
  primordia	
  of	
   the	
   limb	
  skeletal	
  elements.	
  While	
  Bmp2	
  expression	
   is	
  posteriorly	
  restricted,	
  Bmp4	
  and	
  Bmp7	
  are	
  expressed	
  more	
  widespread	
  and	
   restricted	
   to	
   the	
  distal	
  mesenchyme	
  during	
  progression	
  of	
   limb	
  bud	
  development	
  (Fig.	
  3;	
  see	
  e.g.	
  Michos	
  et	
  al.,	
  2004).	
  The	
   activity	
  of	
  BMP	
   ligands	
   is	
  modulated	
  by	
   the	
   extra-­‐cellular	
  BMP	
  antagonists,	
  among	
  them	
  GREM1,	
  NOGGIN,	
  Follistatin-­‐like	
  1	
  (Fstl1),	
  whose	
  genetic	
  inactivation	
  results	
  in	
  limb	
  phenotypes.	
  In	
  particular,	
  Grem1	
  is	
  expressed	
  in	
  the	
  posterior	
  mesenchyme	
  that	
  responds	
  to	
  SHH	
  signaling,	
  but	
  its	
  initially	
  posterior-­‐restricted	
  expression	
  expands	
  distal-­‐anterior	
   during	
   progression	
   of	
   limb	
   bud	
   outgrowth	
   and	
   becomes	
   restricted	
   to	
   the	
  interdigital	
   domains	
   during	
   formation	
   of	
   the	
   digit	
   primordia	
   (Zuniga	
   et	
   al.,	
   2012).	
   The	
  expression	
   of	
   Noggin	
   is	
   only	
   activated	
   during	
   formation	
   of	
   the	
   digit	
   primordia,	
  concurrent	
   with	
   down-­‐regulation	
   of	
   Grem1	
   (Brunet	
   et	
   al.,	
   1998;	
   Danesh	
   et	
   al.,	
   2009;	
  Zuniga	
   et	
   al.,	
   2012).	
  Bmpr1a	
  and	
  Bmpr2	
  are	
   expressed	
   at	
   high	
   levels	
   by	
   the	
   limb	
   bud	
  mesenchyme	
   (Danesh	
   et	
   al.,	
   2009).	
   As	
   Bmpr1a	
   is	
   required	
   to	
   transduce	
   mesenchymal	
  BMP	
   activity	
   in	
   the	
   AER	
   (see	
   below),	
   it	
   must	
   be	
   expressed	
   in	
   the	
   ectoderm;	
   but	
   its	
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ectodermal	
   expression	
   has	
   not	
   been	
   described.	
  Bmpr1b	
   is	
   expressed	
   uniformly	
   in	
   both	
  limb	
  bud	
  compartments.	
  Smad4	
  is	
   co-­‐expressed	
  with	
  Smad1,	
  Smad5	
  and	
  Smad8	
  in	
  both	
  mesenchyme	
   and	
   ectoderm	
   from	
  early	
   limb	
  bud	
   stages	
   onward	
   (Wong	
   et	
   al.,	
   2012).	
   In	
  chicken	
  limb	
  buds,	
  Smad6	
  and	
  Smad7	
  are	
  co-­‐expressed	
  in	
  two	
  proximal	
  domains	
  during	
  early	
   stages,	
   while	
   expression	
   shifts	
   to	
   the	
   sub-­‐AER	
   mesenchyme	
   at	
   later	
   stages	
  (Vargesson	
  and	
  Laufer,	
  2009).	
  Finally,	
  the	
  direct	
  transcriptional	
  targets	
  of	
  BMP	
  signaling	
  
Id1,	
   Id3,	
   Msx1	
   and	
   Msx2	
   are	
   expressed	
   in	
   spatio-­‐temporally	
   dynamic	
   patterns,	
   which	
  reflect	
  the	
  changes	
  in	
  BMP	
  activity	
  during	
  limb	
  bud	
  development	
  (Hollnagel	
  et	
  al.,	
  1999;	
  Pizette	
  and	
  Niswander,	
  2001).	
  The	
  main	
  limb	
  phenotypes	
  resulting	
  from	
  loss-­‐of-­‐function	
  studies	
  in	
  mouse	
  embryos	
  are	
  summarized	
  in	
  Table	
  1	
  and	
  the	
  functional	
  relevance	
  of	
  the	
  dynamics	
  of	
  BMP	
  signaling	
  interactions	
  is	
  discussed	
  below.	
  	
  	
  
	
  	
  
Fig.	
  3	
  Expression	
  pattern	
  of	
  BMP	
  ligands	
  and	
  genetic	
  interactions	
  of	
  BMP	
  activity	
  during	
  
limb	
  bud	
  development.	
  (A)	
  Early	
  polarization	
  of	
  the	
  dorso-­‐ventral	
  (D-­‐V)	
  axis	
  and	
  establishment	
  of	
   AER	
   require	
   high	
   BMP	
   activity.	
   Genetic	
   evidence	
   suggests	
   that	
   mesenchymal	
   BMP4	
   signals	
  through	
  BMPR1A	
  receptors	
  in	
  the	
  ventral	
  ectoderm	
  to:	
  1)	
  polarize	
  the	
  D-­‐V	
  axis	
  through	
  EN1	
  and	
  2)	
  establish	
  the	
  AER.	
  (B)	
  During	
  initiation	
  of	
   limb	
  patterning,	
  BMPs	
  trigger	
  the	
  expression	
  of	
  the	
  BMP	
   antagonist	
   Grem1	
   in	
   the	
   posterior	
   mesenchyme.	
   This	
   creates	
   conditions	
   permissive	
   to	
  activation	
  of	
  FGF4,	
  FGF9	
  and	
  FGF17	
  in	
  the	
  posterior	
  AER	
  (low	
  BMP	
  activity),	
  which	
  in	
  turn	
  results	
  in	
  up-­‐regulation	
  of	
  Shh	
  in	
  the	
  posterior	
  mesenchyme.	
  In	
  addition,	
  SHH	
  sustains	
  Grem1	
  expression	
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and	
   drives	
   its	
   distal-­‐anterior	
   expansion.	
   (C)	
   To	
   initiate	
   chondrogenesis,	
   high	
   BMP	
   activity	
   is	
  required.	
   This	
   is	
   achieved	
   by	
   1)	
   down-­‐regulation	
   of	
  Grem1	
  by	
   AER-­‐FGFs	
   and	
   GLI3R	
   and	
   2)	
   the	
  refractoriness	
   of	
   Shh	
   descendants	
   to	
   Grem1	
   expression.	
   Timely	
   down-­‐regulation	
   of	
   AER-­‐Fgf	
  expression	
  by	
  BMP	
  activity	
  restricts	
  the	
  limb	
  bud	
  to	
  pentadactyly.	
  Color	
  code	
  for	
  the	
  upper	
  panels.	
  Orange:	
  BMP	
  ligand	
  expression;	
  Blue:	
  Grem1;	
  Red:	
  AER-­‐FGF;	
  Yellow:	
  Shh;	
  Green:	
  GLI3R.	
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Table	
  1.	
  Limb	
  phenotypes	
  associated	
  with	
  inactivation/aberration	
  in	
  BMP	
  pathway	
  
components	
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  BMP	
  activity	
  during	
  D-­‐V	
  axis	
  specification	
  and	
  AER	
  establishment	
  In	
   early	
   mouse	
   limb	
   buds,	
   BMP2	
   is	
   expressed	
   by	
   the	
   ventral	
   ectoderm	
   and	
  mesenchyme,	
  while	
  BMP4	
  and	
  BMP7	
  are	
  more	
  widely	
  expressed	
  (Fig.	
  3A;	
  Danesh	
  et	
  al.,	
  2009;	
  Yi	
  et	
  al.,	
  2000).	
  In	
  chicken	
  limb	
  buds,	
  BMP	
  ligands,	
  Msx1	
  and	
  Msx2	
  target	
  genes	
  are	
  expressed	
  by	
  the	
  ventral	
  ectoderm	
  and	
  mesenchyme	
  before	
  AER	
  formation	
  (Pizette	
  and	
  Niswander,	
  2001).	
  Misexpression	
  of	
   the	
  BMP	
  antagonist	
  Noggin	
   in	
   the	
   limb	
  bud	
  ectoderm	
  abolishes	
  En1	
  expression,	
  results	
   in	
  ectopic	
  Wnt7a	
  and	
  Lmx1b	
  expression	
  in	
  the	
  ventral	
  ectoderm	
  and	
  may	
   result	
   in	
   induction	
   of	
   ectopic	
   AER-­‐like	
   structure	
   expressing	
   Fgf8	
   (Pizette	
   and	
  Niswander,	
   2001;	
  Wang	
   et	
   al.,	
   2004).	
   In	
   contrast,	
   misexpression	
   of	
   constitutive	
   active	
  BMP	
   receptors	
   (BMPR1A	
   and	
   BMPR1B)	
   results	
   in	
   dorsalization	
   of	
   AER,	
   ectopic	
   dorsal	
  expression	
   of	
  En1	
   and	
   reduction	
   of	
   the	
  Wnt7a	
  and	
  Lmx1b	
  expression	
   domains	
   (Pizette	
  and	
   Niswander,	
   2001).	
   These	
   studies	
   indicate	
   that	
   high	
   BMP	
   activity	
   in	
   the	
   ventral	
  ectoderm	
  is	
  required	
  for	
  definition	
  of	
  the	
  D-­‐V	
  boundary	
  and	
  AER	
  establishment.	
  
En1,	
   which	
   functions	
   in	
   dorsal	
   restriction	
   of	
   Wnt7a	
   and	
   Lmx1b,	
   does	
   not	
   act	
  downstream	
  BMP	
   signaling	
   to	
   specify	
   the	
  D-­‐V	
   axis	
   and	
   the	
   AER,	
   because	
  En1	
  deficient	
  mouse	
   limb	
   buds	
   still	
   form	
   an	
   AER	
   and	
   Fgf8	
   is	
   activated	
   correctly,	
   although	
   the	
   AER	
  structure	
   fails	
   to	
   compact	
   subsequently	
   (Loomis	
   et	
   al.,	
   1998;	
   Pizette	
   and	
   Niswander,	
  2001).	
  Conversely,	
  MSX1,	
  which	
  is	
  a	
  BMP	
  target	
  in	
  the	
  early	
  limb	
  bud	
  mesenchyme	
  acts	
  downstream	
   BMP	
   signaling	
   to	
   mediate	
   its	
   ventralization	
   effect.	
   This	
   was	
   shown	
   as	
  ectodermal	
  misexpression	
  of	
  Msx1	
  results	
  in	
  formation	
  of	
  ectopic	
  dorsal	
  AER	
  (Pizette	
  and	
  Niswander,	
  2001).	
  However,	
  D-­‐V	
  axis	
  specification	
  is	
  not	
  affected	
  in	
  Msx1	
  deficient	
  limb	
  buds,	
  suggesting	
  that	
  the	
  Msx1	
  deficiency	
  is	
  compensated	
  (Satokata	
  and	
  Maas,	
  1994).	
  Genetic	
   inactivation	
   of	
   BMP	
   signaling	
   pathway	
   at	
   different	
   levels	
   has	
   provided	
   new	
  insights	
   into	
   its	
   early	
   functions	
   during	
   limb	
   field	
   and	
   AER	
   formation.	
   The	
   Prx1-­‐Cre	
  transgene	
   (Logan	
   et	
   al.,	
   2002)	
   drives	
   Cre	
   recombinase	
   expression	
   into	
   the	
   forelimb	
  mesenchyme	
  around	
   the	
   time	
  when	
   the	
  AER	
   is	
  established.	
   Inactivation	
  of	
  Bmp4	
  in	
   the	
  forelimb	
  bud	
  using	
   the	
  Prx1-­‐Cre	
  transgene	
  results	
   in	
   severe	
   truncations	
  of	
   the	
   forelimb	
  and	
  AER	
  agenesis	
  (Benazet	
  et	
  al.,	
  2009).	
  The	
  same	
  phenotype	
  is	
  observed	
  when	
  BMP4	
  is	
  inactivated	
  using	
  a	
  tamoxifen-­‐inducible	
  Cre	
  prior	
  to	
  AER	
  formation,	
  whereas	
  inactivation	
  after	
   AER	
   formation	
   results	
   in	
   polydactyly	
   (Benazet	
   et	
   al.,	
   2009;	
   Selever	
   et	
   al.,	
   2004).	
  These	
   results	
   reveal	
   the	
   transient	
   requirement	
   of	
   BMP4	
   for	
   AER	
   formation	
   and	
   its	
  subsequent	
   role	
   in	
   restricting	
   the	
   autopod	
   to	
   pentadactyly	
   (Benazet	
   et	
   al.,	
   2009).	
  Inactivation	
   of	
   either	
   BmpR1a,	
   BmpR1b,	
   BmpR2,	
   Bmp2	
   or	
   Bmp7	
   does	
   not	
   impair	
   AER	
  formation	
   (Bandyopadhyay	
   et	
   al.,	
   2006;	
   Gamer	
   et	
   al.,	
   2011;	
   Yoon	
   et	
   al.,	
   2005).	
   These	
  results	
  suggest	
  that	
  BMP4	
  signals	
  to	
  the	
  ectoderm	
  to	
  establish	
  the	
  AER.	
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Brn4-­‐Cre-­‐driven	
  early	
  inactivation	
  of	
  Bmpr1a	
  in	
  the	
  ventral	
  limb	
  bud	
  ectoderm	
  results	
  in	
   partial	
   limb	
   agenesis	
   and/or	
   severe	
   skeletal	
   truncations	
   due	
   to	
   impaired	
   AER	
  formation.	
  This	
  phenotype	
  phenocopies	
   the	
  mesenchymal	
  deletion	
  of	
  Bmp4,	
   suggesting	
  that	
  BMP4	
  signals	
  through	
  ectodermal	
  BMPR1A	
  to	
  instruct	
  AER	
  establishment	
  (Fig.	
  3A).	
  Conversely,	
   the	
  mutant	
   forelimb	
   only	
   displays	
   subtle	
  malformations	
   (Ahn	
   et	
   al.,	
   2001).	
  
Msx2-­‐Cre-­‐driven	
   inactivation	
   of	
   BmpR1a	
   in	
   the	
   ventral	
   limb	
   bud	
   ectoderm	
   and	
   AER	
  disrupts	
  AER	
   induction	
  and	
   results	
   in	
   limb	
  agenesis	
   (Pajni-­‐Underwood	
  et	
   al.,	
   2007).	
  As	
  delayed	
   inactivation	
   results	
   in	
   normal	
   development,	
   these	
   results	
   point	
   to	
   a	
   time-­‐restricted	
   requirement	
   of	
   BmpR1a	
   in	
   the	
   ventral	
   ectoderm	
   during	
   AER	
   establishment.	
  Msx2-­‐Cre-­‐driven	
  conditional	
  deletion	
  of	
  Smad4	
  in	
  the	
  limb	
  bud	
  ectoderm	
  at	
  early	
  stages	
  disrupts	
  AER	
   formation	
   and	
   results	
   in	
  dysmorphisms	
   and	
  bifurcation	
  of	
   the	
  phalanges,	
  ectrodactyly	
   and	
   occasional	
   loss	
   of	
   zeugopod	
   elements	
   (Benazet	
   and	
   Zeller,	
   2013).	
  Similarly,	
   inactivation	
   of	
  Bmp2	
  and	
  Bmp4	
   in	
   the	
   ectoderm	
   results	
   in	
   dysmorphism	
   and	
  bifurcation	
   of	
   phalanges	
   (Maatouk	
   et	
   al.,	
   2009).	
   Interestingly,	
   all	
   cases	
   of	
   diminished	
  ectodermal	
   BMP	
   signaling	
   still	
   permissive	
   to	
   AER	
   formation,	
   resulted	
   in	
   impaired	
   AER	
  compaction,	
   elongation	
   along	
   the	
   A-­‐P	
   axis	
   and	
   failure	
   in	
   correct	
   formation	
   of	
   AER-­‐FGF	
  signalling.	
   In	
   particular,	
   AER-­‐Fgf8	
   expression	
   was	
   increased	
   and	
   prolonged,	
   which	
   is	
  likely	
   the	
  cause	
  of	
   the	
  alterations	
   in	
  autopod	
  development	
  (Ahn	
  et	
  al.,	
  2001;	
  Choi	
  et	
  al.,	
  2012;	
  Maatouk	
  et	
  al.,	
  2009;	
  Pajni-­‐Underwood	
  et	
  al.,	
  2007;	
  Selever	
  et	
  al.,	
  2004;	
  Wang	
  et	
  al.,	
  2004).	
   These	
   results	
   indicate	
   that:	
   1)	
   ectodermal	
  Smad4	
   is	
   required	
   for	
  AER	
   formation	
  downstream	
   of	
   BMP2	
   and	
   BMP4	
   ligands,	
   to	
   restrain	
   AER-­‐FGF	
   signaling	
   and	
   prohibit	
  excessive	
  autopod	
  outgrowth;	
  2)	
  after	
  AER	
  establishment,	
  ectodermal	
  BMP2	
  and	
  BMP4	
  act	
   independently	
   of	
   SMAD4	
   to	
  modulate	
   AER-­‐FGF	
   activity	
   and	
   restrict	
   the	
   autopod	
   to	
  pentadactyly.	
   In	
   all	
   cases,	
   reduction	
   of	
   BMP-­‐signaling	
   activity	
   in	
   the	
   ectoderm	
   impairs	
  interdigital	
   cell	
   death,	
   which	
   results	
   in	
   interdigital	
   webbing.	
   This	
   webbing	
   is	
   due	
   to	
  increased	
   and	
   delayed	
   shutdown	
   of	
   AER-­‐FGF	
   signalling:	
   indeed,	
   the	
   combined	
  inactivation	
  of	
  BmpR1a,	
  Fgf4	
  and	
  Fgf8	
  in	
  the	
  limb	
  ectoderm	
  rescues	
  interdigital	
  cell	
  death	
  (Pajni-­‐Underwood	
  et	
  al.,	
  2007).	
  	
  
	
  
BMP	
  activity	
  during	
  limb	
  patterning	
  and	
  outgrowth	
  As	
  mentioned	
  above,	
  GREM1-­‐mediated	
  antagonism	
  of	
  BMP	
  activity	
  is	
  necessary	
  for	
  the	
  establishment	
  of	
   the	
  positive	
   e-­‐m	
   feedback	
   loop	
   that	
   in	
   turn	
   sustains	
   the	
  expression	
  of	
  
Shh	
   and	
   AER-­‐Fgf	
   during	
   distal	
   progression	
   of	
   limb	
   bud	
   development	
   (Fig.	
   3B).	
   Grem1	
  inactivation	
   disrupts	
   A-­‐P	
   polarity,	
   induces	
   cell	
   death	
   and	
   reduces	
   the	
   mesenchymal	
  progenitors.	
   Heterozygosity	
   for	
   the	
  Bmp4	
  gene	
   partially	
   rescues	
   Grem1	
  deficiency	
   and	
  
	
   29	
  
further	
  genetic	
  reduction	
  of	
  Bmp4	
  rescues	
  cell	
  death	
  and	
  limb	
  skeletal	
  elements	
  (Benazet	
  et	
  al.,	
  2009).	
  This	
  study	
  also	
  revealed	
  the	
  higher	
  genetic	
  relevance	
  of	
  Bmp4	
  with	
  respect	
  to	
  the	
  other	
  BMP	
  ligands	
  during	
  limb	
  bud	
  development.	
  During	
   limb	
   bud	
   outgrowth	
   and	
   patterning,	
   the	
   posterior	
   localization	
   of	
   the	
   Grem1	
  domain	
   together	
   with	
   the	
   anterior	
   expression	
   of	
   GLI3R,	
   which	
   down-­‐regulates	
  Grem1,	
  likely	
  produces	
  an	
  anterior	
   limb	
  domain	
  characterized	
  by	
  high	
  BMP	
  activity	
  (Khokha	
  et	
  al.,	
   2003;	
   Lopez-­‐Rios	
   et	
   al.,	
   2012).	
   Indeed,	
   genetic	
   analysis	
   shows	
   that	
   BMP	
   ligands	
  cooperate	
   with	
   GLI3	
   to	
   reduce	
   the	
   size	
   of	
   the	
   anterior	
   limb	
   domain	
   and	
   restrict	
   the	
  autopod	
   to	
  pentadactyly	
   (Bandyopadhyay	
  et	
  al.,	
  2006;	
  Hui	
  and	
   Joyner,	
  1993;	
  Selever	
  et	
  al.,	
  2004).	
  	
  
	
  
Tissue	
  differentiation	
  and	
  initiation	
  of	
  chondrogenesis	
  in	
  the	
  limb	
  Between	
  E11.5	
  and	
  E12,	
  mesenchymal	
  condensations	
  in	
  the	
  limb	
  bud	
  core	
  begin	
  to	
  form	
  and	
  outline	
   the	
   future	
   skeletal	
   elements	
   that	
   form	
   subsequently	
  by	
   endochondral	
   bone	
  formation	
   (for	
   review	
   see	
   Long	
   and	
   Ornitz,	
   2013).	
   In	
   parallel,	
   the	
   connective	
   tissue	
  differentiates	
  to	
  give	
  rise	
  to	
  tendons,	
   ligaments,	
  perichondrium,	
   loose	
  connective	
  tissue,	
  dermis,	
   muscle	
   and	
   endothelium	
   (see	
   ten	
   Berge	
   et	
   al.,	
   2008).	
  While	
   most	
   of	
   the	
   limb	
  structures	
   derive	
   from	
   the	
   lateral	
   plate	
  mesoderm,	
  muscle	
   and	
   endothelium	
   precursor	
  cells	
  originate	
  from	
  progenitors	
  that	
  migrate	
  from	
  the	
  somites	
  into	
  the	
  limb	
  bud,	
  where	
  they	
  expand	
  and	
  commit	
  to	
  their	
  respective	
  fates	
  (Buckingham	
  et	
  al.,	
  2003;	
  Chevallier	
  et	
  al.,	
  1977;	
  Yvernogeau	
  et	
  al.,	
  2012).	
  	
  The	
   specification	
   of	
   these	
   tissues	
   is	
   revealed	
   by	
   the	
   activation	
   of	
  molecular	
  markers,	
  such	
   as	
   Sox9	
   for	
   osteo/chondroprogenitors,	
   Scleraxis	
   (Scx)	
   for	
   tendons,	
   Growth	
   and	
  
differentiation	
  factor	
  5	
  (Gdf5)	
  and	
  Four-­‐jointed	
  (Fjx)	
  for	
  joints,	
  MyoD	
  and	
  Myf5	
  for	
  muscle	
  precursors	
   (Francis-­‐West	
   et	
   al.,	
   1999;	
   Francis-­‐West	
   et	
   al.,	
   2003;	
   Rock	
   et	
   al.,	
   2005;	
  Schweitzer	
   et	
   al.,	
   2001;	
   Wright	
   et	
   al.,	
   1995).	
   Molecular	
   cues	
   from	
   the	
   ectoderm	
   (in	
  particular	
  the	
  AER)	
  orchestrate	
  tissue	
  differentiation	
  such	
  that	
  e.g.	
  condensations	
  occur	
  predominantly	
   in	
   the	
   limb	
   core	
   mesenchyme.	
   In	
   particular,	
   WNT	
   signaling	
   by	
   the	
  ectoderm	
   inhibits	
   chondrogenesis	
   and	
   promotes	
   cell	
   proliferation	
   in	
   the	
   underlying	
  mesenchyme	
  (Hartmann	
  and	
  Tabin,	
  2001;	
  Rudnicki	
  and	
  Brown,	
  1997;	
  Solursh,	
  1984;	
  ten	
  Berge	
   et	
   al.,	
   2008).	
   WNT3a	
   commits	
   mesenchymal	
   cells	
   to	
   different	
   connective	
   tissue	
  fates,	
  depending	
  on	
  the	
  time	
  of	
  exposure.	
  Conversely,	
  combined	
  exposure	
  to	
  WNT3a	
  and	
  FGF8	
  preserves	
  the	
  chondrogenic	
  potential	
  of	
  mesenchymal	
  progenitors	
  (ten	
  Berge	
  et	
  al.,	
  2008).	
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FGF	
   signaling,	
   by	
   the	
  AER	
  and	
  mesenchyme,	
  promotes	
   cell	
   survival	
   and	
  proliferation,	
  which	
   ultimately	
   control	
   the	
   length	
   of	
   skeletal	
   primordia	
   and	
   number	
   of	
   digit	
   ray	
  primordia	
   (Davidson	
   et	
   al.,	
   2005;	
   Yu	
   and	
   Ornitz,	
   2008;	
   Yu	
   et	
   al.,	
   2003).	
   FGF	
   and	
   BMP	
  signaling	
  up-­‐regulate	
  the	
  expression	
  of	
  the	
  Sry-­‐related	
  SOX9	
  transcription	
  factor	
  (Bi	
  et	
  al.,	
  1999;	
   Murakami	
   et	
   al.,	
   2000;	
   Pan	
   et	
   al.,	
   2008;	
   Wright	
   et	
   al.,	
   1995).	
   The	
   Sox9	
  haploinsufficiency	
   is	
   associated	
   with	
   severe	
   forms	
   of	
   chondrodysplasia	
   in	
   mice	
   and	
  results	
   in	
   campomelic	
   dysplasia	
   in	
   humans	
   (OMIM	
   Entry	
   #	
   114290;	
   Bi	
   et	
   al.,	
   1999).	
  Complete	
   inactivation	
   of	
  Sox9	
   in	
   the	
   limb	
  bud	
  mesenchyme	
   results	
   in	
   skeletal	
   agenesis	
  (Akiyama	
   et	
   al.,	
   2002).	
   Furthermore,	
   Sox9	
  drives	
   the	
   expression	
   of	
   Sox5	
  and	
   Sox6,	
   and	
  interacts	
   with	
   them	
   to	
   control	
   chondrogenesis	
   (Akiyama	
   et	
   al.,	
   2002;	
   Lefebvre	
   et	
   al.,	
  2001).	
  Sox9	
  also	
   interacts	
   genetically	
  with	
  Scx	
   to	
   control	
   the	
   cartilage-­‐tendon	
   interface	
  (Blitz	
  et	
  al.,	
  2013;	
  Sugimoto	
  et	
  al.,	
  2013).	
  In	
  vitro	
  analysis	
  using	
  high-­‐density	
  micromass	
  cultures	
   provided	
   evidence	
   that	
   Sox9	
   is	
   dispensable	
   for	
   cell	
   compaction	
   during	
  condensation	
   of	
   mesenchymal	
   progenitors.	
   Rather,	
   SOX9	
   is	
   necessary	
   to	
   maintain	
   the	
  cellular	
  aggregates,	
  possibly	
  by	
  promoting	
  their	
  chondrogenic	
  differentiation.	
  In	
  contrast,	
  BMP	
   signaling	
   is	
   required	
   for	
   compaction	
   of	
   mesenchymal	
   progenitors	
   (Barna	
   and	
  Niswander,	
  2007).	
  The	
  molecular	
  interactions	
  initiating	
  cell	
  aggregation	
  and	
  compaction	
  of	
  mesenchymal	
  progenitors	
  are	
  not	
  known.	
  Moreover,	
  several	
  signaling	
  pathways	
  inhibit	
  aggregation	
   and/or	
   chondrogenic	
   differentiation,	
   such	
   as	
   the	
   WNT,	
   NOTCH	
   and	
   RA	
  signaling	
  pathways	
  (for	
  review	
  see	
  Long	
  and	
  Ornitz,	
  2013).	
  However,	
  limb	
  mesenchymal	
  progenitors	
  exhibit	
  an	
  inherent	
  property	
  to	
  initiate	
  chondrogenic	
  differentiation	
  in	
  high-­‐density	
  cultures	
  under	
  the	
   influence	
  of	
  BMP	
  and	
  TGFβ	
  signaling	
  (Barna	
  and	
  Niswander,	
  2007).	
  	
  
	
  
	
  
BMP	
  activity	
  during	
  initiation	
  of	
  chondrogenic	
  differentiation	
  During	
  initiation	
  of	
  chondrogenic	
  differentiation	
  Bmp2	
  and	
  Bmp7	
  become	
  expressed	
  by	
  the	
  prospective	
  interdigital	
  cells,	
  while	
  the	
  Bmp4	
  expression	
  domain	
  gets	
  restricted	
  to	
  the	
  distal-­‐most	
  mesenchyme	
   at	
   E12.0	
   (Benazet	
   et	
   al.,	
   2009;	
   Dunn	
   et	
   al.,	
   1997;	
   Dupe	
   et	
   al.,	
  1999;	
  Laufer	
  et	
  al.,	
  1994;	
  Yang	
  et	
  al.,	
  1998b).	
  In	
  parallel,	
  phosphorylated	
  forms	
  of	
  SMAD1,	
  -­‐5	
  and	
  -­‐8	
  are	
  strongly	
  expressed	
  in	
  the	
  distal-­‐most	
  mesenchyme	
  and,	
  to	
  a	
  lesser	
  extent,	
  in	
  the	
  prospective	
  interdigital	
  mesenchyme	
  and	
  at	
  the	
  tip	
  of	
  digit	
  condensations	
  (Suzuki	
  et	
  al.,	
   2008;	
   Witte	
   et	
   al.,	
   2010).	
   BmpR1b	
   is	
   expressed	
   by	
   the	
   digit	
   condensations,	
   while	
  
BmpR1a	
   remains	
   diffuse	
   throughout	
   the	
  mesenchyme,	
  with	
   higher	
   levels	
   in	
   the	
   distal-­‐most	
  mesenchyme	
   (Degenkolbe	
   et	
   al.,	
   2013;	
   Zou	
   et	
   al.,	
   1997).	
   The	
  Msx2	
  and	
   Id1	
  target	
  genes	
   are	
   also	
   expressed	
   by	
   the	
   interdigital	
   mesenchyme	
   (Evans	
   and	
   O'Brien,	
   1993;	
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Montero	
  et	
  al.,	
  2001).	
  In	
  general,	
  BMP	
  signaling	
  promotes	
  outgrowth	
  of	
  skeletal	
  elements	
  to	
  the	
  detriment	
  of	
  joint	
  formation.	
  For	
  instance,	
  genetic	
  inactivation	
  of	
  the	
  BMP	
  antagonist	
  Noggin	
  results	
  in	
  fewer	
  and	
  larger	
  cartilage	
  elements	
  and	
  failure	
  of	
  joint	
  formation	
  (Brunet	
  et	
  al.,	
  1998).	
  In	
  contrast,	
  compound	
  mesenchymal	
  inactivation	
  of	
  both	
  Bmp2	
  and	
  Bmp4	
  induces	
  a	
  severe	
  chondrodysplastic	
  phenotype	
  (Bandyopadhyay	
  et	
  al.,	
  2006).	
  Mesenchymal	
   condensation	
   is	
   characterized	
   by	
   the	
   transient	
   up-­‐regulation	
   of	
  proteoglycans	
  such	
  as	
  tenascin,	
  syndecan	
  and	
  versican	
  and	
  of	
  adhesion	
  molecules	
  like	
  N-­‐CAM	
  and	
  N-­‐cadherin.	
  During	
  chondrogenic	
  differentiation,	
  molecular	
  evidence	
   indicates	
  that	
  BMP	
  signaling	
  up-­‐regulates	
  Sox9,	
  which	
  in	
  turn	
  functions	
  by	
  activating	
  Collagen	
  type	
  II	
  (COL	
  type	
  II),	
  COL	
  type	
  IX,	
  COL	
  type	
  XI	
  and	
  aggrecan	
  in	
  chondrocytes	
  (Bell	
  et	
  al.,	
  1997;	
  Gao	
  et	
  al.,	
  2013;	
  Lefebvre	
  et	
  al.,	
  2001;	
  Sekiya	
  et	
  al.,	
  2000;	
  Yoon	
  et	
  al.,	
  2005).	
  N-­‐cadherin	
  mediates	
   calcium-­‐dependent	
   homotypic	
   cell-­‐cell	
   interactions.	
   In	
   an	
   in	
   vitro	
   system,	
  BMP2-­‐stimulated	
   condensation	
   results	
   in	
   N-­‐cadherin	
   re-­‐distribution	
   to	
   adherens	
  junctions	
  (Haas	
  and	
  Tuan,	
  1999).	
  Moreover,	
  N-­‐cadherin	
  at	
  adherens	
  junctions	
  modulates	
  the	
  nuclear	
  activity	
  of	
  the	
  transcription	
  factor	
  β-­‐catenin	
  (Fischer	
  et	
  al.,	
  2002;	
  Modarresi	
  et	
  al.,	
  2005).	
  What	
   is	
   known	
   about	
   contribution	
   of	
   BMP	
   signaling	
   inducing	
   chondrogenic	
  differentiation	
   steps	
   mainly	
   comes	
   from	
   in	
   vivo	
   limb	
   manipulation	
   and	
   gene	
  misexpression	
   experiments	
   or	
   from	
   the	
   used	
   of	
   micromass	
   cultures.	
   Pizette	
   and	
  Niswander	
  (2000)	
  showed	
  a	
  dual	
  role	
  for	
  BMP	
  ligands	
  in	
  mesenchymal	
  aggregation	
  and	
  induction	
   of	
   chondrogenesis	
   (Pizette	
   and	
   Niswander,	
   2000).	
   When	
   BMP	
   ligands	
   are	
  sequestered	
   by	
   misexpression	
   of	
   NOGGIN,	
   the	
   prospective	
   chondrogenic	
   progenitors	
  undergo	
   a	
   cell	
   fate	
   switch	
   towards	
   loose	
   connective	
   tissue.	
   When	
   NOGGIN	
   is	
  misexpressed	
  over	
  condensing	
  tissue,	
  Gdf5	
  expression	
  domain	
  is	
  expanded.	
  GDF5	
   belongs	
   to	
   the	
   TGFβ	
   superfamily,	
   is	
   structurally	
   related	
   to	
   BMP2	
   and	
   BMP4	
  ligands	
  and	
  shares	
  the	
  same	
  receptors	
  (Mueller	
  and	
  Nickel,	
  2012).	
  GDF5	
  is	
  expressed	
  by	
  joint	
  primordia	
  and	
  its	
  genetic	
   inactivation	
  results	
   in	
  brachypodia	
  characterized	
  by	
   loss	
  of	
   joints,	
  and	
  hypoplasia	
  of	
  metacarpal	
  and	
  carpal	
  bones	
   in	
  mouse	
  embryos	
  (Storm	
  and	
  Kingsley,	
  1999;	
  Yi	
  et	
  al.,	
  2000).	
  Conditional	
   inactivation	
   of	
   BmpR1a	
   in	
   chondrocytes	
   (using	
   the	
   Col2-­‐Cre	
   transgene),	
  results	
   in	
   overall	
   shorter	
   limb	
   skeletal	
   elements	
  with	
   a	
  major	
   dysplasia	
   of	
   the	
   scapula.	
  Instead,	
   inactivation	
   of	
   BmpR1b	
   results	
   in	
   loss	
   of	
   the	
   proximal-­‐most	
   phalanges.	
   The	
  compound	
  inactivation	
  of	
   the	
  type	
  I	
  BMP	
  receptors	
  results	
   in	
  agenesis	
  of	
   limb	
  skeleton,	
  whereas	
  a	
  single	
  functional	
  allele	
  of	
  BmpR1b	
  rescues	
  all	
  the	
  skeletal	
  elements,	
  which	
  are	
  however	
  shorter	
  with	
  a	
  dysplastic	
  scapula	
  and	
  loss	
  of	
  phalanges	
  (Yoon	
  et	
  al.,	
  2005;	
  Yoon	
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et	
   al.,	
   2006).	
  The	
   compound	
  conditional	
   inactivation	
  of	
  Smad1	
  and	
  Smad5	
   in	
   the	
  COL2-­‐expressing	
  chondrocytes	
  phenocopies	
  the	
  Bmp	
  receptor	
  type	
  I	
  phenotypes.	
  (Retting	
  et	
  al.,	
  2009).	
   These	
   limb	
   skeletal	
   defects	
   are	
   a	
   consequence	
   of	
   reduced	
   proliferation	
   and	
  increased	
   cell	
   death	
   in	
   growth	
   plate	
   and	
   impaired	
   terminal	
   differentiation	
   of	
  chondrocytes	
   (Yoon	
   et	
   al.,	
   2006).	
   Surprisingly,	
   conditional	
   inactivation	
   of	
   Smad4	
  using	
  the	
  Col2-­‐Cre	
   transgene	
  results	
   in	
  dwarfism	
  and	
  delayed	
  ossification,	
  suggesting	
   that	
   the	
  chondrogenic	
  steps	
  that	
  follow	
  the	
  activation	
  of	
  COL2	
  in	
  chondrocytes	
  are	
  mostly	
  driven	
  by	
  Smad4-­‐independent,	
  Smad1/5-­‐dependent	
  mechanisms	
  (Zhang	
  et	
  al.,	
  2005).	
  	
  
	
  
Congenital	
  limb	
  malformations	
  associated	
  with	
  aberrant	
  BMP	
  signaling	
  Limb	
   phenotypes	
   associated	
   with	
   impaired	
   expression	
   of	
   BMP	
   signaling-­‐related	
  molecules	
   in	
   the	
  mouse	
  often	
  mirror	
   the	
  contribution	
  of	
  BMP	
  signaling	
  pathway	
  during	
  human	
   limb	
   development	
   (for	
   review	
   see	
   Zuniga	
   et	
   al.,	
   2012).	
   Congenital	
   human	
   limb	
  malformations	
   include	
  several	
  types	
  of	
  autosomal-­‐dominant	
  brachydactylies	
  (OMIM	
  Ref	
  #112600,	
   #611377	
   and	
   #113100)	
   associated	
   with	
   mutations	
   affecting	
   the	
   coding	
  sequence	
   (CDS)	
   or	
   regulatory	
   regions	
   of	
   BMP	
   pathway	
   genes	
   such	
   as	
   BmpR1b,	
   Gdf5,	
  
Noggin	
  and	
  Bmp2	
  (Dathe	
  et	
  al.,	
  2009;	
  Lehmann	
  et	
  al.,	
  2006;	
  Lehmann	
  et	
  al.,	
  2007;	
  Ploger	
  et	
  al.,	
  2008).	
  Human	
  cases	
  of	
  brachydactyly	
  sometimes	
  exhibit	
  additional	
  occurrence	
  of	
  proximal	
   symphalangism	
   (OMIM	
   Ref	
   #615298)	
   and	
   carpal	
   synosthosis	
   (OMIM	
   Ref	
  #186400;	
  Degenkolbe	
  et	
  al.,	
  2013;	
  Lehmann	
  et	
  al.,	
  2007).	
  Homozygous	
  disruption	
  of	
  the	
  limb-­‐specific	
   cis-­‐regulatory	
   region	
   of	
   Grem1	
   is	
   associated	
   with	
   the	
   rare	
   autosomal	
  recessive	
  Cenani-­‐Lenz	
  syndactyly	
  syndrome	
  (OMIM	
  Ref	
  #212780;	
  Dimitrov	
  et	
  al.,	
  2010).	
  In	
   contrast	
   mutations	
   in	
   the	
   Sclerostin	
   gene,	
   which	
   encodes	
   another	
   BMP	
   antagonist,	
  result	
   in	
   sclerostosis	
   characterized	
   by	
   syndactyly	
   and	
   bone	
   over-­‐growth	
   (OMIM	
   Ref	
  #269500;	
   Collette	
   et	
   al.,	
   2012).	
   Mutations	
   in	
   Bmp4	
   reading	
   frame	
   cause	
   the	
  Anophthalmia-­‐microphthalmia	
   multi-­‐systemic	
   disorder	
   that	
   includes	
   polysyndactly	
  (OMIM	
  Ref	
  #607932;	
  Bakrania	
  et	
  al.,	
  2008).	
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5.	
  AIMS	
  OF	
  THE	
  THESIS	
  	
  I	
   started	
  my	
  doctoral	
   studies	
   in	
  developmental	
  biology	
  under	
   the	
  supervision	
  of	
  Prof.	
  Dr.	
  Rolf	
  Zeller	
  with	
  the	
  intent	
  to	
  widen	
  my	
  knowledge	
  and	
  technical	
  skills	
  with	
  respect	
  to	
  the	
   immunology	
   background	
   I	
   acquired	
   during	
   my	
   master’s	
   thesis.	
   Indeed,	
   the	
  investigation	
  of	
   developmental	
   processes	
  has	
  helped	
  me	
   to	
   face	
   the	
  high	
   complexity	
   of	
  gene	
  behaviors,	
  signal	
  interactions	
  and	
  tissue	
  dynamics.	
  The	
   aim	
   of	
   this	
   thesis	
   is	
   to	
   dissect	
   the	
   genetic	
   contribution	
   of	
   canonical	
   signaling	
   at	
  different	
   stages	
   of	
   limb	
   development	
   with	
   the	
   use	
   of	
   several	
   limb-­‐conditional	
  inactivations	
  of	
  Smad4,	
  alone	
  or	
  in	
  the	
  context	
  of	
  mutant	
  backgrounds.	
  In	
  addition,	
  I	
  was	
  expected	
   to:	
   1)	
   generate	
   an	
   in	
   vivo	
  sensor	
   of	
   the	
   BMP	
   activity,	
   for	
   a	
   detailed	
   temporal	
  analysis	
   of	
   the	
   signaling	
  dynamics	
   and	
  perturbations	
  upon	
  pharmacological	
   treatments	
  or	
  genetic	
  defects;	
  2)	
   implement	
  new	
  techniques	
   in	
   the	
   laboratory,	
   including	
   the	
   three-­‐dimensional	
   embryo/tissue	
   optical	
   projection	
   tomography	
   (OPT)	
   scanning	
   and	
   the	
  complementation	
   assay	
   for	
   fast	
   generation	
   of	
   cis-­‐regulatory	
   element	
   reporter	
  embryos/mice.	
  The	
   genetic	
   analysis	
   of	
   the	
   Smad4	
  mutation	
   in	
   the	
   limb	
   was	
   accomplished	
   at	
   the	
  beginning	
   of	
   my	
   third	
   year	
   in	
   this	
   laboratory,	
   contributing	
   a	
   co-­‐first	
   author	
   paper	
  (Benazet	
  et	
  al.,	
  2012).	
  On	
  the	
  other	
  hand,	
  the	
  generation	
  of	
  the	
  BMP	
  activity	
  sensor	
  was	
  delayed	
  by	
  several	
  pitfalls,	
  including	
  problems	
  in	
  targeting	
  and	
  germ-­‐line	
  transmission.	
  I	
  have	
  managed	
  to	
  successfully	
  implement	
  the	
  OPT	
  scanning	
  technique	
  in	
  the	
  lab	
  with	
  the	
  help	
  of	
  Frédéric	
  Laurent	
  and	
  Erkan	
  Uenal,	
  and	
  the	
  setting	
  up	
  of	
  the	
  aggregation	
  chimera	
  protocols	
  is	
  almost	
  finalized.	
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6.	
  MATERIAL	
  AND	
  METHODS	
  
	
  
Genetic	
  crosses	
  of	
  mouse	
  strains	
  All	
  strains	
  are	
  kept	
  in	
  C57BL/6	
  genetic	
  background	
  unless	
  otherwise	
  stated.	
  All	
  mice	
  and	
  embryos	
  were	
  genotyped	
  by	
  PCR	
  amplification	
  of	
  diagnostic	
  biopsies	
  (primers	
  are	
  listed	
  in	
  Table	
  1).	
  	
  	
  
Genetic	
  crosses	
  of	
  Smad4	
  alleles	
  The	
  Smad4flox	
  conditional	
  allele	
  (Yang	
  et	
  al.,	
  2002)	
  was	
  inactivated	
  either	
  using	
  the	
  Prx1-­‐
CreTg	
   in	
  the	
  mouse	
  limb	
  bud	
  mesenchyme	
  from	
  about	
  9.5	
  days	
  post	
  coitum	
  (E9.5;	
  Logan	
  et	
  al.),	
  or	
  using	
  the	
  Hoxa13-­‐CreTg	
  knock-­‐in	
  allele	
  during	
  autopod	
  development	
  from	
  about	
  E10.75	
   onwards	
   (Lopez-­‐Rios	
   et	
   al.,	
   2012;	
   Scotti	
   and	
   Kmita,	
   2012).	
   The	
   Smad4flox	
   was	
  crossed	
   to	
   the	
  Hoxb6-­‐CreTg	
   to	
   inactivate	
   Smad4	
   in	
   the	
   hindlimb	
   field	
   and	
   the	
   posterior	
  forelimb	
  mesoderm	
  (Lowe	
  et	
  al.,	
  2000).	
  The	
  Msx2-­‐Cre	
  allele	
  (Sun	
  et	
  al.,	
  2000)	
  was	
  used	
  to	
  inactivate	
   the	
  Smad4flox	
  allele	
   in	
   the	
   limb	
  bud	
  ectoderm	
   from	
  about	
  E9.5	
  onward	
   in	
   the	
  presence	
   of	
   two	
   Grem1	
   null	
   alleles	
   (Grem1Δ;	
   see	
   Michos	
   et	
   al.,	
   2004).	
   The	
   Smad4	
   null	
  allele	
  (Smad4Δ) was	
  obtained	
  by	
  crossing	
  Smad4flox	
  allele	
  with	
  a	
  CMV-­‐Cre	
  deleter	
  mouse	
  strain	
  (Schwenk	
  et	
  al.,	
  1995).	
  Smad4Δ/Δ	
  embryos	
  are	
  lethal	
  between	
  E6.5	
  and	
  E8.5	
  due	
  to	
  defective	
   epiblast	
   proliferation	
   and	
   impaired	
   mesoderm	
   induction,	
   whereas	
  heterozygous	
  animals	
  are	
  phenotypically	
  normal	
  (Yang	
  et	
  al.,	
  1998a).	
  
	
  
	
  
Inactivation	
  of	
  Smad4	
  in	
  the	
  mesenchyme	
  
Prx1-­‐CreTg-­‐positive	
  mice	
  were	
  crossed	
  with	
  mice	
  carrying	
   the	
  Smad4Δ	
  allele	
   to	
  generate	
  the	
  Prx1-­‐CreTg/+;	
  Smad4Δ/+	
  compound	
  heterozygous	
  males.	
  These	
  males	
  were	
  crossed	
  with	
  
Smad4flox/flox	
  females	
   to	
  obtain	
  experimental	
  embryos	
   that	
   carried	
  a	
   constitutive	
  deleted	
  and	
   a	
   conditionally	
   inactivated	
   allele	
   (Smad4Δ/ΔM).	
   A	
   similar	
   procedure	
   was	
   used	
   to	
  generate	
   Hoxb6-­‐CreTg/+;	
   Smad4Δ/+	
   males	
   and	
   Smad4Δ/ΔHb6	
   experimental	
   embryos.	
  Moreover,	
  mice	
  carrying	
  the	
  conditional	
  β-­‐Actin-­‐GFP	
  locus	
  in	
  a	
  Balb/c	
  background	
  were	
  mated	
  to	
  Hoxb6-­‐Cre	
  transgene	
  to	
  generate	
  reporter	
  embryos	
  to	
  monitor	
  the	
  Cre-­‐mediated	
  recombination	
   (Jagle	
   et	
   al.,	
   2007).	
   Smad4+/+,	
   Smad4flox/+,	
   Smad4flox/flox,	
   Smad4ΔM/+,	
  
Smad4ΔHb6/+	
  or	
  Prx1-­‐CreTg/+	
  embryos	
  were	
  used	
  as	
  controls	
  and	
  are	
  collectively	
  referred	
  to	
  as	
  ‘Wt’.	
  	
  
	
  
	
   35	
  
Inactivation	
  of	
  Smad4	
  in	
  the	
  autopod	
  
Hoxa13-­‐CreTg	
  knock-­‐in	
  transgene	
  was	
  crossed	
  either	
  with	
  Smad4Δ/+	
  or	
  Smad4flox/flox	
  mice	
  to	
  get	
  Hoxa13-­‐CreTg/+;	
  Smad4Δ/+	
  and	
  Hoxa13-­‐CreTg/+;	
  Smad4flox/+	
  males.	
  These	
  males	
  were	
  crossed	
   with	
   Smad4flox/flox	
   females	
   to	
   obtain	
   a	
   total	
   of	
   180	
   embryos.	
   In	
  Hoxa13-­‐CreTg/+;	
  
Smad4flox/+	
   males,	
   the	
   Hoxa13-­‐CreTg	
   transgene	
   failed	
   to	
   ectopically	
   recombine	
   the	
  
Smad4flox	
   allele	
   in	
   the	
   germ-­‐line	
   approximately	
   25%	
   of	
   all	
   cases,	
   thus	
   providing	
   the	
  progeny	
   with	
   two	
   conditional	
   alleles	
   to	
   be	
   inactivated.	
   Thus,	
   either	
   Smad4Δ/ΔA13	
   or	
  
Smad4ΔA13/ΔA13	
   embryos	
   were	
   used	
   as	
   experimental	
   samples.	
   Smad4+/+,	
   Smad4flox/+,	
  
Smad4flox/flox,	
  Smad4ΔM/+,	
  Smad4ΔHb6/+	
  or	
  Hoxa13-­‐CreTg/+	
  embryos	
  were	
  used	
  as	
  controls	
  and	
  collectively	
  referred	
  to	
  as	
  ‘Wt’.	
  	
  
	
  
Inactivation	
  of	
  Smad4	
  in	
  the	
  AER	
  in	
  a	
  Grem1-­‐deficient	
  genetic	
  background	
  In	
  order	
   inactivate	
  Smad4	
  in	
   the	
  AER	
  of	
  mouse	
  embryos	
  deficient	
   for	
  Grem1	
   (Grem1Δ/Δ;	
  
Smad4Δ/ΔAER),	
   the	
   following	
   genetic	
   crosses	
   were	
   done:	
  Msx2-­‐CreTg/+	
   males	
   were	
  mated	
  with	
  Grem1Δ/+	
   females	
   to	
  generate	
  Msx2-­‐CreTg/+;	
  Grem1Δ/+	
  mice,	
  and	
  to	
  Smad4Δ/+	
   females	
  to	
  generate	
  Msx2-­‐CreTg/+;	
  Smad4Δ/+	
  mice.	
  The	
  compound	
  mutant	
  mice	
  were	
  inter-­‐crossed	
  to	
   get	
   Msx2-­‐CreTg/(Tg/+);	
   Grem1Δ/+;	
   Smad4Δ/+	
   males.	
   Compound	
   Grem1Δ/+;	
   Smad4flox/flox	
  females	
  were	
   obtained	
   by	
   crossing	
  Grem1Δ/+	
  males	
  with	
  Smad4flox/flox	
   females	
   and	
   inter-­‐crossing	
   the	
   progeny	
   that	
   exhibited	
   a	
   Grem1Δ/+;	
   Smad4flox/+	
   genotype.	
   Grem1Δ/Δ;	
  
Smad4Δ/ΔAER	
   embryos	
   were	
   compared	
   with	
   Grem1+/+;	
   Smad4L/+,	
   Grem1Δ/+;	
   Smad4L/+,	
  
Grem1+/+;	
  Smad4Δ/L	
  (overall	
  referred	
  to	
  as	
  Wild-­‐type	
  controls	
  ‘Wt’).	
  	
  
	
  
Inactivation	
  of	
  Smad4	
  in	
  the	
  limb	
  bud	
  mesenchyme	
  of	
  Shh	
  deficient	
  embryos	
  
ShhΔ/Δ;	
   Smad4Δ/ΔM	
   compound	
   mutant	
   embryos	
   were	
   obtained	
   with	
   the	
   same	
   kind	
   of	
  crosses	
   as	
   for	
  Grem1Δ/Δ;	
   Smad4Δ/ΔAER	
   embryos	
   (ShhΔ	
   allele	
   comes	
   from	
   St-­‐Jacques	
   et	
   al.,	
  1998).	
  
	
  
	
  
Genetic	
  crosses	
  of	
  Bmp2	
  and	
  Bmp4	
  alleles	
  
Prx1-­‐CreTg	
  allele	
  was	
  used	
  to	
  inactivate	
  both	
  Bmp2flox	
  (Ma	
  and	
  Martin,	
  2005)	
  and	
  Bmp4flox	
  (Liu	
  et	
  al.,	
  2004)	
  conditional	
  alleles	
  to	
  generate	
  compound	
  mutant	
  embryos.	
  Briefly,	
   Prx1-­‐CreTg/Tg	
  mice	
   were	
   crossed	
   with	
   Bmp2flox/flox	
  and	
   Bmp4flox/flox	
   conditional	
  alleles	
   to	
   get	
   Prx1-­‐CreTg/+;	
   Bmp2flox/+	
   and	
   Prx1-­‐CreTg/+;	
   Bmp4flox/+	
   compound	
   transgenic	
  mice,	
  respectively.	
  These	
  mice	
  were	
  further	
  mated	
  to	
  generate	
  Prx1-­‐CreTg/(Tg/+);	
  Bmp2flox/+;	
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Bmp4flox/+	
  males.	
   Females	
  were	
  generated	
  by	
  mating	
  Bmp2flox/flox	
   to	
  Bmp4flox/flox	
  mice	
   and	
  the	
  progeny	
  was	
   inter-­‐crossed	
   to	
  get	
   the	
  Bmp2flox/flox;	
  Bmp4flox/flox	
   genotype.	
  Prx1-­‐CreTg/+;	
  
Bmp2ΔM/ΔM;	
   Bmp4ΔM/ΔM	
   embryos	
   were	
   compared	
   to	
   control	
   embryos	
   	
   (Bmp2flox/+;	
  
Bmp4flox/+,	
  Bmp2flox/flox;	
  Bmp4flox/+	
  or	
  Bmp2flox/+;	
  Bmp4flox/flox).	
  	
  	
  
Table	
  1.	
  Genotyping	
  primers	
  
Gene	
   Forward	
  primer	
   Reverse	
  primer	
   Allele	
  
Cre	
   5'-­‐GCCTGCATTACCGGTCGATGCAACGA-­‐3'	
   5'-­‐GTGGCAGATGGCGCGGCAACACCATT-­‐3'	
   Tg	
  
Prx1-­‐Cre	
   5'-­‐GGGCTCTCTCCTTAGCTTCCC-­‐3'	
   5'-­‐CCTGGCGATCCCTGAACATGTCC-­‐3'	
   Tg	
  
Msx2-­‐Cre	
   5'-­‐AACAACTCTGCTGACTGCTCCTG-­‐3'	
   5'-­‐CCTGGCGATCCCTGAACATGTCC-­‐3'	
   Tg	
  
Hoxa13-­‐Cre	
   5'-­‐CGTAATCTGGCATTTCTGGGGATTG-­‐3'	
   5'-­‐CCAGAGTCATCCTTAGCGCCGTAAA-­‐3'	
   Tg	
  (knock-­‐in)	
  
Hoxb6-­‐Cre	
  
	
  5'-­‐GCTAAAACCCAATCTCGGCTAT-­‐3'	
   5'-­‐AGCATTTTCCAGGTATGCTCAG-­‐3'	
   Tg	
  
Smad4	
   5'-­‐GGGCAGCGTAGCATATAAGAC-­‐3'	
   5'-­‐CCTGACCCAAACGTCACCTTC-­‐3'	
   Wt/Flox	
  allele	
  
	
   	
   5'-­‐AAGAGCCACAGGTCAAGCAG-­‐3'	
   Null	
  allele	
  Grem1	
   5'-­‐ATGAATCGCACCGCATACACTG-­‐3'	
   5'-­‐TCCAAGTCGATGGATATGCAACG-­‐3'	
   Wt	
  allele	
  (Michos	
  et	
  al.,2004)	
  
	
  
5'-­‐GGCACATGGCTGAATATCGACGG-­‐3'	
   5'-­‐AAGCGCCTCCCCTACCCGGTA-­‐3'	
   Null	
  allele	
  (Michos	
  et	
  al.,2004)	
  
Bmp2	
   5'-­‐GCTTGGTCTGGTAATCTTCCT-­‐3'	
   5'-­‐AGGGATGCTGCTGTTTCTGGA-­‐3'	
   Wt/flox	
  allele	
  
	
   	
   5'-­‐AAGCGCCTCCCCTACCCGGTA-­‐3'	
   Null	
  allele	
  
Bmp4	
   5'-­‐GCTAAGTTTTGCTGGTTTGC-­‐3'	
   5'-­‐GCCCATGAGCTTTTCTGAGA-­‐3'	
   Wt/flox	
  (Liu	
  et	
  al.,	
  2004)	
  
Shh	
   5’-­‐GAAGAGATCAAGGCAAGCTCTGGC-­‐3'	
   5’-­‐ATGCTGGCTCGCCTGGCTGTGGAA-­‐3'	
   Wt	
  allele	
  
	
   	
   5’-­‐GGACACCATTCTATGCAGGG-­‐3'	
   Null	
  allele	
  	
  	
  	
  
Whole	
  Mount	
  In	
  Situ	
  Hybridization	
  (WISH)	
  	
  The	
  protocol	
  for	
  WISH	
  was	
  previously	
  described	
  (Probst	
  et	
  al.,	
  2013)	
  and	
  is	
  an	
  adaptation	
  of	
  the	
  original	
  protocol	
  from	
  Wilkinson	
  (1992)	
  .	
  Embryos	
  were	
  dissected,	
  phenotyped	
  and	
  number	
  of	
  somites	
  recorded	
  (counted	
  up	
  to	
  E12.0)	
   and	
   fixed	
   overnight	
   (ON)	
   at	
   4°C	
   in	
   4%	
   paraformaldehyde	
   (PFA)	
   in	
   phosphate	
  buffer	
  saline	
  (PBS).	
  The	
  day	
  after	
  they	
  were	
  dehydrated	
  in	
  progressively	
  higher	
  methanol	
  concentration	
   in	
   PBS	
   and	
   0.1%	
   Tween-­‐20	
   (PBT),	
   and	
   stored	
   at	
   -­‐20°C	
   for	
   further	
   use.	
  Unless	
  stated,	
  all	
  steps	
  were	
  performed	
  with	
  gentle	
  rocking	
  for	
  mixing.	
  The	
  first	
  day	
  of	
  WISH,	
  experimental	
  and	
  control	
  embryos	
  were	
  age-­‐matched	
  by	
  somite	
  number	
   and	
   limb	
   shape,	
   re-­‐hydrated	
   through	
   progressively	
   lower	
   methanol	
  concentration	
  into	
  PBT	
  and	
  cleared	
  in	
  6%	
  hydrogen	
  peroxide	
  (AppliChem)	
  in	
  PBT	
  for	
  15	
  min.	
  Embryos	
  were	
  washed	
  with	
  PBT	
  (3	
  times)	
  and	
  digested	
  with	
  10	
  μg/ml	
  Proteinase	
  K	
  (PK,	
  Merck)	
  for	
  a	
  time	
  period	
  ranging	
  from	
  15	
  min	
  and	
  1	
  h	
  according	
  to	
  embryos	
  size	
  and	
  sample	
   thickness.	
  For	
  ectodermal	
  probes,	
  a	
  4-­‐min	
  digestion	
  with	
  5	
  μg/ml	
  PK	
  was	
  used.	
  From	
   PK	
   treatment	
   until	
   re-­‐fixation,	
   samples	
   are	
   kept	
   still	
   –	
   i.e.	
   not	
   rocking	
   -­‐.	
   The	
   PK	
  digestion	
  was	
  stopped	
  using	
  freshly	
  prepared	
  2	
  mg/ml	
  glycine	
  in	
  PBT	
  and	
  embryos	
  were	
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washed	
  twice	
  in	
  PBT.	
  Embryos	
  were	
  re-­‐fixed	
  with	
  0.2%	
  glutaraldehyde,	
  4%	
  PFA	
  in	
  PBT	
  for	
  20	
  min	
  at	
  Room-­‐Temperature	
  (RT)	
  and	
  washed	
  twice	
  with	
  PBT.	
  Embryos	
  were	
  then	
  equilibrated	
   into	
  pre-­‐warmed	
  pre-­‐hybridization	
  mix	
  at	
  70°C	
  for	
  1	
  hr	
  or	
   longer	
  and	
  pre-­‐hybridization	
  mix	
  was	
   then	
   replaced	
   by	
   probe	
   solution	
   (10	
   μl	
   of	
   probe	
   in	
   1	
  ml	
   of	
   pre-­‐hybridization	
  mix)	
  ON	
  at	
  70°C.	
  Digoxigenin-­‐labelled	
  antisense	
  riboprobes	
  were	
  prepared	
  from	
   linearized	
   and	
   transcribed	
   plasmid	
   containing	
   the	
   cloned	
   cDNA	
   of	
   interest.	
   The	
  riboprobes	
  were	
  purified	
  using	
  two	
  steps	
  of	
  ethanol	
  precipitation,	
  the	
  first	
  with	
  and	
  the	
  second	
  without	
  adding	
   linearized	
  polyacrylamide.	
  Probes	
  were	
  heated	
  5	
  min	
  at	
  85°C	
   in	
  pre-­‐hybridization	
  mix	
  and	
  equilibrated	
  at	
  70°C	
  before	
  use.	
  Probes	
  were	
  re-­‐used	
  several	
  times	
  and	
  stored	
  at	
  -­‐20°C.	
  The	
   second	
   day	
   of	
  WISH,	
   embryos	
  were	
   brought	
   through	
   several	
   steps	
   (100%,	
   75%,	
  50%,	
  25%)	
  of	
  pre-­‐hybridization	
   solution/	
  2x	
  SSC	
   (pH	
  4.5)	
  at	
  70°C.	
  Embryos	
  were	
   then	
  washed	
   twice	
   in	
   2x	
   SSC,	
   0.1%	
   CHAPS	
   (Sigma)	
   for	
   30	
  min	
   at	
   70°C	
   and	
   treated	
  with	
   20	
  μg/ml	
  RNase	
  A	
  (Sigma)	
   in	
  2x	
  SSC,	
  0.1%	
  CHAPS	
   for	
  25	
  min	
  at	
  37°C.	
  Embryos	
  were	
   then	
  washed	
   twice	
   with	
   maleic	
   acid	
   buffer	
   (10	
   min	
   at	
   RT)	
   and	
   twice	
   for	
   30	
   min	
   at	
   70°C.	
  Embryos	
  were	
  washed	
  further	
  in	
  TBST	
  (3	
  times	
  for	
  5	
  min	
  RT)	
  and	
  blocked	
  in	
  10%	
  goat	
  serum	
  in	
  TBST	
  (blocking	
  buffer)	
  for	
  at	
  least	
  1	
  h.	
  Blocking	
  buffer	
  was	
  replaced	
  with	
  anti-­‐digoxigenin	
   fragment	
   antigen-­‐binding	
   conjugated	
   with	
   alkaline	
   phosphatase	
   (Roche)	
  diluted	
  1:5000	
  in	
  1%	
  goat	
  serum	
  in	
  TBST.	
  Samples	
  were	
  incubated	
  ON	
  at	
  4°C.	
  	
  The	
  third	
  day	
  of	
  WISH,	
  embryos	
  were	
  washed	
  RT	
  several	
  times	
  with	
  TBST	
  over	
  the	
  day	
  and	
  left	
  in	
  TBST	
  ON	
  at	
  4°C.	
  The	
  fourth	
  day	
  of	
  WISH,	
  embryos	
  were	
  equilibrated	
  in	
  NTMT	
  for	
  3	
  times,	
  10	
  min	
  each	
  at	
   RT	
   and	
   then	
  moved	
   into	
   1	
  ml	
   of	
   BM	
  Purple	
   (Roche	
   cat.	
  No	
   11442074001).	
   Samples	
  were	
  developed	
  in	
  the	
  dark,	
  then	
  washed	
  with	
  PBT	
  at	
  least	
  3	
  times	
  and	
  moved	
  into	
  PBS.	
  Results	
  were	
  documented	
  using	
  a	
  Leica	
  stereomicroscope	
  with	
  digital	
  camera.	
  Alternatively,	
   WISH	
   was	
   performed	
   for	
   OPT	
   imaging.	
   To	
   this	
   end,	
   the	
   following	
  modifications	
   were	
   used	
   in	
   order	
   to	
   ensure	
   a	
   better	
   penetrance	
   of	
   the	
   chromogenic	
  substrate	
  into	
  the	
  embryos:	
  First	
   day	
   WISH:	
   hydrogen	
   peroxide	
   treatment	
   was	
   kept	
   for	
   1	
   hr	
   instead	
   of	
   15	
   min;	
  glycine	
  step	
  was	
  not	
  used;	
  re-­‐fixation	
  was	
  performed	
  at	
  4°C	
  for	
  1	
  hr;	
  incubation	
  with	
  pre-­‐hybridization	
  solution	
  was	
  performed	
  1	
  x	
  20	
  min	
  RT	
  and	
  1	
  x	
  3	
  hr	
  at	
  70°C.	
  Second	
  day	
  WISH:	
  embryos	
  were	
  moved	
  in	
  post-­‐hybridization	
  solution	
  and,	
  from	
  here,	
  to	
  progressively	
  higher	
   concentration	
  of	
   2x	
   SSC.	
  After	
   SSC	
   equilibration,	
   embryos	
  were	
  washed	
  twice	
  in	
  2x	
  SSC	
  +	
  0.1%	
  CHAPS	
  at	
  70°C	
  for	
  30	
  min,	
  then	
  once	
  with	
  0.2x	
  SSC	
  +	
  0.1%	
  CHAPS	
   at	
   70°C	
   for	
   30	
  min	
   and	
   finally	
   once	
  with	
   0.2x	
   SSC	
   +	
   0.1%	
  CHAPS	
  while	
   cooling	
  down	
   to	
   RT	
   for	
   30	
   min;	
   samples	
   were	
   then	
   washed	
   with	
   TNT	
   once	
   for	
   10	
   min	
   and	
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blocked	
   in	
   blocking	
   solution	
   at	
   4°C	
   for	
   4	
   hr.	
   Antibody	
   was	
   diluted	
   1:2000	
   in	
   blocking	
  solution	
  and	
  incubation	
  was	
  performed	
  ON	
  at	
  4°C.	
  Third	
   day	
   WISH:	
   washes	
   were	
   performed	
   with	
   TNT	
   +	
   0.1%	
   bovine	
   serum	
   albumin	
  (BSA).	
  Fourth	
  day	
  WISH:	
  embryos	
  were	
  equilibrated	
  in	
  NMT	
  +	
  0.1%	
  Triton	
  x-­‐100	
  twice	
  for	
  30	
  min,	
  then	
  washed	
  3	
  times	
  10	
  min	
  in	
  NMT	
  and	
  stained	
  with	
  a	
  mix	
  of	
  nitro-­‐blue	
  tetrazolium	
  and	
  5-­‐bromo-­‐4-­‐chloro-­‐3-­‐indolyphosphate:	
  BCIP	
  (3.5	
  μg/ml)	
  +	
  NBT	
  (0.3	
  μg/ml)	
  in	
  NMT.	
  	
  
	
  
Embryo	
  trunk	
  culture	
  and	
  limb	
  bud	
  grafting	
  Embryos	
   were	
   isolated	
   either	
   at	
   E10.5	
   –	
   E10.75	
   (34-­‐39	
   somites)	
   or	
   E11.5	
   (45	
   –	
   50	
  somites)	
  in	
  tissue	
  culture-­‐grade	
  PBS	
  in	
  plastic	
  Petri	
  dishes,	
  then	
  moved	
  into	
  6-­‐well	
  plates	
  containing	
   pre-­‐equilibrated	
   culture	
  medium	
   (see	
   below)	
   and	
   kept	
   inside	
   the	
   incubator	
  (37°C,	
  5%	
  CO2).	
  Embryos	
  were	
   then	
  processed	
   individually:	
   the	
  head	
  and	
   the	
  hindlimb	
  together	
   with	
   the	
   posterior-­‐most	
   part	
   were	
   removed	
   and	
   the	
   remaining	
   trunk	
   was	
  further	
  cleaned	
  of	
  the	
  heart	
  and	
  the	
  ventral	
  tissue.	
  Then,	
  a	
  small	
  hole	
  was	
  made	
  into	
  the	
  right	
   forelimb	
   with	
   a	
   sharpened	
   tungsten	
   needle	
   and	
   the	
   customized	
   heparin-­‐coated	
  beads	
  (see	
  below)	
  were	
  placed	
  into	
  the	
  hole.	
  The	
  trunks	
  were	
  positioned	
  on	
  a	
  V-­‐shaped	
  metal	
  grid	
   in	
  a	
  24-­‐well	
  plate	
  at	
   the	
   interface	
  between	
  culture	
  medium	
  and	
  air,	
  with	
   the	
  help	
  of	
  thin	
  pins.	
  Trunks	
  were	
  cultured	
  for	
  the	
  indicated	
  time	
  at	
  37°C,	
  6.5%	
  CO2.	
  After	
  the	
  incubation	
   period,	
   pins	
   were	
   removed	
   and	
   the	
   trunks	
   were	
   washed	
   3	
   x	
   5	
   min	
   in	
   PBS	
  before	
  imaging.	
  An	
  ON	
  fixation	
  with	
  4%	
  PFA	
  in	
  PBS	
  at	
  4°C	
  followed	
  if	
  the	
  samples	
  were	
  to	
  be	
  processed	
  for	
  WISH.	
  	
  	
  
Culture	
  Medium	
  for	
  embryo	
  trunk	
  culture	
  	
  (prepared	
  freshly	
  on	
  the	
  day	
  of	
  use):	
  	
  
• 500	
  ml	
  Dulbecco’s	
  Modified	
  Eagle	
  Medium	
  (1x),	
  liquid	
  (high	
  glucose)	
  (Cat.	
  41966-­‐	
  029,	
  Gibco)	
  
• 5	
  ml	
  L-­‐glutamine	
  (Cat.	
  25030-­‐024,	
  Gibco)	
  
• 2.5	
  ml	
  penicillin-­‐streptomycin	
  (Cat.	
  15140-­‐122,	
  Gibco)	
  
• 5	
  ml	
  non-­‐essential	
  amino	
  acids	
  (Cat.	
  11140-­‐035,	
  Gibco)	
  
• 5	
  ml	
  sodium	
  pyruvate	
  (Cat.	
  11360-­‐039,	
  Gibco)	
  
• 5	
  ml	
  D-­‐glucose	
  (45%	
  solution)	
  (Cat.	
  G8769,	
  Sigma)	
  
• 0.5	
  ml	
  L-­‐ascorbic	
  acid	
  (Cat.	
  A4034,	
  Sigma)	
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• 5	
  ml	
  lactic	
  acid	
  (Cat.	
  L4388,	
  Sigma)	
  
• 0.5	
  ml	
  d-­‐biotin/vitam	
  B12	
  (Cat.	
  B4639	
  and	
  V6629	
  respectively,	
  Sigma)	
  
• 0.5	
  ml	
  PABA	
  (Cat.	
  A9878,	
  Sigma)	
  	
  L-­‐ascorbic	
   acid	
   and	
   lactic	
   acid	
   were	
   dissolved	
   in	
   PBS	
   and	
   DMEM,	
   respectively,	
   and	
  filtered	
  through	
  a	
  0.22	
  μm	
  sieve	
  on	
  the	
  day	
  of	
  use.	
  	
  Stocks:	
  
• d-­‐biotin:	
  0.2	
  mg	
  per	
  ml	
  DMEM.	
  Filter	
  through	
  0.22	
  μm	
  filter,	
  0.5	
  ml	
  aliquots	
  stored	
  at	
  	
  -­‐20°C;	
  
• Vitamin	
  B12:	
  40	
  μg	
  per	
  ml	
  DMEM.	
  Filter	
  through	
  0.22	
  μm	
  filter,	
  0.5	
  ml	
  aliquots	
  	
  stored	
  at	
  -­‐20°C;	
  
• PABA:	
  2	
  mg	
  per	
  ml	
  PBS.	
  Filter	
  through	
  0.22	
  μm	
  filter,	
  make	
  0.5	
  ml	
  aliquots	
  stored	
  at	
  	
  -­‐20°C.	
  
	
  
Loading	
  of	
  beads	
  with	
  proteins	
  Heparin-­‐Acrylic	
  beads	
  (Cat.	
  H5263,	
  Sigma)	
  were	
  washed	
  in	
  a	
  drop	
  of	
  PBS	
  before	
  moving	
  them	
   in	
   a	
   drop	
   of	
   hrBMP4	
   (R&D,	
   0.1	
   mg/ml)	
   and	
   incubated	
   on	
   ice	
   in	
   a	
   humidified	
  environment	
   for	
   30	
  min.	
   After	
   incubation,	
   beads	
   were	
   left	
   on	
   ice	
   in	
   a	
   drop	
   of	
   culture	
  medium	
  before	
  implantation.	
  	
  	
  
Skeletal	
  preparations	
  Embryos	
   older	
   than	
  E14	
  were	
   isolated	
   and	
  placed	
   in	
   ice-­‐cold	
  PBS	
   for	
   anesthesia.	
   Then	
  they	
  were	
  euthanized	
  by	
  exsanguination.	
  Subsequently	
   the	
  carcass	
  was	
  eviscerated	
  and	
  macerated	
  ON	
   in	
   tap	
  water,	
   and	
   dehydrated	
   in	
   95%	
   ethanol	
   from	
   one	
   to	
   several	
   days.	
  Liver	
  biopsies	
  were	
  taken	
  for	
  genotyping.	
  Alcian	
  blue	
  staining	
  (30	
  mg	
  Alcian	
  Blue	
  8GX	
  –	
  Sigma	
   -­‐,	
   85%	
   (v/v)	
   ethanol,	
   20%	
   (v/v)	
   glacial	
   acetic	
   acid)	
  was	
   performed	
  ON	
   and	
  was	
  followed	
  by	
  one-­‐day	
  washing	
  with	
  95%	
  ethanol.	
  Embryos	
  were	
  then	
  cleared	
  in	
  1%	
  (w/v)	
  potassium	
   hydroxide	
   (KOH)	
   in	
   distilled	
   water	
   for	
   about	
   10	
   min,	
   counterstained	
   with	
  Alizarin	
  Red	
  (50	
  mg	
  Alizarin	
  Red	
  –	
  Sigma	
  -­‐,	
  in	
  1%	
  (w/v)	
  KOH)	
  for	
  1	
  hr	
  and	
  cleared	
  in	
  1%	
  KOH	
   for	
   an	
   additional	
   hour.	
   Embryos	
   were	
   then	
   moved	
   through	
   progressively	
   higher	
  ratio	
  of	
  glycerol/1%	
  KOH	
  solutions	
  according	
   to	
   the	
  speed	
  of	
   the	
  clearing	
  process	
   till	
   a	
  final	
   stocking	
   solution	
   (80%	
   glycerol	
   in	
   water).	
   Embryos	
   were	
   pictured	
   on	
   a	
   Leica	
  stereomicroscope.	
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Whole	
  mount	
  immunofluorescence	
  (WIF)	
  	
  Embryos	
  were	
  dissected	
  and	
  processed	
  for	
  fixation	
  and	
  dehydration	
  the	
  same	
  way	
  as	
  for	
  WISH.	
  The	
  first	
  day	
  of	
  WIF,	
  embryos	
  were	
  rehydrated	
  through	
  decreasing	
  methanol/PBT	
  ratio	
  solutions,	
  washed	
  once	
  in	
  PBT	
  for	
  5	
  min	
  and	
  once	
  in	
  H2O	
  for	
  5	
  min.	
  Embryos	
  were	
  further	
  permeabilized	
  in	
  pre-­‐chilled	
  acetone	
  at	
  -­‐20°C	
  for	
  15-­‐20	
  min,	
  washed	
  in	
  PBT	
  and	
  moved	
  in	
  Immunoblock	
  solution	
  (5%	
  goat	
  serum	
  in	
  Immunowash	
  solution)	
  for	
  at	
  least	
  2	
  hr.	
  Embryos	
  were	
  incubated	
  for	
  4	
  days	
  at	
  4°C	
  in	
  Immunoblock	
  solution	
  containing	
  rabbit-­‐monoclonal	
  SMAD4	
  antibody	
  (Abcam,	
  ab40759)	
  diluted	
  1:100	
  and	
  0.1%	
  Na	
  Azide.	
  After	
  primary	
  antibody	
  incubation,	
  embryos	
  were	
  washed	
  7	
  x	
  15	
  min	
  followed	
  by	
  1	
  x	
  2	
  hrs	
  in	
  Immunowash	
   solution	
   and	
   blocked	
   in	
   Immunoblock	
   solution	
   for	
   about	
   2	
   hrs.	
   Embryos	
  were	
   moved	
   into	
   Immunoblock	
   solution	
   containing	
   Alexa	
   Fluor	
   594	
   Goat-­‐anti-­‐Rabbit	
  (Life	
  Technologies)	
  diluted	
  1:250	
  and	
  0.1%	
  Na	
  Azide,	
  and	
  were	
   incubated	
  ON	
  at	
  4°C	
   in	
  the	
   dark	
   for	
   additional	
   4	
   days.	
   After	
   incubation,	
   embryos	
   were	
   washed	
   8	
   x	
   15	
  min	
   in	
  Immunowash	
  solution	
  and	
  2	
  x	
  5	
  min	
  in	
  PBT.	
  After	
  this	
  step,	
  samples	
  were	
  processed	
  for	
  OPT	
  imaging.	
  
	
  
	
  
OPT	
  imaging	
  The	
  OPT	
  scanner	
  (Bioptonics,	
  MRC,	
  Edinburgh)	
  allows	
  three	
  dimensional	
  (3D)	
  imaging	
  of	
  tissue	
   up	
   to	
   15	
  mm	
   in	
   depth	
   by	
   picturing	
   several	
   projection	
   of	
   fluorescent	
   or	
   colored	
  biological	
   specimen	
   and	
   reconstructing	
   the	
   3D	
   signal	
   (Sharpe	
   et	
   al.,	
   2002).	
   Processed	
  biological	
  specimen	
  are	
  embedded	
  in	
  a	
  low-­‐melting	
  point	
  agarose	
  (Sigma)	
  and	
  glued	
  on	
  a	
  magnet	
   suited	
   for	
  OPT	
   scanning	
   (Bioptonics).	
   Specimens	
  were	
  dehydrated	
   in	
  methanol	
  ON	
  and	
  cleared	
  in	
  one	
  part	
  Benzyl	
  Alcohol	
  and	
  two	
  parts	
  Benzyl	
  Benzoate	
  (BABB,	
  Sigma)	
  ON.	
   Specimens	
   were	
   scanned	
   at	
   either	
   high	
   (1024x1024	
   pixels)	
   or	
   intermediate	
  resolution	
  (512x512	
  pixels)	
  using	
  Skyscan	
  software	
  (Bioptonics,	
  MRC	
  Technology).	
  Auto-­‐fluorescence	
   in	
   the	
   GFP1	
   filter	
   (425/40	
   nm,	
   475	
   nm	
   LP)	
   was	
   used	
   to	
   detect	
   sample	
  anatomy.	
   Bright	
   field	
   or	
   the	
   TXR	
   filter	
   (560/40	
   nm,	
   610	
   nm	
   LP)	
   was	
   used	
   to	
   image	
  NBT/BCIP	
   stainings	
   or	
   fluorescent	
   signals,	
   respectively.	
   Projection	
   reconstruction	
   was	
  performed	
   using	
   NRecon	
   software	
   (SkyScan)	
   and	
   analyzed	
   using	
   Bioptonics	
   Viewer	
  (Bioptonics,	
  MRC	
  Technology).	
  Rendering	
  images	
  were	
  either	
  taken	
  using	
  the	
  maximum	
  intensity	
   projection	
   function	
   or	
   creating	
   iso-­‐surfaces	
   with	
   Bioptonics	
   Viewer	
  (parameters:	
   25%	
   iso-­‐surface	
   quality	
   and	
   50%	
  gaussian	
   smoothing).	
   Iso-­‐surfaces	
  were	
  always	
  compared	
  to	
  the	
  strength	
  and	
  distribution	
  of	
  the	
  original	
  signal	
  to	
  exclude	
  overt	
  manipulation	
  of	
  the	
  result.	
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Cell	
  death	
  detection	
  using	
  lysotracker	
  Lysotracker	
   Red	
   DND-­‐99	
   (Invitrogen)	
   is	
   a	
   fluorescent	
   probe	
   (max	
   absorption	
   577	
   nm,	
  max	
  emission	
  590	
  nm)	
  conjugated	
  to	
  a	
  weak	
  base.	
  It	
  is	
  highly	
  permeable	
  to	
  membranes	
  and	
   is	
   trapped	
   and	
   accumulates	
   in	
   acidic	
   organelles	
   (mostly	
   lysosomes),	
   providing	
   a	
  specific	
   and	
   sensitive	
   tool	
   for	
   cell	
   death	
   detection.	
   Embryos	
   were	
   dissected	
   in	
   Hank’s	
  balanced	
   salt	
   solution	
   (HBSS)	
   and	
   incubated	
   in	
   a	
   pre-­‐warmed	
   solution	
   of	
   HBSS.	
  Lysotracker	
   probe	
   was	
   diluted	
   1:200,	
   at	
   37°C	
   in	
   the	
   dark	
   for	
   45	
   min.	
   Embryos	
   were	
  incubated	
   in	
   the	
   Lysotracker	
   solution	
   and	
   then	
  washed	
   5	
   x	
   10	
  min	
  with	
   RT	
  HBSS	
   and	
  fixed	
  ON	
  with	
  4%	
  PFA	
  in	
  PBS	
  at	
  4°C	
  in	
  the	
  dark.	
  The	
  day	
  after,	
  samples	
  were	
  dehydrated	
  in	
  methanol	
   through	
   solutions	
   of	
   increasing	
  methanol/PBT	
   ratio,	
   cleared	
   in	
   BABB	
   and	
  imaged	
   at	
   a	
   Leica	
   stereomicroscope.	
   Auto-­‐fluorescence	
  was	
   also	
   captured	
   and	
   used	
   to	
  outline	
   the	
   limb	
   profile	
   with	
   a	
   white	
   dotted	
   line	
   (image	
   processing	
   was	
   performed	
   in	
  Adobe	
  Photoshop®).	
  
	
  
	
  
Quantitative	
  Real-­‐time	
  PCR	
  (RT-­‐qPCR)	
  analysis	
  Forelimb	
  pairs	
  were	
  collected	
  and	
  stored	
  in	
  RNAlater	
  (Ambion).	
  Alternatively,	
  embryoid	
  bodies	
   (EBs)	
   were	
   trypsinized	
   and	
   stored	
   in	
   RNAlater.	
   RNA	
   isolation	
   was	
   performed	
  using	
  the	
  RNeasy	
  Micro	
  kit	
  (Qiagen)	
  or	
  by	
  phenol/chloroform	
  extraction	
  with	
  addition	
  of	
  LPA	
  carrier.	
  cDNA	
  was	
  synthetized	
  using	
  Superscript	
   III	
  (Invitrogen).	
  For	
  quantification	
  of	
   transcript	
   levels,	
   the	
  ABI	
  Prism	
  7000	
  real	
   time	
  PCR	
  machine	
  and	
  Power	
  SYBR	
  Green	
  PCR	
   Master	
   Mix	
   (Applied	
   Biosystems)	
   were	
   used.	
   Primers	
   are	
   listed	
   in	
   Table	
   2.	
   The	
  relative	
  quantification	
  cycle	
  values	
  (Cq)	
  were	
  normalized	
  over	
  Cq	
  values	
  of	
  the	
  ribosomal	
  protein	
   L19	
   (RPL19),	
   which	
   was	
   used	
   as	
   internal	
   standard.	
   The	
   values	
   obtained	
   for	
  samples	
   of	
  mutant	
   limb	
   bud	
  were	
   calculated	
   relative	
   to	
   the	
  mean	
   value	
   obtained	
   from	
  controls	
  set	
  for	
  100%.	
  Statistical	
  significance	
  was	
  assigned	
  using	
  Mann-­‐Whitney	
  tests	
  and	
  results	
  are	
  reported	
  as	
  mean	
  ±	
  Standard	
  Variation	
  (SD).	
  At	
  least	
  eight	
  samples	
  were	
  used	
  per	
  experiment	
  and	
  each	
  one	
  is	
  represented	
  by	
  a	
  dot.	
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Table	
  2.	
  Primers	
  for	
  RT-­‐qPCR	
  
cDNA	
   Forward	
  primer	
   Reverse	
  primer	
  
Bmp2	
   5'-­‐ATGTGGAGACTCTCTCAATG-­‐3'	
   5'-­‐ACGCTAGAAGACAGCGGTC-­‐3'	
  
Bmp4	
   5'-­‐AGCCGAGCCAACACTGTGA-­‐3'	
   5'-­‐GTTCTCCAGATGTTCTTCGTGATG-­‐3'	
  
Bmp7	
   5'-­‐TGTGGCAGAAAACAGCAGCA-­‐3'	
   5'-­‐TCAGGTGCAATGATCCAGTCC-­‐3'	
  
Dcn	
   5'-­‐GCACAGCATAAGTATATCCAGGTCG-­‐3'	
   5'-­‐GCTCGGCAGAAGTCATTTTGC-­‐3'	
  
Fgf8	
   5’-­‐GCTAAAACCCAATCTCGGCTAT-­‐3’	
   5'-­‐AGCATTTTCCAGGTATGCTCAG-­‐3'	
  
Lgals8	
   5'-­‐TACAAAAGCCAGGCAAGCTCCA-­‐3'	
   5'-­‐TCGGGCATTGGTGTTCACTTCC-­‐3'	
  
Ncam1	
   5'-­‐GATATTGTTCCCAGCCAAGGA-­‐3'	
   5'-­‐TTGGGGGAGAACCAGGAGATGT-­‐3'	
  
RhoC	
   5'-­‐TGCGATCCGAAAGAAGCTGGTG-­‐3'	
   5'-­‐CCATCCACTTCGATGTCGGCTA-­‐3'	
  
Rpl19	
   5'-­‐ACCCTGGCCCGACGG-­‐3'	
   5'-­‐TACCCTTTCCTCTTCCCTATGCC-­‐3'	
  
Scx	
   5'-­‐AACACCCAGCCCAAACAGAT-­‐3'	
   5'-­‐TTCTGTCACGGTCTTTGCTCA-­‐3'	
  
Smad4	
   5'-­‐TTTCCAATCATCCTGCTCCTGA-­‐3'	
   5'-­‐AACGTCTCTCCTACCTGAACGTCC-­‐3'	
  
Sox9	
   5'-­‐TCGACGTCAATGAGTTTGACCA-­‐3'	
   5'-­‐ATGCCGTAACTGCCAGTGTAGG-­‐3'	
  	
  
	
  
Limb	
  bud	
  mesenchymal	
  cell	
  culture	
  Forelimbs	
  were	
  dissected	
  in	
  ice-­‐cold	
  PBS	
  and	
  digested	
  with	
  2%	
  trypsin-­‐EDTA	
  for	
  30	
  min	
  at	
  4°C	
  mildly	
  shaking.	
  Single-­‐cell	
  suspension	
  was	
  obtained	
  by	
  pipetting	
  up-­‐and-­‐down	
  in	
  DMEM/F12	
   medium	
   supplemented	
   with	
   100	
   Units/ml	
   penicillin,	
   100	
   μg/ml	
  streptomycin	
  and	
  10%	
  FBS	
  (Gibco-­‐BRL).	
  Cells	
  were	
  centrifuged	
  at	
  1200	
  rpm	
  for	
  5	
  min,	
  re-­‐suspended	
  at	
  7.5	
  x	
  105	
  cells/	
  300μl	
  and	
  seeded	
  into	
  eight-­‐well	
  chamber	
  slides	
  (Ibidi,	
  300μl	
  per	
  well).	
  Cells	
  were	
  cultured	
  for	
  48	
  hr,	
  washed	
  in	
  PBS	
  and	
  fixed	
  in	
  4%	
  PFA	
  in	
  PBS	
  for	
  30	
  min	
  RT.	
  After	
  fixation,	
  cells	
  were	
  washed	
  3	
  x	
  5	
  min	
  in	
  PBS	
  RT	
  and	
  permeabilized	
  with	
  0.3%	
  Triton	
  x-­‐100	
  in	
  PBT,	
  15	
  min	
  RT.	
  Blocking	
  was	
  performed	
  in	
  10%	
  goat	
  serum,	
  0.3%	
  triton	
  x-­‐100	
  in	
  PBT,	
  1	
  hr	
  RT.	
  Cells	
  were	
  incubated	
  with	
  rabbit	
  polyclonal	
  anti-­‐SOX9	
  (Millipore)	
  1:500	
  and	
  mouse	
  monoclonal	
  anti-­‐collagen	
  type	
  II	
  (Thermo	
  Scientific)	
  1:200	
  in	
  1%	
  goat	
  serum	
  in	
  PBS,	
  ON	
  at	
  4°C.	
  The	
  day	
  after,	
  cells	
  were	
  washed	
  3	
  x	
  5	
  min	
  in	
  PBT	
  at	
  RT	
   and	
   incubated	
   with	
   secondary	
   antibody	
   goat	
   anti-­‐mouse	
   Alexa	
   Fluor	
   488	
   diluted	
  1:500	
  or	
  goat	
  anti-­‐rabbit	
  Alexa	
  Fluor	
  594	
  diluted	
  1:500	
  in	
  1%	
  goat	
  serum	
  in	
  PBS,	
  1	
  hr	
  at	
  RT	
   in	
   the	
   dark.	
   Cells	
   were	
   washed	
   3	
   x	
   5	
   min	
   in	
   PBT,	
   counterstained	
   with	
   Hoechst	
   (1	
  μg/ml)	
   5	
  min	
   and	
  washed	
   again,	
   then	
   stored	
   at	
   4°C	
   in	
   PBS	
   in	
   the	
   dark.	
   Samples	
  were	
  analysed	
  using	
  a	
  SP5	
  Leica	
  confocal	
  microscope.	
  	
  	
  
	
  
	
  
	
   43	
  
General	
  cloning	
  protocols	
  Restriction	
   digestions	
   of	
   vectors	
   and	
   inserts	
  were	
   performed	
  with	
   restriction	
   enzymes	
  either	
  from	
  Roche	
  or	
  New	
  England	
  Biolabs	
  (NEB).	
  Digestion	
  products	
  were	
  gel-­‐extracted	
  and	
   purified	
   with	
   the	
   QIAquick	
   Gel	
   Extraction	
   Kit	
   (QIAGEN).	
   For	
   vector	
   de-­‐phosphorylation,	
   the	
   rAPID	
   alkaline	
   phosphatase	
   kit	
   (Roche)	
   was	
   used.	
   The	
   T4	
   ligase	
  (NEB)	
   was	
   used	
   for	
   ligation	
   reaction	
   at	
   RT	
   for	
   10-­‐15	
   min	
   or	
   ON	
   at	
   4°C.	
   Dialysis	
   was	
  accomplished	
  using	
  nitrocellulose	
  MFTM-­‐Membrane	
  Filters	
   (Millipore)	
   for	
  30	
  min	
  at	
  RT.	
  Electroporation	
  was	
  performed	
  in	
  chemical	
  or	
  electrical	
  competent	
  bacteria	
  (XL1	
  blue	
  or	
  HB101)	
  using	
  a	
  MicroPulserTM	
  (BioRad).	
  Purification	
  of	
  plasmid	
  DNA	
  from	
  bacteria	
  was	
  performed	
   using	
   the	
   QIAGEN	
   Plasmid	
   Midi	
   Kit	
   or	
   the	
   NucleoBond®	
   Xtra	
   Midi	
   Kit	
  (Macherey	
  Nagel).	
  	
  	
  
Embryonic	
  stem	
  cells	
  (ES	
  cells)	
  and	
  embryonic	
  fibroblasts	
  (EMFI)	
  cultures	
  ES	
  cell	
  lines	
  were	
  cultured	
  at	
  37°C	
  in	
  7.5%	
  CO2	
  and	
  checked	
  daily	
  under	
  the	
  microscope	
  for	
  morphological	
  assessment.	
  Medium	
  was	
  replaced	
  every	
  day	
  and	
  cells	
  were	
  split	
  every	
  second	
  day	
   at	
   1:4,	
   1:5	
  or	
  1:6	
   according	
   to	
  necessity	
   and	
   type	
  of	
   cell	
   line.	
  ES	
   cells	
  were	
  grown	
  on	
  a	
  layer	
  of	
  EMFIs	
  prepared	
  in	
  the	
  laboratory.	
  An	
  EMFI	
  vial	
  was	
  thawed	
  at	
  37°C	
  in	
  10	
  ml	
  of	
  EMFI	
  medium,	
  spun	
  at	
  1200	
  rpm	
  for	
  5	
  min	
  and	
  re-­‐suspended	
  in	
  3	
  ml	
  of	
  EMFI	
  medium.	
  Cells	
  were	
  then	
  diluted	
  and	
  seeded	
  onto	
  5	
  x	
  10	
  cm	
  cell	
  culture	
  dishes	
  (BD).	
  They	
  were	
   kept	
   in	
   culture	
   for	
   2-­‐3	
   days	
   till	
   they	
   reached	
   confluence	
   and	
   either	
   passaged	
   or	
  mitomycin-­‐treated.	
   For	
   passaging,	
   cells	
   were	
   washed	
   with	
   4	
   ml	
   pre-­‐warmed	
   trypsin,	
  0.05%	
  EDTA	
   (Millipore)	
   and	
   incubated	
   for	
   5	
  min	
   at	
   37°C,	
   collected	
  with	
   7	
  ml	
   of	
   EMFI	
  medium,	
  spun	
  and	
  seeded	
  between	
  1:2	
  to	
  1:8	
  according	
  to	
  necessity.	
  EMFI	
  were	
  passaged	
  maximum	
   twice.	
   EMFIs	
  were	
   growth-­‐arrested	
   by	
  Mitomycin	
   treatment	
   using	
   10	
   μg/ml	
  Mitomycin	
  C	
  (Sigma)	
  in	
  EMFI	
  medium	
  for	
  2	
  hr.	
  Mitomycin	
  C-­‐treated	
  dishes	
  of	
  confluent	
  EMFIs	
  were	
  used	
  no	
  longer	
  than	
  one	
  week.	
  ES	
  cells	
  were	
  split	
  using	
  pre-­‐warmed	
  trypsin-­‐EDTA	
  (0.05%;	
  Sigma):	
  a	
  first	
  wash	
  was	
  followed	
  by	
  a	
  15	
  min	
  incubation	
  at	
  37°C	
  (3	
  ml	
  for	
  10	
  cm	
  dishes	
  and	
  2	
  ml	
  for	
  6	
  cm	
  dishes).	
  ES	
  cells	
  were	
  then	
  pipetted	
  up-­‐and-­‐down	
  (7-­‐10	
  times)	
  to	
  prepare	
  a	
  single-­‐cell	
  suspension,	
  ES	
  cell	
  medium	
  added	
  (7	
  ml	
  for	
  10	
  cm	
  dishes	
  and	
   4	
  ml	
   for	
   6	
   cm	
   dishes)	
   and	
   cells	
   pipetted	
   up-­‐and-­‐down	
   4-­‐5	
   times	
   for	
   blocking	
   the	
  trypsin	
  digestion.	
  Pre-­‐plating	
  for	
  15	
  min	
  allowed	
  most	
  EMFIs	
  to	
  attach	
  to	
  the	
  dish.	
  Cells	
  in	
  suspension	
   were	
   collected	
   and	
   spun	
   1200	
   rpm	
   for	
   5	
   min.	
   Cells	
   were	
   re-­‐suspended	
   in	
  fresh	
  media	
  and	
  plated.	
  Alternatively	
  gelatin-­‐coated	
  plates	
  were	
  used.	
  To	
  this	
  end,	
  a	
  0.1%	
  solution	
  of	
  gelatin	
  in	
  water	
  (Sigma)	
  was	
  autoclaved	
  and	
  stored	
  sterile	
  for	
  up	
  to	
  4-­‐5	
  months	
  at	
  RT.	
  Cell	
  culture	
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dishes	
  were	
  treated	
  with	
  gelatin	
  for	
  5-­‐10	
  min	
  at	
  RT	
  and	
  left	
  to	
  dry	
  for	
  an	
  additional	
  5-­‐10	
  min	
   before	
   use.	
   ES	
   cells	
   were	
   frozen	
   in	
   freshly-­‐prepared	
   pre-­‐cooled	
   ES	
   cell	
   freezing	
  media;	
   about	
   5-­‐6	
   1.5	
  ml	
   pre-­‐cooled	
   NUNC	
   Cryovials	
   were	
   filled	
   with	
   1.5	
  ml	
   of	
   ES	
   cell	
  suspension	
  collected	
  from	
  a	
  10	
  cm	
  culture	
  dish,	
  stored	
  ON	
  at	
  -­‐80°C	
  and	
  moved	
  to	
  liquid	
  nitrogen	
   the	
   day	
   after.	
   ES	
   cells	
   were	
   thawed	
   at	
   37°C	
   in	
   a	
   water	
   bath;	
   cells	
   were	
   then	
  resuspended	
  in	
  10	
  ml	
  ES	
  cell	
  medium,	
  spun	
  and	
  resuspended	
  in	
  fresh	
  ES	
  cell	
  medium	
  for	
  seeding	
  onto	
  culture	
  dishes.	
  	
  	
  
Media	
  for	
  ES	
  cell	
  and	
  EFMI:	
  
-­‐	
  ES	
  cell	
  medium	
  DMEM	
  +	
  4.5g/l	
  Glucose	
  (Gibco	
  41966029)	
   500	
  ml	
  Hyclone	
  Fetal	
  Calf	
  Serum	
  (FCS)	
   94	
  ml	
   (15%)	
  Penicillin-­‐Streptomycin	
  (100u-­‐0.1mg/ml)	
   6.25	
  ml	
  (Gibco	
  15140-­‐122)	
  L-­‐Glutamin	
  (200mM)	
   6.25	
  ml	
  (Gibco	
  25030-­‐024)	
  β	
  Mercapto-­‐Ethanol	
   1.25	
  ml	
  (Gibco	
  31350-­‐010)	
  Leukemia	
  Inhibitory	
  Factor	
  (LIF)	
  (107U/ml)	
   62.5	
  μl	
  (EsGRO	
  LIF	
  TM	
  Gibco	
  13275-­‐029)	
  Non	
  Essential	
  Amino	
  Acids	
  (100X)	
   10	
  ml	
  (Gibco	
  11140-­‐035)	
  Sodium	
  Pyruvate	
  (100mM)	
   	
   	
   	
   10	
  ml	
  (Gibco	
  11360-­‐039)	
  	
  FCS	
  (tested	
  for	
  germ-­‐line	
  transmission)	
  was	
  0.22	
  μm	
  filtered	
  (NOT	
  heat-­‐inactivated).	
  	
  
-­‐	
  EMFI	
  medium	
  DMEM	
  +	
  4.5g/l	
  Glucose	
  (Gibco	
  41966029)	
   500	
  ml	
  FCS	
  (same	
  as	
  for	
  ECS	
  medium)	
   58	
  ml	
  	
   (10%)	
  Penicillin-­‐Streptomycin	
  (100U-­‐0.1mg/ml)	
   5.8	
  ml	
  (Sigma	
  P-­‐0781)	
  L-­‐Glutamin	
  (200mM)	
   5.8	
  ml	
  (Sigma	
  G-­‐7513)	
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-­‐	
  ES	
  cell	
  freezing	
  medium	
  40%	
  FCS	
  (cold)	
  10%	
  DMSO	
  (Sigma	
  D-­‐8418)	
  Cold	
  50%	
  ES	
  medium	
  (-­‐	
  LIF;	
  cold)	
  Filtered	
  with	
  syringe	
  and	
  kept	
  cold	
  until	
  use.	
  	
  	
  
Embryoid	
  body	
  (EB)	
  culture	
  2x104	
  ES	
  cells	
  were	
  incubated	
  in	
  a	
   loosened-­‐cap	
  conical	
  polypropylene	
  1.5ml	
  screw	
  cap	
  micro	
   tube	
   (Sarstedt)	
   in	
   1ml	
   of	
   differentiation	
  medium	
   (ES	
   cell	
  medium	
   –	
   see	
   above	
   -­‐	
  without	
   LIF)	
   for	
   5	
   days	
   at	
   37°C,	
   5%	
   CO2	
   to	
   obtain	
   EBs	
   according	
   to	
   the	
   established	
  protocol	
  (Kurosawa	
  et	
  al.,	
  2003).	
  The	
  EBs	
  were	
  then	
  transferred	
  to	
  a	
  gelatin-­‐coated	
  IBIDI	
  chamber	
  (suited	
  to	
  confocal	
  imaging)	
  and	
  cultured	
  in	
  differentiation	
  medium	
  for	
  up	
  to	
  12	
  days	
  at	
  37°C,	
  5%	
  CO2.	
  	
  
	
  
Statistics	
  The	
  statistics	
  used	
  to	
  quantitatively	
  assess	
   the	
  experimental	
  results	
  are	
  specified	
   in	
   the	
  relative	
   sections	
   or	
   in	
   the	
   Figure	
   legends.	
   Prism	
   (GraphPad)	
   and/or	
   Excel	
   (Microsoft)	
  were	
  used	
  for	
  statistical	
  analysis	
  and	
  graphic	
  design.	
  Note:	
   the	
   reproducibility	
   of	
   all	
   results	
   was	
   assessed	
   in	
   at	
   least	
   (i.e.	
   minimally)	
   three	
  independent	
  experiments.	
  	
  
	
  
Additional	
  and	
  general	
  solutions	
  	
  
-­‐	
  Pre-­‐hybridization	
  mix	
  50%	
  formamide	
  (deionized,	
  extra	
  pure)	
  5x	
  SSC	
  pH	
  4.5	
  2%	
  Blocking	
  Powder	
  (Roche	
  Cat.	
  No.	
  1096176)	
  0.1%	
  Tween-­‐20	
  0.5%	
  CHAPS	
  (Sigma)	
  50	
  μg/ml	
  yeast	
  RNA	
  (Sigma	
  R-­‐8759)	
  5	
  mM	
  EDTA	
  50	
  μg/ml	
  heparin	
  (Sigma	
  H5515)	
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-­‐	
  Post-­‐hybridization	
  mix	
  50%	
  formamide	
  (deionized,	
  extra	
  pure)	
  5x	
  SSC	
  pH	
  4.5	
  0.1%	
  Triton	
  x-­‐100	
  0.5%	
  CHAPS	
  (Sigma)	
  	
  
-­‐	
  20x	
  SSC,	
  pH	
  4.5	
  3M	
  NaCl	
  0.3	
  M	
  Na3citrate:2H2O	
  Adjust	
  pH	
  to	
  4.5	
  with	
  1M	
  HCl	
  	
  
-­‐	
  Maleic	
  Acid	
  Buffer	
  100	
  mM	
  maleic	
  acid	
  150	
  mM	
  NaCl	
  Adjust	
  pH	
  to	
  7.5	
  	
  
-­‐	
  TBST	
  140	
  mM	
  NaCl	
  2.7	
  mM	
  KCl	
  25	
  mM	
  Tris	
  HCl,	
  pH	
  7.5	
  1%	
  Tween-­‐20	
  	
  
-­‐	
  NTMT	
  (prepared	
  fresh)	
  100	
  mM	
  NaCl	
  100mM	
  Tris	
  9.5	
  50	
  mM	
  MgCl2	
  1%	
  Tween-­‐20	
  	
  
-­‐	
  TNT	
  50	
  mM	
  Tris	
  HCl	
  pH	
  7.5	
  150	
  mM	
  NaCl	
  0.1%	
  Triton	
  x-­‐100	
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-­‐	
  NMT	
  100	
  mM	
  Tris	
  HCl	
  pH	
  9.5	
  100	
  mM	
  NaCl	
  50	
  mM	
  MgCl2	
  	
  
-­‐	
  Blocking	
  solution	
  for	
  OPT-­‐oriented	
  protocol	
  6.5	
  %	
  goat	
  serum	
  2%	
  (w/v)	
  BSA	
  50	
  mM	
  Tris	
  HCl	
  pH	
  7.5	
  150	
  mM	
  NaCl	
  0.1%	
  Triton	
  x-­‐100	
  	
  
-­‐	
  Immunowash	
  solution	
  1%	
  (w/v)	
  BSA	
  1%	
  dimethyl	
  sulfoxide	
  (DMSO)	
  1%	
  Triton	
  x-­‐100	
  0.1%	
  Tween-­‐20	
  Bring	
  to	
  volume	
  with	
  PBS	
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7.	
  RESULTS	
  
	
  Some	
  of	
  the	
  results	
  contained	
  in	
  this	
  section	
  have	
  been	
  published	
  in:	
  Benazet,	
  J.D.*,	
  E.	
  Pignatti*,	
  A.	
  Nugent,	
  E.	
  Unal,	
  F.	
  Laurent,	
  and	
  R.	
  Zeller.	
  2012.	
  Smad4	
  is	
  
required	
  to	
  induce	
  digit	
  ray	
  primordia	
  and	
  to	
  initiate	
  the	
  aggregation	
  and	
  
differentiation	
  of	
  chondrogenic	
  progenitors	
  in	
  mouse	
  limb	
  buds.	
  Development.	
  139:4250-­‐4260.	
  *	
  First	
  co-­‐authors.	
  	
  	
  
Conditional	
  inactivation	
  of	
  Smad4	
  in	
  the	
  limb	
  bud	
  mesenchyme	
  Space-­‐	
   and	
   time-­‐restricted	
   inactivation	
   of	
   Smad4	
   allowed	
   us	
   to	
   study	
   BMP	
   signaling	
  requirements	
   in	
   a	
   focused	
  manner	
   and,	
   at	
   the	
   same	
   time,	
   to	
   target	
   the	
   canonical	
   BMP	
  pathway	
  in	
  a	
  global	
  fashion,	
  avoiding	
  complex	
  genetic	
  experiments	
  based	
  on	
  inactivating	
  multiple	
  ligands	
  or	
  receptors.	
  
Prx1-­‐Cre-­‐mediated	
   inactivation	
   of	
  Smad4	
   in	
   the	
   limb	
  mesenchyme	
   (Smad4Δ/ΔM)	
   led	
   to	
  the	
   formation	
   of	
   stunted	
   paddle-­‐like	
   limb	
   structures	
   (Fig.	
   1A).	
   In	
   addition,	
   gross	
  morphological	
  analysis	
  of	
  Smad4Δ/ΔM	
  mutant	
  embryos	
  revealed	
  reduced	
  liver	
  size	
  and	
  the	
  formation	
  of	
  a	
  sub-­‐epithelial	
  edema	
  dorsally	
  to	
  the	
  neural	
  tube	
  at	
  E14.5	
  (Fig.1A).	
  Skeletal	
  preparations	
   showed	
   that	
   both	
   forelimbs	
   and	
   hindlimbs	
   were	
   devoid	
   of	
   skeletal	
  elements,	
  with	
   the	
  exception	
  of	
  a	
   remnant	
  of	
   the	
  pelvis	
  at	
  E14.5	
   (Fig.	
  1B),	
  whereas	
   the	
  axial	
   skeleton	
   was	
   unaffected.	
   The	
   residual	
   pelvis	
   skeletal	
   element	
   was	
   likely	
   a	
  consequence	
   of	
   the	
   delayed	
   activation	
   of	
   the	
   Prx1-­‐Cre	
   transgene	
   in	
   the	
   hindlimb	
  mesenchyme	
   (between	
   E9.5	
   and	
   E10.5)	
   in	
   comparison	
   to	
   the	
   forelimb	
   mesenchyme	
  (E9.25;	
  Logan	
  et	
  al.,	
  2002).	
  Since	
  this	
  initial	
  analysis	
  suggested	
  a	
  late-­‐onset	
  phenotype,	
  we	
  looked	
  at	
  the	
  clearance	
  of	
  Smad4	
  transcripts	
  and	
  products.	
  We	
  noted	
  that	
  recombination	
  of	
  Smad4	
  occurs	
   around	
  E9.5	
   in	
   the	
   forelimb	
  mesenchyme,	
  whereas	
   levels	
   of	
  Smad4	
   in	
  the	
  paraxial	
  mesoderm	
  are	
  also	
  reduced	
  due	
  to	
  the	
  presence	
  of	
  a	
  constitutive	
  null	
  allele	
  (Fig.	
   1C).	
  Whole-­‐mount	
   immunofluorescence	
   revealed	
   that	
   SMAD4	
  protein	
  was	
   cleared	
  from	
  the	
   forelimb	
  mesenchyme	
  at	
  about	
  E9.75	
  (Fig.	
  1D).	
  As	
  expected,	
   recombination	
  of	
  
Smad4	
   did	
   not	
   occur	
   in	
   the	
   ventral	
   ectoderm	
   and	
   SMAD4	
   proteins	
   maintained	
   in	
   the	
  ectoderm	
   (Fig.	
   1D,	
   arrowheads	
   in	
   central	
   and	
   right-­‐most	
   panels).	
   In	
   addition,	
   the	
  expression	
  of	
  Msx2,	
  which	
  is	
  a	
  well-­‐established	
  BMP	
  signaling	
  readout	
  (see	
  Introduction),	
  was	
  down-­‐regulated	
  in	
  the	
  mesenchyme	
  by	
  E10.0	
  (Fig.	
  1E);	
  the	
  residual	
  Msx2	
  expression	
  is	
  likely	
  due	
  to	
  long-­‐lived	
  transcripts.	
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Fig.1.	
  Smad4	
  inactivation	
  in	
  the	
  limb	
  mesenchyme	
  driven	
  by	
  Prx1-­‐Cre	
  transgene.	
  (A)	
  Dark-­‐field	
   picture	
   of	
   whole	
   embryo	
   at	
   day	
   E14.5	
   allows	
   gross	
   morphological	
   analysis	
   of	
   Smad4Δ/ΔM	
  phenotype;	
   stunted	
   paddle-­‐like	
   structures	
   replace	
   the	
   elongated	
   wild-­‐type	
   limb	
   and	
   no	
   finger	
  primordia	
   appear	
   in	
   the	
   mutant	
   (experiment	
   by	
   J.D.B.).	
   (B)	
   Alcian	
   blue-­‐stained	
   skeletal	
  preparations	
   at	
  E14.5	
   reveal	
   the	
   absence	
  of	
   any	
   forelimb	
  and	
  hindlimb	
   skeletal	
   structure	
   in	
   the	
  
Smad4Δ/ΔM	
  mutant	
   embryos,	
   apart	
   from	
  a	
   remnant	
   of	
   pelvis	
   skeleton	
   (experiment	
   by	
   J.D.B.).	
   (C)	
  WISH	
  with	
  a	
  Smad4	
  probe	
  covering	
  exon	
  8,	
  which	
  is	
  deleted	
  in	
  the	
  adopted	
  Smad4Δ	
  allele.	
  At	
  23-­‐24	
  somites,	
   amounts	
   of	
  Smad4	
   transcripts	
   in	
   the	
   forelimbs	
   correlate	
  with	
   the	
   number	
   of	
  wild-­‐type	
  alleles	
   (experiment	
   by	
   J.D.B.).	
   (D)	
   OPT	
   rendering	
   of	
   a	
   whole-­‐mount	
   immunofluorescence	
  experiment	
  on	
  forelimbs	
  at	
  29	
  somites	
  (wild-­‐type)	
  and	
  27	
  somites	
  (Smad4Δ/ΔM),	
  showing	
  deletion	
  of	
  SMAD4	
  proteins	
  in	
  the	
  mutant	
  mesenchyme	
  and	
  persistence	
  of	
  proteins	
  in	
  the	
  ventral	
  ectoderm	
  (white	
   arrowheads)	
   with	
   respect	
   to	
   the	
   wild-­‐type	
   limb.	
   The	
   dotted	
   line	
   in	
   the	
   central	
   panel	
  indicates	
  the	
  approximate	
  position	
  of	
   the	
  OPT	
  virtual	
  section	
  shown	
  in	
  the	
  right-­‐most	
  panel.	
  (E)	
  
Msx2	
  gene	
  transcripts	
  are	
  detected	
  as	
  readout	
  of	
  BMP	
  signaling	
  activity	
  in	
  the	
  Smad4Δ/ΔM	
  mutant	
  in	
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comparison	
   to	
   the	
   wild-­‐type	
   forelimb	
   at	
   30	
   somites.	
   1-­‐5:	
   digit	
   identities;	
   r:	
   radius;	
   u:	
   ulna;	
   h:	
  humerus;	
  s:	
  scapula;	
  t:	
  tibia;	
  f:	
  fibula;	
  p:	
  pelvis.	
  FL:	
  forelimb;	
  HL:	
  hindlimb.	
  	
  	
  
Smad4	
  functions	
  as	
  part	
  of	
  the	
  SHH/GREM1/FGF	
  feedback	
  loop	
  Previous	
  studies	
  revealed	
  that	
   the	
  expression	
  of	
  Grem1	
  depends	
  on	
  both	
  Bmp4	
  and	
  Shh	
  (see	
   Introduction	
   and	
   Benazet	
   et	
   al.,	
   2009).	
   In	
   light	
   of	
   this,	
   we	
   sought	
   to	
   understand	
  whether	
  BMP4-­‐driven	
  signaling	
  was	
  mediated	
  by	
  canonical	
  SMAD4-­‐transduced	
  pathway	
  during	
   patterning	
   of	
   the	
   forelimb.	
   Conditional	
   inactivation	
   of	
   Smad4	
   in	
   the	
   limb	
  mesenchyme	
  led	
  to	
  down-­‐regulation	
  of	
  Grem1	
  transcripts,	
  and	
  particularly	
  impaired	
  the	
  anterior	
  expansion	
  of	
  its	
  expression	
  (Fig.	
  2A,	
  panels	
  on	
  the	
  left).	
  Grem1	
  expression	
  levels	
  were	
  also	
  down-­‐regulated	
  upon	
  constitutive	
  inactivation	
  of	
  Shh	
  (see	
  Chiang	
  et	
  al.,	
  2001).	
  In	
   addition,	
   ShhΔ/Δ	
   forelimbs	
   exhibited	
   ectopic	
   expression	
   of	
   Grem1	
   in	
   the	
   proximal	
  posterior-­‐most	
   forelimb	
   domain,	
   partially	
   overlapping	
   the	
   Shh	
   and	
   Tbx2	
   expression	
  domains	
   (see	
   e.g.	
   Farin	
   et	
   al.,	
   2013	
   for	
   Tbx2	
   expression	
   domain).	
   We	
   found	
   that	
  compound	
   inactivation	
  of	
  Shh	
   and	
  Smad4	
   results	
   in	
   loss	
  of	
  Grem1	
   expression,	
   revealing	
  that	
  Smad4	
  is	
  required	
  for	
  the	
  Shh/Grem1/Fgf4	
  feedback	
  loop	
  (Fig.	
  2A,	
  left-­‐most	
  panel).	
  The	
  AER-­‐Fgf4/8	
  domains	
  in	
  the	
  Smad4Δ/ΔM	
  limb	
  buds	
  are	
  enlarged	
  along	
  the	
  D-­‐V	
  axis	
  in	
  comparison	
  to	
  wild-­‐type	
  controls	
  (Fig.	
  2A,	
  right	
  panels),	
  which	
  points	
  to	
  a	
  defect	
  in	
  AER	
  compaction.	
   Quantitative	
   transcript	
   analysis	
   revealed	
   the	
   up-­‐regulation	
   of	
   Fgf8	
  expression	
   in	
   Smad4Δ/ΔM	
   limbs	
   at	
   E10.5	
   (Fig.	
   2E).	
   Shh	
   inactivation	
   results	
   in	
   down-­‐regulation	
   of	
   Fgf8	
   expression	
   levels	
   and	
   clearance	
   of	
   Fgf4	
   transcripts	
   (Chiang	
   et	
   al.,	
  2001).	
   The	
   additional	
   inactivation	
   of	
   Smad4	
   in	
   the	
   mesenchyme	
   did	
   not	
   further	
   alter	
  AER-­‐Fgf8	
  and	
  Fgf4	
  expression	
  in	
  the	
  ShhΔ/Δ	
  genetic	
  background.	
  We	
   also	
   noticed	
   that	
   the	
   Shh	
   transcription	
   domain	
   was	
   expanded	
   proximally	
   in	
   the	
  
Smad4Δ/ΔM	
   limb	
  bud	
  mesenchyme	
  (Fig.	
  2B,	
  black	
  arrowhead),	
   likely	
  as	
  a	
  consequence	
  of	
  the	
  proximal	
  expansion	
  of	
  AER-­‐FGF	
  domain	
  (Fig.	
  2A,	
  dorsal	
  view	
  of	
  Fgf8	
  expression	
  in	
  the	
  
Smad4Δ/ΔM	
  mutant	
  background).	
  Analysis	
  of	
  later	
  stages	
  (E11.75	
  and	
  E12.5)	
  showed	
  that	
  Shh,	
  Fgf4	
  and	
  Fgf8	
  transcripts	
  were	
  maintained	
   in	
   the	
   Smad4Δ/ΔM	
   limb	
   for	
   longer	
   than	
   in	
   the	
   wild-­‐type	
   controls	
   (Fig.	
  2C,D;	
   see	
   arrowheads).	
   This	
   is	
   indicative	
   of	
   delayed	
   termination	
   of	
   the	
  SHH/GREM1/AER-­‐FGF	
   feedback	
   loop.	
   Indeed,	
   Shh	
   expression	
   was	
   stronger	
   in	
   the	
  
Smad4Δ/ΔM	
  mutant	
   forelimb	
   buds	
  with	
   respect	
   to	
  wild-­‐type	
   controls	
   at	
   E11.75	
   (Fig.	
   2C,	
  upper	
   panels);	
   at	
   E12.5,	
   Smad4Δ/ΔM	
   limb	
   buds	
   showed	
   a	
   residual	
   posterior-­‐proximal	
  domain	
   of	
   Shh	
   expression	
   (Fig.	
   2C,	
   lower	
   panels,	
   see	
   black	
   arrowhead).	
   Similarly,	
  expression	
   of	
   Fgf4	
   transcripts,	
   which	
   was	
   terminated	
   around	
   E11.75	
   in	
   the	
   wild-­‐type,	
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persisted	
   in	
   an	
   anterior	
   domain	
   in	
   mutant	
   forelimb	
   buds	
   (Fig.	
   2D,	
   upper	
   panels).	
  Furthermore,	
  Fgf8	
  expression	
  was	
   also	
   prolonged	
   in	
   comparison	
   to	
  matched	
  wild-­‐type	
  forelimb	
  buds	
  (Fig.	
  2D,	
  lower	
  panels).	
  	
  	
  	
  
	
  	
  
Fig.	
  2.	
  Genetic	
  involvement	
  of	
  mesenchymal	
  Smad4	
  in	
  the	
  SHH/GREM1/AER-­‐FGF	
  feedback	
  
loop.	
   (A)	
   (From	
   left	
   to	
   right)	
  Grem1,	
  Fgf8,	
  Fgf4	
   transcripts	
   expression	
   in	
  wild-­‐type,	
   Smad4Δ/ΔM,	
  
ShhΔ/Δ	
   and	
  Smad4Δ/ΔM;	
  ShhΔ/Δ	
   forelimbs	
   at	
   E10.25	
   (31-­‐35	
   somites).	
   For	
  Fgf8	
  probe,	
   a	
   dorsal	
   and	
  AER-­‐oriented	
  view	
  are	
  reported.	
  Fgf4	
  signal	
  is	
  only	
  depicted	
  from	
  the	
  AER.	
  (B)	
  Shh	
  expression	
  in	
  wild-­‐type	
  and	
  Smad4Δ/ΔM	
  forelimbs	
  at	
  35	
  somites.	
  The	
  arrowhead	
  points	
  at	
  proximal	
  expansion	
  of	
  
Shh	
  domain	
  in	
  the	
  mutant	
  limb.	
  (C)	
  Shh	
  expression	
  at	
  E11.75	
  (50	
  somites,	
  upper	
  panel)	
  and	
  E12.5	
  (60	
   somites,	
   lower	
   panel)	
   in	
   wild-­‐type	
   and	
   Smad4Δ/ΔM	
  mutant	
   forelimbs.	
   The	
   black	
   arrowhead	
  points	
  at	
  the	
  delayed	
  termination	
  of	
  Shh	
  transcripts	
  in	
  the	
  mutant	
  limb.	
  (D)	
  Delayed	
  termination	
  of	
   Fgf4	
   and	
   Fgf8	
   transcripts	
   (upper	
   panel	
   –	
   50	
   somites	
   -­‐	
   and	
   lower	
   panel	
   –	
   60	
   somites	
   -­‐,	
  respectively)	
   in	
   wild-­‐type	
   and	
   Smad4Δ/ΔM	
   forelimbs.	
   Black	
   arrowhead	
   points	
   at	
   residual	
   Fgf4	
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transcripts	
   in	
   the	
   anterior-­‐proximal	
   region	
   of	
   mutant	
   forelimb.	
   (E)	
   Fgf8	
   transcript	
   levels	
  quantified	
  by	
  RT-­‐qPCR	
   in	
  E10.5	
   (~35	
   somites)	
   forelimbs	
   from	
  wild-­‐type	
   and	
  Smad4Δ/ΔM	
  mutant	
  embryos.	
   Expression	
   is	
   significantly	
   higher	
   in	
   the	
  mutant	
   samples	
   (P≤0.01).	
   Data	
   are	
   shown	
   as	
  mean	
  ±	
  SD.	
  All	
   the	
  experiments	
  of	
  this	
  figure	
  were	
  performed	
  by	
  J.D.B.	
  apart	
  from	
  Fgf4	
  and	
  Fgf8	
  panels	
  shown	
  in	
  (A).	
  	
  	
  
Expression	
  of	
  BMP	
  ligands	
  depends	
  on	
  Smad4	
  in	
  the	
  mesenchyme	
  We	
  wondered	
  whether	
  Smad4	
  is	
  required	
  in	
  the	
  mesenchyme	
  to	
  modulate	
  the	
  expression	
  of	
  BMP	
   ligands.	
  We	
   then	
  used	
  WISH	
  and	
  RT-­‐qPCR	
  quantification	
  on	
  E10.5	
   forelimbs	
   to	
  analyze	
   the	
   expression	
   of	
   BMP	
   ligands.	
   We	
   observed	
   that	
   Bmp2	
   transcripts	
   were	
   up-­‐regulated	
  in	
  the	
  posterior	
  domain	
  and	
  down-­‐regulated	
  in	
  the	
  AER	
  of	
  Smad4Δ/ΔM	
  limb	
  buds	
  (Fig.	
  3A).	
  Both	
  Bmp4	
  and	
  Bmp7	
  were	
  slightly	
  up-­‐regulated	
  in	
  mutant	
  limb	
  buds,	
  although	
  their	
  spatial	
  distribution	
  was	
  unchanged.	
  RT-­‐qPCR	
  quantification	
  revealed	
  significant	
  up-­‐regulation	
   of	
   Bmp7	
   transcripts,	
   while	
   Bmp4	
   levels	
   were	
   not	
   significantly	
   altered	
   (Fig.	
  3B,C).	
   Altogether,	
   these	
   results	
   point	
   to	
   the	
   possible	
   presence	
   of	
   a	
   Smad4-­‐dependent	
  feedback	
  loop	
  regulating	
  the	
  expression	
  of	
  BMP	
  ligands.	
  	
  
	
  	
  
Fig.	
  3.	
  Effects	
  of	
  mesenchymal	
  inactivation	
  of	
  Smad4	
  on	
  BMP	
  ligands.	
  (A,B,C)	
  BMP	
  ligands	
  were	
  quantified	
  in	
  wild-­‐type	
  versus	
  Smad4Δ/ΔM	
  mutant	
  forelimbs	
  by	
  WISH	
  (upper	
  panels)	
  and	
  by	
  RT-­‐qPCR	
   (lower	
   panels)	
   at	
   E10.5	
   (~35	
   somites).	
   RT-­‐qPCR	
   results	
   are	
   reported	
   as	
   mean	
   ±	
   SD.	
  Three-­‐stars	
  indicate	
  significance	
  at	
  P≤0.001.	
  S4Δ/ΔM:	
  Smad4Δ/ΔM.	
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Analysis	
  of	
  A-­‐P	
  axis	
  development	
  in	
  mouse	
  limb	
  buds	
  lacking	
  mesenchymal	
  Smad4	
  
expression	
  Mesenchymal	
   inactivation	
   of	
   Bmp4	
   by	
   Prx1-­‐CreTg	
   results	
   in	
   anterior	
   expansion	
   of	
  posterior	
  genes	
  and	
  down-­‐regulation	
  of	
  anterior	
  genes	
   in	
  mutant	
   limb	
  buds	
  (Selever	
  et	
  al.,	
  2004).	
  Thus,	
  we	
  wondered	
  to	
  which	
  extent	
  the	
  mesenchymal	
  Smad4	
  deficiency	
  would	
  phenocopy	
   the	
   Bmp4	
   inactivation.	
   We	
   looked	
   at	
   the	
   SHH-­‐dependent	
   Gli1	
   and	
   Ptch1	
  transcripts	
  in	
  the	
  posterior-­‐most	
  limb	
  region	
  and	
  at	
  Alx4	
  transcripts	
  in	
  the	
  anterior-­‐most	
  region	
  in	
  Smad4	
  mutant	
  limb	
  buds	
  at	
  E10.5	
  (Fig.	
  4A,B).	
  We	
  noted	
  that	
  the	
  Gli1	
  expression	
  pattern	
  was	
  unchanged,	
  while	
  Ptch1	
  and	
  Alx4	
  transcripts	
  were	
  slightly	
  down-­‐regulated.	
  
Ptch1	
   transcripts	
   were	
   also	
   more	
   distally	
   restricted	
   (Fig.	
   4A).	
   In	
   the	
   hindlimb,	
   both	
  posterior	
  markers	
  were	
  more	
  distally	
  restricted,	
  whereas	
  Alx4	
  transcripts	
  were	
  extended	
  slightly	
   more	
   posterior	
   (Fig.	
   4B).	
   Altogether,	
   molecular	
   analysis	
   revealed	
   minor	
  alterations,	
  but	
  failed	
  to	
  show	
  major	
  alterations	
  in	
  A-­‐P	
  axis	
  development.	
  	
  	
   	
  
Fig.	
  4.	
  Analysis	
  of	
  A-­‐P	
  axis	
  
upon	
   mesenchymal	
  
inactivation	
  of	
  Smad4.	
  SHH-­‐dependent	
   Gli1	
   and	
   Ptch1	
  genes	
   associated	
   with	
  posterior	
   limb	
   compartment	
  and	
   Alx4	
   in	
   the	
   anterior	
  compartment	
   were	
   analyzed	
  in	
   wild-­‐type	
   and	
   Smad4Δ/ΔM	
  mutant	
   limb	
   buds	
   (at	
   37,	
   36	
  and	
  35	
  somites,	
  respectively).	
  
(A)	
   In	
   the	
   forelimbs,	
   Gli1	
  expression	
   pattern	
   (upper	
  panel)	
  is	
  unchanged.	
  Conversely,	
  Ptch1	
  transcript	
  levels	
  in	
  the	
  posterior	
  and	
  Alx4	
  transcripts	
  in	
  the	
  anterior	
   limb	
  are	
  slightly	
  down-­‐regulated	
  (middle	
  and	
   lower	
  panels).	
  (B)	
   In	
  hindlimb	
  buds	
  both	
  
Gli1	
  and	
  Ptch1	
  transcript	
  levels	
  are	
  slightly	
  reduced	
  while	
  Alx4	
  expression	
  is	
  slightly	
  expanded.	
  FL:	
  forelimb;	
  HL:	
  hindlimb.	
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Smad4	
  inactivation	
  in	
  the	
  autopod	
  primordia	
  The	
  Hoxa13-­‐Cre	
  knock-­‐in	
  transgene	
  (Hoxa13-­‐CreTg)	
  drives	
  Cre	
  recombinase	
  expression	
  in	
  the	
   prospective	
   forelimb	
   autopod	
   starting	
   at	
   about	
   36	
   somites	
   (see	
   Material	
   and	
  Methods).	
  The	
  activity	
  of	
  the	
  Hoxa13-­‐CreTg	
   is	
  restricted	
  to	
  the	
  autopod	
  in	
  forelimb	
  buds,	
  whereas	
   it	
   is	
   also	
   active	
   in	
   the	
   lateral	
  mesoderm	
   at	
   the	
   level	
   of	
   the	
   hindlimb	
   bud	
   (see	
  Material	
  and	
  Methods;	
  see	
  Scotti	
  and	
  Kmita,	
  2012).	
  Therefore,	
  only	
   forelimb	
  buds	
  were	
  analyzed.	
  Hoxa13-­‐CreTg-­‐mediated	
  inactivation	
  of	
  Smad4	
  was	
  used	
  to	
  temporally	
  uncouple	
  the	
  patterning	
  phase	
  of	
   low	
  BMP	
  signaling	
   (between	
  ~28	
   to	
  ~38	
   somites)	
   from	
  a	
   later	
  phase	
  in	
  which	
  BMP	
  signaling	
  rises	
  to	
  induce	
  mesenchymal	
  condensations	
  and	
  modulate	
  (see	
   Introduction).	
  We	
   generated	
   two	
  mutant	
   embryo	
  models	
   that	
   either	
   carry	
   one	
   or	
  two	
   conditionally	
   inactivated	
   alleles	
   (Smad4Δ/ΔA13;	
   Smad4ΔA13/ΔA13,	
   respectively).	
   Apart	
  from	
   a	
   glove-­‐like	
   handplate,	
   no	
   additional	
   abnormalities	
   were	
   detected	
   in	
   Smad4Δ/ΔA13	
  embryos	
  at	
  E14.5	
  (Fig.	
  5A).	
  Smad4Δ/ΔA13	
  and	
  Smad4ΔA13/ΔA13	
  embryos	
  at	
  E14.5	
  showed	
  no	
  carpal,	
   metacarpal	
   and	
   phalangeal	
   bones	
   (Fig.	
   5B)	
   and	
   no	
   additional	
   differences	
   were	
  detected	
  between	
  the	
  two	
  mutant	
  genotypes.	
  We	
   found	
   that	
   Smad4	
   expression	
   was	
   cleared	
   slightly	
   before	
   38-­‐somite	
   stage	
   in	
   the	
  distal	
   and	
   posterior	
   mesenchyme	
   (Fig.	
   5C,	
   left-­‐most	
   panel).	
   This	
   clearance	
   of	
   Smad4	
  transcripts	
  expanded	
  anteriorly	
   in	
  the	
  distal	
  mesenchyme,	
  eventually	
  encompassing	
  the	
  entire	
   autopod	
   primordia	
   by	
   50	
   somites	
   (Fig.	
   5C,	
   central	
   and	
   right-­‐most	
   panels).	
   As	
  expected,	
  Smad4	
  transcripts	
  remained	
  expressed	
  in	
  the	
  proximal	
  limb	
  bud	
  mesenchyme,	
  where	
  the	
  Hoxa13-­‐CreTg	
  allele	
  is	
  not	
  expressed	
  (Fig.	
  5D).	
  Because	
  two	
  conditional	
  alleles	
  have	
   to	
   be	
   inactivated	
   in	
   Smad4ΔA13/ΔA13	
   autopod	
   primordia,	
   we	
   expected	
   the	
   SMAD4	
  clearance	
  to	
  be	
  slower	
  than	
  in	
  the	
  Smad4Δ/ΔA13	
  handplates.	
  This	
  should	
  allow	
  us	
  to	
  study	
  the	
  potential	
  differential	
  requirements	
  of	
  Smad4	
  over	
  a	
  narrow	
  time	
  window	
  during	
  limb	
  bud	
  development.	
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Fig.	
  5.	
  Smad4	
   inactivation	
  in	
  the	
  
limb	
  autopod	
  at	
  late	
  stages	
  driven	
  
by	
   Hoxa13-­‐Cre	
   knock-­‐in	
  
transgene.	
   (A)	
   Bright-­‐field	
   picture	
  of	
  whole	
  embryo	
  at	
  E14.5	
  reveals	
  the	
  absence	
  of	
   finger-­‐like	
  appendages	
  in	
  the	
   Smad4Δ/ΔA13	
   mutant	
   handplates	
  (experiment	
   by	
   J.D.B.).	
   (B)	
   Alcian-­‐blue	
   and	
   Alizarin-­‐red	
   stained	
  skeletal	
   preparations	
   at	
   E14.5	
   show	
  that	
   carpal,	
   metacarpal	
   and	
  phalangeal	
   bones	
   are	
  missing	
   in	
   the	
  
Smad4Δ/ΔA13	
   and	
   Smad4ΔA13/ΔA13	
  mutant	
  forelimbs	
  (lower	
  panels).	
  (C)	
  WISH	
  with	
  Smad4	
  probe	
  outlines	
  the	
  kinetics	
   of	
   Hoxa13-­‐Cre-­‐driven	
  recombination	
  in	
  the	
  forelimb	
  at	
  the	
  stage	
  of	
  39	
  somites	
  (left-­‐most	
  panel),	
  41	
   somites	
   (central	
   panel)	
   or	
   50	
  somites	
   (right-­‐most	
   panel)	
   in	
   the	
  
Smad4Δ/ΔA13	
   genetic	
  background.	
  (D)	
  
Smad4	
  transcripts	
  in	
  the	
  prospective	
  autopod	
   (distal-­‐most	
   part	
   of	
   the	
  limb)	
  are	
  cleared	
  in	
  both	
  Smad4Δ/ΔA13	
  and	
   Smad4ΔA13/ΔA13	
  mutant	
   forelimbs	
  at	
   the	
   stage	
   of	
   50	
   somites	
   (central	
  and	
  right-­‐most	
  panels).	
  Smad4	
  transcript	
   levels	
   in	
   the	
  proximal	
  part	
  of	
   the	
   limb,	
  where	
  Hoxa13-­‐
CreTg	
  is	
  not	
  active,	
  are	
  dependent	
  on	
  the	
  absence	
  or	
  presence	
  of	
  a	
  constitutive	
  null	
  Smad4	
  allele.	
  1-­‐5:	
  digit	
  identities.	
  	
  	
  
Smad4	
   is	
   necessary	
   for	
   initiating	
   chondrogenic	
   differentiation	
   and	
   formation	
   of	
  
digit	
  rays	
  Since	
  Smad4Δ/ΔM	
  mutant	
  forelimbs	
  did	
  not	
  develop	
  any	
  skeleton,	
  we	
  determined	
  if	
  Sox9-­‐expressing	
   chondrogenic	
   progenitors	
   were	
   affected	
   at	
   early	
   stages	
   of	
   limb	
   bud	
  development.	
   In	
   Smad4Δ/ΔM	
   mutant	
   forelimbs,	
   the	
   Sox9	
   expression	
   pattern	
   was	
   mostly	
  unchanged	
   in	
   comparison	
   to	
   the	
  wild-­‐type	
   controls	
   until	
   E11.0	
   (Fig.	
   6A,	
   two	
   left-­‐most	
  panels).	
   At	
   E11.5	
   the	
  donut-­‐like	
   expression	
  of	
  Sox9	
   in	
  wild-­‐type	
   limb	
  buds	
  was	
  broken	
  into	
  a	
  proximal	
  element	
  and	
  a	
  distal	
  half-­‐moon	
  shape	
  in	
  Smad4Δ/ΔM	
  mutant	
  forelimb	
  buds.	
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This	
   altered	
   pattern	
   remained	
   at	
   E12.25,	
   while	
   the	
   Sox9	
   transcripts	
   outlined	
   the	
   digit	
  primordia	
   in	
   wild-­‐type	
   controls	
   (Fig.	
   6A,	
   two	
   right-­‐most	
   panels).	
   Moreover,	
   the	
   Sox9	
  expression	
   pattern	
   was	
   overall	
   proximalized	
   in	
   the	
   absence	
   of	
   mesenchymal	
   Smad4,	
  likely	
   due	
   to	
   increased	
   FGF	
   signaling	
   by	
   the	
  AER	
   (Fig.	
   6A,	
   second-­‐last	
   images	
   from	
   the	
  right,	
   white	
   brackets).	
   OPT	
   image	
   analysis	
   showed	
   the	
   increase	
   of	
   Sox9-­‐positive	
  chondrogenic	
   precursors	
   in	
   the	
   prospective	
   stylopod	
   element	
   and	
   the	
   concurrent	
  thinning	
   of	
   the	
   distal-­‐most	
   Sox9	
   domain	
   in	
   the	
   mutant	
   forelimbs	
   (Fig.	
   6B,	
   white	
  arrowheads	
  and	
  brackets).	
  In	
  the	
  absence	
  of	
  mesenchymal	
  Smad4,	
  Sox9	
  transcripts	
  never	
  extended	
  to	
  the	
  distal	
  limb	
  bud	
  where	
  the	
  digit	
  primordia	
  appear	
  by	
  E12.0	
  (Fig.	
  6B,	
  right-­‐most	
  panels).	
  To	
  gain	
  further	
  insight,	
  we	
  used	
  the	
  Hoxa13-­‐CreTg	
  knock-­‐in	
  transgene	
  to	
  study	
  the	
  Smad4	
  requirement	
  directly	
  during	
  handplate	
  development	
  and	
  specification	
  of	
  digit	
  primordia	
  between	
  around	
  36-­‐	
  to	
  40-­‐somites	
  (E10.75	
  –	
  E11.0).	
  We	
  first	
  established	
  that	
  the	
  knock-­‐in	
  Hoxa13-­‐CreTg	
   transgene	
   did	
   not	
   result	
   in	
   a	
   phenotype	
   on	
   its	
   own	
   or	
   in	
   combination	
  with	
  one	
  conditional	
  Smad4	
  allele	
  (Fig.	
  6C,	
  two	
  left-­‐most	
  panels).	
  In	
  Smad4ΔA13/ΔA13	
  mutant	
  limb	
  buds,	
  four	
  Sox9-­‐positive	
  digit	
  primordia	
  formed,	
  while	
  only	
  the	
  two	
  posterior-­‐most	
  digit	
  primordia	
  formed	
  in	
  the	
  Smad4Δ/ΔA13	
  limb	
  buds	
  (Fig.	
  6C,	
  two	
  right-­‐most	
  panels).	
  We	
  inferred	
   that	
   the	
   two	
   posterior	
   digit	
   primordia	
   are	
   either	
   specified	
   earlier	
   than	
   the	
  anterior	
  primordia,	
   or	
   require	
  Smad4	
   for	
   a	
   shorter	
   time.	
  This	
   analysis	
   reveals	
   the	
   tight	
  time	
   frame	
   in	
   which	
   digit	
   primordia	
   depend	
   on	
   Smad4	
   for	
   specification	
   of	
   their	
  chondrogenic	
  fate.	
  In	
  Bmp2ΔM/ΔM;	
  Bmp4ΔM/ΔM	
   double	
  mutant	
   limb	
   bud,	
   the	
   Sox9-­‐positive	
   primordia	
   for	
   the	
  two	
  posterior-­‐most	
  digits	
  fail	
  to	
  form	
  (see	
  Bandyopadhyay	
  et	
  al.,	
  2006).	
  We	
  reproduced	
  this	
  result,	
   looking	
  at	
  50-­‐somite	
   forelimbs.	
  Consistently	
  with	
  previous	
  results,	
  Sox9	
  was	
  not	
  expressed	
  in	
  the	
  posterior	
  forelimb	
  domain	
  and	
  only	
  anterior	
  Sox9-­‐positive	
  digit	
  rays	
  formed	
  (Fig.	
  6D,	
  panels	
  on	
  the	
  left).	
  Moreover,	
  Decorin	
  (Dcn)	
  transcripts,	
  which	
  encode	
  a	
  small	
   leucine-­‐rich	
   proteoglycan	
   that	
   regulates	
   the	
   assembly	
   of	
   non-­‐chondrogenic	
  collagen	
  fibers	
  (Danielson	
  et	
  al.,	
  1997),	
  label	
  the	
  region	
  of	
  the	
  posterior	
  digit	
  primordia	
  in	
  the	
  Bmp2ΔM/ΔM;	
  Bmp4ΔM/ΔM	
  mutant	
   forelimb,	
  whereas	
   in	
   the	
  anterior	
  digit	
  rays	
  Dcn	
  is	
  no	
  longer	
  expressed	
  (Fig.	
  6D,	
  two	
  right-­‐most	
  panels).	
  To	
  understand	
  whether	
  the	
  autopod	
  was	
  specified	
  in	
  the	
  absence	
  of	
  mesenchymal	
  Smad4	
  we	
  analysed	
  the	
  expression	
  of	
  Hoxa13.	
  The	
  spatial	
  distribution	
  of	
  the	
  Hoxa13	
  transcripts	
  (labeling	
  the	
  prospective	
  autopod)	
  was	
  not	
  altered	
  in	
  Smad4	
  mutant	
  limb	
  buds,	
  but	
  digit	
  and	
   interdigit	
   domains	
   (labeled	
  by	
  Cyp26b1	
  and	
  Dlx5,	
   respectively)	
  were	
   lost	
   (Fig.	
   6E),	
  consistent	
  with	
  the	
  failure	
  to	
  form	
  digits	
  in	
  Smad4Δ/ΔM	
  mutant	
  limb	
  buds.	
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Fig.	
  6.	
  Smad4	
  regulates	
  Sox9-­‐mediated	
  chondrogenic	
  specification	
  in	
  digit	
  primordia.	
  (A)	
  WISH	
  time-­‐course	
  (from	
  E10	
  to	
  E12.25)	
   for	
  Sox9	
  transcripts	
   in	
  wild-­‐type	
  and	
  Smad4Δ/ΔM	
  mutant	
  forelimbs.	
  White	
  bars	
  span	
  the	
  distance	
  between	
  the	
  distal-­‐most	
  Sox9	
  expression	
  domain	
  and	
  the	
  AER.	
   Experiment	
   performed	
   by	
   J.D.B.	
   (B)	
   Iso-­‐surface	
   OPT	
   rendering	
   of	
   the	
   Sox9	
   expression	
  domains	
  in	
  wild-­‐type	
  and	
  Smad4Δ/ΔM	
  mutant	
  forelimbs	
  at	
  E11	
  (41	
  somites),	
  E11.5	
  (44	
  somites)	
  and	
  E12	
   (52	
   somites).	
   White	
   brackets	
   mark	
   the	
   length	
   of	
   the	
   arch	
   that	
   Sox9	
   expression	
   pattern	
  outlines	
  in	
  the	
  limb	
  core.	
  White	
  arrows	
  point	
  at	
  a	
  proximal	
  element	
  specified	
  by	
  Sox9	
  expression,	
  most	
  likely	
  corresponding	
  to	
  the	
  prospective	
  stylopod.	
  (C)	
  Spatial	
  distribution	
  of	
  Sox9	
  in	
  the	
  digit	
  primordia	
  of	
  E12.5	
  forelimbs	
  from	
  Hoxa13-­‐CreTg-­‐positive	
  embryos	
  carrying	
  different	
  combinations	
  of	
  conditional	
  or	
  constitutive	
  Smad4	
  alleles.	
  The	
  two	
  left-­‐most	
  pictures	
  were	
  taken	
  by	
  J.D.B.	
  (D)	
  On	
  the	
  left	
  panels,	
  Sox9	
  expression	
  pattern	
  in	
  wild-­‐type	
  and	
  Bmp2ΔM/ΔM;Bmp4ΔM/ΔM	
  forelimbs	
  at	
  E11.75	
  (50	
   somites);	
   in	
   the	
   middle	
   panels,	
   OPT-­‐captured	
   expression	
   pattern	
   of	
   Dcn	
   on	
   wild-­‐type	
   and	
  
Bmp2ΔM/ΔM;Bmp4ΔM/ΔM	
  mutant	
  forelimbs	
  at	
  about	
  50	
  somites	
  from	
  a	
  dorsal	
  view.	
  The	
  white	
  broken	
  line	
  represents	
  the	
  approximate	
  levels	
  at	
  which	
  the	
  artificial	
  sections	
  from	
  an	
  AER-­‐oriented	
  view	
  are	
   taken	
   in	
   the	
   panels	
   on	
   the	
   right.	
   Brackets	
   indicate	
   the	
   posterior-­‐most	
   part	
   of	
   the	
   limb,	
   to	
  highlight	
   the	
   differences	
   in	
  Dcn	
  expression	
   between	
  wild-­‐type	
   and	
  Bmp2ΔM/ΔM;Bmp4ΔM/ΔM	
   limbs.	
  
(E)	
   Spatial	
   distribution	
   of	
   Hoxa13,	
   Cyp26b1	
   and	
   Dlx5	
   transcripts	
   in	
   wild-­‐type	
   and	
   Smad4Δ/ΔM	
  mutant	
   forelimbs	
   at	
   E12.5	
   (experiment	
   performed	
   by	
   J.D.B).	
   s:	
   scapula;	
   h:	
   humerus;	
   r:radius;	
  u:ulna;	
  1,2,3,4,5:	
  identities	
  of	
  the	
  digit	
  primordia.	
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Smad4	
   is	
   required	
   for	
   cell	
   aggregation	
   and	
   initiation	
   of	
   chondrogenic	
  
differentiation	
  We	
  established	
  a	
  high-­‐cell	
  density	
   in	
  vitro	
  culture	
  system	
  for	
  an	
  in-­‐depth	
  analysis	
  of	
  the	
  dynamic	
   properties	
   and	
   molecular	
   features	
   of	
   limb	
   bud	
   mesenchymal	
   cells	
   lacking	
  
Smad4.	
   Wild-­‐type	
   limb	
   bud	
   cells	
   cultured	
   for	
   48	
   hrs	
   (obtained	
   from	
   E11.5	
   embryos),	
  formed	
  cellular	
  aggregates	
  that	
  express	
  the	
  SOX9	
  protein	
  and	
  COL	
  type	
  II	
  in	
  the	
  core	
  (Fig.	
  7A).	
  In	
  contrast,	
  Smad4-­‐deficient	
  cells	
  did	
  not	
  form	
  aggregates	
  and	
  did	
  not	
  produce	
  COL	
  type	
  II	
  protein.	
  Furthermore,	
  mutant	
  cells	
  did	
  not	
  maintain	
  the	
  expression	
  of	
  SOX9,	
  which	
  appeared	
  down-­‐regulated	
  in	
  comparison	
  to	
  wild-­‐type	
  controls	
  (Fig.	
  7B).	
  Next,	
  we	
  treated	
  wild-­‐type	
   derived	
   high-­‐density	
   cultures	
   with	
   two	
   small	
   molecule	
   inhibitors,	
  dorsomorphin	
   and	
   SB431542,	
   that	
   specifically	
   block	
   either	
   BMP-­‐	
   or	
   TGFβ-­‐specific	
  receptor	
   activity,	
   respectively	
   (Yu	
   et	
   al.,	
   2008;	
   Inman	
   et	
   al.,	
   2002).	
   Both	
   treatments	
  resulted	
  in	
  phenotypes	
  similar	
  to	
  the	
  ones	
  of	
  limb	
  bud	
  mesenchymal	
  cells	
  lacking	
  Smad4	
  (compare	
  results	
   in	
  Fig.7	
  and	
  Fig.8).	
  Taken	
  together,	
   this	
  analysis	
  shows	
  that	
  both	
  BMP	
  and	
   TGFβ	
   receptor-­‐driven	
   pathways	
   are	
   fundamental	
   for	
   cell	
   aggregation,	
   early	
  chondrogenic	
   differentiation	
   (COL	
   type	
   II	
   expression)	
   and	
   maintenance	
   of	
   SOX9	
  expression	
  (Fig.	
  8A,B,C).	
  	
  	
   	
  	
  
Fig.	
   7.	
   Mesenchymal	
   Smad4	
  
is	
   fundamental	
   for	
   formation	
  
of	
   aggregates,	
   chondrogenic	
  
differentiation	
   and	
  
maintenance	
  of	
  SOX9	
  in	
  a	
  cell-­‐
based	
   model.	
   (A)	
  Immunofluorescence	
  using	
  high-­‐density	
   cultures	
   at	
   48	
   hrs	
  (mesenchymal	
   cells	
   obtained	
  from	
   limbs	
   at	
   E11.5)	
   reveals	
  aggregates	
   outlined	
   by	
   SOX9	
  (red)	
  and	
  marked	
  by	
  COL	
  type	
  II	
  (green)	
   expression	
   in	
   wild-­‐type	
  samples.	
   (B)	
   High-­‐density	
   culture	
   performed	
   using	
   Smad4Δ/ΔM	
   cells	
   results	
   in	
   reduced	
   SOX9	
  expression,	
  impaired	
  cell	
  aggregation	
  and	
  differentiation.	
  White	
  rectangles	
  indicate	
  the	
  positions	
  of	
  the	
  enlargements	
  shown	
  below.	
  (Experiment	
  performed	
  by	
  Frédéric	
  Laurent).	
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Fig.	
   8.	
   Small-­‐molecule	
  
treatment	
   of	
   a	
   high-­‐density	
  
culture	
   system	
   reveals	
   the	
  
importance	
   of	
   both	
   BMP	
   and	
  
TGFβ	
   receptors	
   for	
   initiation	
   of	
  
chondrogenesis.	
   	
   	
   (A)	
  Immunofluorescence	
   on	
   48-­‐hours	
  high-­‐density	
   culture	
   (mesenchymal	
  cells	
   obtained	
   from	
   limbs	
   at	
   E11.5)	
  reveals	
  aggregates	
  outlined	
  by	
  SOX9	
  (red)	
   and	
   marked	
   by	
   COL	
   type	
   II	
  (green)	
   expression	
   in	
   the	
  wild-­‐type	
  samples	
   in	
   the	
   presence	
   of	
   0.1%	
  DMSO	
   (same	
   solvent	
   concentration	
  used	
   for	
   experiments	
   in	
   panels	
   B	
  and	
   C).	
   (B,C)	
   When	
   high-­‐density	
  cultures	
   are	
   treated	
   either	
   with	
  Dorsomorphin	
   (10μM,	
   inhibitor	
   of	
  BMP	
  receptors)	
  or	
  SB431542	
  (10μM,	
  inhibitor	
  of	
  TGFβ	
  receptors),	
  aggregation	
  and	
  chondrogenic	
  differentiation	
  are	
  impaired,	
  and	
  SOX9	
  expression	
  is	
  not	
  maintained.	
  White	
  rectangles	
  indicate	
  the	
  positions	
  of	
  the	
  enlargements	
  shown	
  below.	
  	
  	
  
Smad4	
   controls	
   chondrogenic	
   differentiation	
   and	
   restricts	
   non-­‐chondrogenic	
   cell	
  
fates	
  The	
  potential	
   role	
  of	
  Smad4	
   in	
   regulating	
   limb	
   cell	
   fates	
  was	
   assessed	
  by	
   analyzing	
   the	
  distribution	
   of	
   specific	
   markers	
   for	
   different	
   cell	
   lineages	
   specification.	
   Col2a1	
   is	
  activated	
   downstream	
   Sox9	
  and	
  marks	
   cells	
   that	
   undergo	
   chondrogenic	
   differentiation	
  (e.g.	
  during	
  formation	
  of	
  digit	
  primordia),	
  whereas	
  Col1a2	
  expression	
  marks	
  connective	
  tissues	
   such	
   as	
   skin,	
   tendons,	
   ligaments	
   and	
  muscle-­‐associated	
   connective	
   tissues	
   (Fig.	
  9A,	
   upper	
   panels;	
   see	
   Introduction).	
   Upon	
  mesenchymal	
   inactivation	
   of	
   Smad4,	
   Col2a1	
  transcripts	
   were	
   down-­‐regulated	
   in	
   the	
   forelimbs.	
   At	
   E12.5	
   and	
   E13.5,	
   the	
   Col2a1	
  expression	
   was	
   very	
   much	
   reduced.	
   Conversely,	
   Col1a2	
   expression	
   was	
   strongly	
   up-­‐regulated	
  from	
  E11.5	
  onwards	
  in	
  mutant	
  limb	
  buds	
  in	
  comparison	
  to	
  wild-­‐type	
  controls.	
  In	
  particular,	
  the	
  Col1a2	
  expression	
  domain	
  extended	
  into	
  the	
  limb	
  distal	
  mesenchyme	
  of	
  mutant	
  limb	
  buds	
  by	
  E13.5,	
  pointing	
  to	
  the	
  absence	
  of	
  restrictive	
  cues.	
  The	
  same	
  applies	
  to	
   the	
   expression	
   domains	
   of	
  Dcn,	
  Scx	
   and	
  Fjx1,	
   the	
   latter	
   being	
   a	
  marker	
   for	
   ligament	
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progenitors.	
  Dcn	
  expression	
  in	
  Smad4Δ/ΔM	
  mutant	
  limb	
  buds	
  was	
  up-­‐regulated	
  and	
  spread	
  throughout	
   the	
   limb,	
   including	
   the	
   distal	
   region	
   normally	
   occupied	
   by	
   mesenchymal	
  condensations	
   (compare	
   Fig.	
   9C	
   with	
   Fig.	
   6D).	
   The	
   Scx	
  expression	
   domain,	
   which	
   was	
  localized	
   in	
  the	
  sub-­‐ectoderm	
  at	
   the	
   level	
  of	
   the	
  digit	
  primordia	
   in	
  wild-­‐type	
   limb	
  buds,	
  expanded	
   throughout	
   the	
   entire	
   sub-­‐ectodermal	
   region	
   in	
   the	
   Smad4Δ/ΔM	
  mutant	
   limb	
  (Fig.	
  9D).	
  The	
  Fjx1	
  domain,	
  which	
  localized	
  to	
  the	
  prospective	
  joints	
  in	
  the	
  wild-­‐type	
  limb	
  buds,	
  was	
  also	
  spread	
  throughout	
  the	
  mutant	
  mesenchyme	
  (Fig.	
  9E).	
  Interestingly,	
  for	
  all	
  three	
  molecules	
  expression	
  levels	
  were	
  up-­‐regulated	
  already	
  at	
  E11.5	
  (between	
  47-­‐	
  and	
  50-­‐somite	
  stage),	
  before	
  the	
  differentiation	
  of	
  mesenchymal	
  cells	
  took	
  place	
  in	
  wild-­‐type	
  limb	
   buds	
   (Fig.	
   9C,D,E).	
  Dcn	
   and	
   Scx	
   transcripts	
   were	
   found	
   up-­‐regulated	
   also	
   by	
   RT-­‐qPCR,	
  whereas	
  Sox9	
  transcripts	
  were	
  significantly	
  reduced	
  (Fig.	
  9G).	
  We	
  then	
   looked	
  at	
  the	
   progenitors	
   of	
   the	
   skeletal	
  muscles	
   (marked	
  by	
  MyoD1	
   transcription	
   factor),	
  which	
  migrate	
   from	
   the	
   somites	
   into	
   limb	
   buds	
   (reviewed	
   in	
   Buckingham	
   et	
   al.,	
   2003).	
   The	
  spatial	
   distribution	
   of	
   MyoD1	
   transcripts	
   was	
   unchanged	
   at	
   E11.5	
   (Fig.	
   9F,	
   left-­‐most	
  panel).	
  We	
  found	
  that	
  MyoD1-­‐labeled	
  migrating	
  progenitors	
  could	
  not	
  organize	
  properly	
  in	
  the	
  Smad4Δ/ΔM	
  mutant	
  limb	
  at	
  E12.5-­‐E13.5	
  (Fig.	
  9F,	
  right-­‐most	
  panels).	
  This	
  phenotype	
  is	
  likely	
  caused	
  by	
  the	
  lack	
  of	
  cartilaginous	
  structures	
  and	
  tendon	
  progenitors,	
  which	
  are	
  responsible	
   for	
   organizing	
  muscle	
   precursors	
   during	
   tissue	
   differentiation	
   (Blitz	
   et	
   al.,	
  2009).	
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Fig.	
   9.	
   Smad4	
   controls	
   a	
   switch	
   in	
   chondrogenic	
   cell	
   fate	
   while	
   restricting	
   alternative	
  
lineages.	
   (A,B)	
   Spatial	
   distribution	
   of	
   Col2a1	
   (A)	
   and	
   Col1a2	
   (B)	
   transcripts	
   in	
   wild-­‐type	
   and	
  
Smad4Δ/ΔM	
  mutant	
  forelimbs	
  at	
  E11.5	
  (~47-­‐50	
  somites),	
  E12.5	
  and	
  E13.5.	
  (C,D)	
  Distribution	
  of	
  Dcn	
  
(C)	
  and	
  Scx	
  (D)	
   transcripts	
  in	
  wild-­‐type	
  and	
  Smad4Δ/ΔM	
  mutant	
  forelimbs	
  at	
  E11.5	
  (left	
  panel)	
  or	
  with	
  OPT	
   rendering	
   at	
   E12.5	
   (middle	
   and	
   right	
   panels).	
  Middle	
   panels	
   show	
  a	
   dorsal	
   view.	
  The	
  white	
  broken	
  line	
  represents	
  the	
  approximate	
  levels	
  at	
  which	
  the	
  artificial	
  sections	
  from	
  an	
  AER-­‐oriented	
  view	
  are	
   taken	
   in	
   the	
   right-­‐most	
  panels.	
  OPT	
  scans	
   in	
   these	
  panels	
  were	
  performed	
  by	
  Erkan	
  Uenal.	
  (E,F)	
  Distribution	
  of	
  Fjx1	
  (E)	
  and	
  MyoD1	
  (F)	
  transcripts	
  in	
  wild-­‐type	
  and	
  Smad4Δ/ΔM	
  mutant	
   forelimbs	
  at	
  E11.5	
   (~47	
  somites),	
  E12.5	
  and	
  E13.5	
  (G)	
  RT-­‐qPCR	
  quantification.	
  Dcn	
  and	
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Scx	
  transcripts	
  are	
  up-­‐regulated	
  in	
  Smad4Δ/ΔM	
  mutant	
  limb	
  buds	
  (P≤0.06	
  and	
  P≤0.05,	
  respectively),	
  whereas	
   Sox9	
   transcripts	
   are	
   down-­‐regulated	
   in	
   comparison	
   to	
   wild-­‐type	
   controls.	
   RNA	
   was	
  obtained	
  from	
  E11.75	
  (about	
  50	
  somites)	
   forelimb	
  buds;	
  8	
  Smad4Δ/ΔM	
   limb	
  buds	
  were	
  processed	
  and	
   compared	
   to	
   stage-­‐matched	
   controls.	
   Results	
   are	
   reported	
   as	
  mean	
   ±	
   SD.	
   Significance,	
   one	
  star:	
  P≤0.05.	
  See	
  Material	
  and	
  Methods	
  for	
  additional	
  information.	
  	
  	
  
Minor	
  alterations	
  in	
  cell	
  death	
  are	
  observed	
  following	
  mesenchymal	
  inactivation	
  of	
  
Smad4	
  As	
  part	
  of	
  our	
  analysis	
  we	
  checked	
  for	
  possible	
  alteration	
  in	
  cell	
  death	
  and	
  proliferation.	
  In	
  the	
  Smad4Δ/ΔM	
  mutant	
  limb	
  we	
  detected	
  an	
  ectopic/enhanced	
  spot	
  of	
  cell	
  death	
  in	
  the	
  limb	
  core	
  around	
  E10.5	
  and	
  E11.5	
  (Fig.	
  10A,B;	
  white	
  and	
  black	
  arrowheads	
  on	
  left-­‐most	
  panels).	
   As	
   expected,	
   interdigital	
   cell	
   death	
   was	
   suppressed	
   in	
   Smad4Δ/ΔM	
   mutant	
   limb	
  buds	
   at	
   E13.5	
   (Fig.	
   10A,B;	
   right-­‐most	
   panels).	
   Cell	
   death	
   was	
   assessed	
   using	
   the	
  fluorescent	
   probe	
   Lysotracker®	
   and	
   by	
   analysis	
   of	
   the	
   Cathepsin	
   D	
   (Cstd)	
   expression	
  pattern	
  (Zuzarte-­‐Luis	
  et	
  al.,	
  2007).	
  No	
  differences	
  where	
  apparent	
  in	
  comparing	
  the	
  two	
  methods	
  (Fig.	
  10,	
  compare	
  panels	
  A	
  and	
  B).	
  Concomitantly,	
   cell	
   proliferation	
   was	
   addressed	
   by	
   Dr.	
   Ashleigh	
   Nugent	
   with	
   a	
   Ki67	
  immunostaining	
   on	
   limb	
   sections	
   (see	
   Benazet	
   et	
   al.,	
   2012),	
   but	
   no	
   alterations	
   in	
  proliferation	
  were	
  observed	
  up	
  to	
  E12.5.	
  	
  
	
  
Fig.	
  10.	
  Cell	
  death	
  is	
  not	
  significantly	
  altered	
  by	
  inactivation	
  of	
  mesenchymal	
  Smad4.	
  (A)	
  Detection	
  of	
  cell	
  death	
  in	
  wild-­‐type	
  and	
  Smad4Δ/ΔM	
  mutant	
  forelimbs	
  with	
  LysoTracker®	
  tracer	
  in	
  a	
  time-­‐course	
  experiment	
  from	
  E10.5	
  to	
  E13.5.	
  White	
  arrowheads	
  point	
  at	
  cell	
  death	
  domains	
  in	
  the	
  limb	
  core	
  at	
  E10.5	
  and	
  E11.5.	
  (B)	
  Cathepsin	
  D	
  (Cstd)	
  probe	
  labels	
  active	
  lysosomes	
  and	
  describes	
  cell	
   death	
   pattern	
   in	
   a	
   less	
   sensitive	
   fashion	
   with	
   respect	
   to	
   LysoTracker®	
   tracer.	
   Black	
  arrowheads	
   point	
   at	
   the	
   cell	
   death	
   domains	
   in	
   the	
   limb	
   core	
   at	
   E11.5.	
   Stages	
   of	
   analysis	
   are	
  indicated	
  in	
  the	
  panels.	
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Genetic	
   analysis	
   of	
   Smad4	
   requirements	
   during	
   limb	
   bud	
   initiation	
   (unpublished	
  results).	
  
Smad4	
  was	
   inactivated	
   in	
   the	
   hindlimb	
   field	
   using	
   the	
   Hoxb6-­‐Cre	
   transgene	
   to	
   study	
  potential	
  roles	
  of	
  Smad4	
  during	
  limb	
  bud	
  initiation.	
  While	
  recombination	
  in	
  the	
  hindlimb	
  is	
   complete,	
   recombination	
   in	
   the	
   forelimb	
  occurs	
  only	
   in	
   the	
  posterior	
   limb	
  domain	
  at	
  about	
   E10.0	
   (Fig.	
   11A).	
   This	
   early	
   Smad4	
   inactivation	
   resulted	
   in	
   a	
   high	
   degree	
   of	
  developmental	
  arrest	
  by	
  about	
  E8.5	
  associated	
  with	
  heart	
  hypertrophy	
  (Fig.	
  11B).	
  Mutant	
  embryos	
   that	
   survived	
   this	
   early	
   arrest	
   developed	
   to	
  E10.25/E10.5.	
  At	
   this	
   stage,	
   dead	
  embryos	
  were	
   recognized	
  as	
   they	
  no	
   longer	
  expressed	
  Sox9	
  and	
  Grem1	
  in	
   somites	
   (Fig.	
  11C).	
   In	
   Smad4Δ/ΔHb6	
  mutant	
   forelimbs	
   Smad4	
  remained	
   expressed	
   in	
   the	
   anterior	
   limb	
  bud	
  mesenchyme,	
  consistent	
  with	
  the	
  posterior	
  activity	
  of	
  the	
  Hoxb6-­‐Cre	
  transgene	
  (Fig.	
  11D,	
   arrowhead).	
  Grem1	
  expression	
  was	
   either	
   unaltered	
   or	
   appeared	
  more	
   diffuse	
   in	
  both	
   fore-­‐	
   and	
  hindlimb	
  buds	
  of	
  Smad4Δ/ΔHb6	
  mutant	
   embryos	
   (Fig.	
  11E,	
   left	
   and	
   central	
  panels).	
  Preliminary	
  results	
  indicated	
  that	
  mutant	
  Smad4Δ/ΔHb6	
  embryos	
  failed	
  to	
  activate	
  
Sox9	
  expression	
  in	
  the	
  core	
  mesenchyme	
  of	
  early	
  limb	
  buds	
  (Fig.	
  11E,	
  right	
  panel).	
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Fig.	
   11	
   Inactivation	
   of	
   Smad4	
   in	
   the	
  
hindlimb	
   field	
  and	
   the	
  posterior	
   forelimb	
  
bud	
   at	
   early	
   stages.	
   (A)	
   β-­‐Actin-­‐GFP	
  reporter	
   transgene	
   is	
   recombined	
   and	
  activated	
   upon	
   expression	
   of	
   the	
   Hoxb6-­‐Cre	
  transgene	
  (see	
  Material	
  and	
  Methods).	
  In	
  the	
  upper	
   panels,	
   one	
   embryo	
   was	
   imaged	
   at	
  E9.0	
   (18	
   somites;	
   n=1);	
   dark-­‐field	
   image	
   is	
  overlapped	
  to	
  the	
  green	
  fluorescent	
  signal.	
  In	
  the	
   lower	
  panels,	
   only	
   the	
   fluorescent	
   signal	
  in	
  the	
  forelimbs	
  (left)	
  and	
  hindlimbs	
  (right)	
  is	
  reported	
   at	
   E10.0	
   (31	
   somites;	
   n=3;	
   contributed	
   by	
   Marco	
   Osterwalder).	
   Recombination	
   only	
  occurs	
   in	
   the	
  hindlimb	
   field	
  and	
   the	
  correspondent	
  axial	
  mesodermal	
   segment	
  of	
   the	
  embryo	
  at	
  E9.0,	
  whereas	
  recombination	
  extends	
  to	
  the	
  posterior	
  region	
  of	
  the	
  forelimbs	
  at	
  E10.0.	
  (B)	
  Dark-­‐field	
   micrographs	
   of	
   representative	
   wild-­‐type	
   and	
   retarded	
   Smad4Δ/ΔHb6	
   embryos	
   collected	
   at	
  E11.5.	
   Smad4Δ/ΔHb6	
   embryos	
   were	
   retrieved	
   with	
   mendelian	
   ratios.	
   However,	
   more	
   than	
   half	
  showed	
  an	
  arrest	
   in	
  development	
  at	
  around	
  E8.5	
  and	
   limb	
  agenesis.	
  Therefore,	
  only	
  embryos	
  of	
  the	
   expected	
  age	
  were	
   collected	
   from	
  each	
   litter.	
   (C)	
  Sox9	
  transcripts	
  detected	
   in	
  wild-­‐type	
  and	
  
Smad4Δ/ΔHb6	
   embryos	
   at	
   E9.75	
   (26	
   somites;	
   n=2).	
   The	
   absence	
   of	
   signal	
   in	
   all	
   tissues	
   of	
  mutant	
  embryos	
   indicates	
   that	
   developmental	
   arrest	
   occurred	
   before	
   collection.	
   (D)	
   Detection	
   of	
  transcripts	
   of	
   Smad4	
   exon	
   8	
   in	
   forelimbs	
   of	
   wild-­‐type,	
   Smad4Δ/flox	
   and	
   Smad4Δ/ΔHb6	
   at	
   E10	
   (30	
  somites,	
  n=2).	
  The	
  Hoxb6-­‐Cre	
  transgene	
  is	
  expressed	
  in	
  the	
  posterior	
  forelimb	
  mesenchyme,	
  which	
  explains	
  the	
  residual	
  anterior	
  expression	
  of	
  Smad4	
  transcripts	
  (black	
  arrowhead).	
  (E)	
  Grem1	
  and	
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Sox9	
  transcripts	
  (n=3	
  and	
  n=1,	
  respectively).	
  On	
  the	
  left,	
  forelimbs	
  from	
  wild-­‐type	
  and	
  Smad4Δ/ΔHb6	
  mutant	
  embryos	
  are	
  shown	
  at	
  E9.75	
  (28	
  somites).	
  Mutant	
  forelimb	
  buds	
  show	
  more	
  diffuse	
  Grem1	
  expression	
  in	
  comparison	
  to	
  wild-­‐type	
  controls.	
  At	
  E10.5,	
  Grem1	
  expression	
  is	
  similar	
  in	
  wild-­‐type	
  and	
  mutant	
  hindlimbs	
  (36	
  somites).	
  On	
  the	
  right,	
  Sox9	
  transcripts	
  are	
  expressed	
  in	
  somites	
  (black	
  arrowheads)	
   but	
   are	
   absent	
   from	
   the	
   posterior	
   mutant	
   forelimb	
   mesenchyme	
   at	
   E10.25	
   (32	
  somites).	
  FL,	
  forelimb;	
  HL,	
  hindlimb;	
  S4,	
  Smad4.	
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8.	
  DISCUSSION	
  	
  In	
   the	
   present	
   study,	
  we	
   used	
   a	
   genetic	
   approach	
   to	
   investigate	
   the	
   roles	
   of	
   SMAD4-­‐mediated	
   canonical	
   BMP	
   signal	
   transduction	
   during	
   limb	
   development.	
   We	
   found	
   that	
  SMAD4	
  is	
  involved	
  in	
  specification	
  of	
  digit	
  primordia	
  and	
  initiation	
  of	
  chondrogenesis.	
  	
  Inactivation	
  of	
  Smad4	
  in	
  the	
  limb	
  mesenchyme	
  during	
  AER	
  formation	
  and	
  compaction	
  (E9.5-­‐	
  E9.75)	
  ultimately	
  results	
  in	
  agenesis	
  of	
  the	
  limb	
  skeleton.	
  Similarly,	
  inactivation	
  of	
  
Smad4	
   in	
   the	
   prospective	
   handplate	
   at	
   later	
   stages	
   (E10.75-­‐E11.0)	
   leads	
   to	
   loss	
   of	
  autopod	
  skeletal	
  structures.	
  These	
  results	
  provide	
  genetic	
  evidence	
  for	
  a	
  role	
  of	
  SMAD4,	
  and	
  likely	
  canonical	
  BMP	
  signal	
  transduction,	
   in	
   initiation	
  of	
  chondrogenesis.	
  Moreover,	
  using	
  Hoxa13-­‐Cre-­‐mediated	
   Smad4	
   inactivation	
   we	
   obtain	
   evidence	
   for	
   a	
   narrow	
   time	
  window	
   for	
   the	
   SMAD4	
   to	
   induce	
   digit	
   primordia.	
   Previous	
   genetic	
   analysis	
   focused	
  mainly	
   on	
   BMP	
   functions	
   in	
   AER	
   formation	
   or	
   in	
   maintenance	
   of	
   chondrocyte	
  proliferation	
   and	
   differentiation	
   failed	
   to	
   uncover	
   roles	
   of	
   BMP	
   signalling	
   in	
   initiating	
  chondrogenic	
   differentiation.	
   For	
   instance,	
   inactivation	
   of	
   BmpR1a	
   in	
   the	
   ventral	
  ectoderm	
  results	
  in	
  limb	
  agenesis	
  due	
  to	
  impaired	
  AER	
  formation	
  (Ahn	
  et	
  al.,	
  2001;	
  Pajni-­‐Underwood	
   et	
   al.,	
   2007);	
   and	
   compound	
   inactivation	
   of	
   BmpR1b	
   and	
   BmpR1a	
   in	
  chondrocytes	
   results	
   in	
   severe	
   chondrodysplasia	
   due	
   to	
   increased	
   cell	
   death	
   and	
  impaired	
  chondrocyte	
  differentiation	
  (Yoon	
  et	
  al.,	
  2005).	
  Experiments	
   with	
   mesenchymal	
   progenitors	
   in	
   culture	
   show	
   that	
   Smad4-­‐deficient	
  mesenchymal	
  cells	
  do	
  not	
  initiate	
  aggregation,	
  which	
  is	
  the	
  first	
  step	
  during	
  formation	
  of	
  the	
  cartilage	
  primordia.	
  This	
  Smad4	
  requirement	
   is	
   the	
   first	
  obvious	
  defect	
  observed	
   in	
  limb	
   buds	
   lacking	
   mesenchymal	
   Smad4,	
   as,	
   in	
   contrast	
   to	
   other	
   BMP	
   pathway-­‐related	
  molecules,	
   AER	
   establishment	
   is	
   not	
   impaired	
   and	
   only	
  minor	
   defects	
   in	
   endochondral	
  bone	
  formation	
  are	
  observed	
  (Benazet	
  et	
  al.,	
  2012;	
  Pajni-­‐Underwood	
  et	
  al.,	
  2007;	
  Zhang	
  et	
   al.,	
   2005).	
   This	
   points	
   to	
   SMAD4-­‐independent	
   BMP	
   signal	
   transduction	
   during	
   limb	
  development.	
   Besides	
   non-­‐canonical	
   BMP	
   signal	
   transduction,	
   evidence	
   supporting	
  SMAD4-­‐independent,	
   SMAD-­‐dependent	
   signaling	
   transduction	
   exists	
   (Liu	
   et	
   al.,	
   1997).	
  Previous	
   analysis	
   of	
   high-­‐density	
   limb	
   bud	
   mesenchymal	
   cell	
   cultures	
   defined	
   several	
  steps	
   of	
   mesenchymal	
   condensation:	
   sorting,	
   aggregation,	
   cluster	
   formation	
   and	
  compaction,	
  the	
  last	
  of	
  which	
  was	
  shown	
  to	
  require	
  BMPs	
  (Barna	
  and	
  Niswander,	
  2007).	
  	
  We	
  show	
  that	
  mesenchymal	
  Smad4	
  is	
  required	
  for	
  Sox9-­‐specification	
  of	
  digit	
  primordia	
  around	
   the	
   time	
   when	
   the	
   autopod	
   is	
   shaped.	
   In	
   the	
   early	
   stages,	
   Sox9	
   expression	
   is	
  unaffected	
   by	
   loss	
   of	
  mesenchymal	
   Smad4	
   (E9.75	
   to	
   E10.75),	
   which	
   is	
   consistent	
   with	
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BMP	
  activity	
  being	
   low	
  due	
   to	
  GREM1	
  antagonism	
  during	
   this	
  phase	
  of	
   limb	
  patterning	
  and	
   outgrowth	
   (Benazet	
   et	
   al.,	
   2009).	
   However,	
   when	
   the	
   increase	
   of	
   BMP	
   activity	
   is	
  required	
   for	
   mesenchymal	
   progenitors	
   to	
   undergo	
   chondrogenesis	
   (Lopez-­‐Rios	
   et	
   al.,	
  2012),	
   Smad4	
   is	
   required	
   to	
   propagate	
   the	
   expression	
   of	
   Sox9	
   in	
   the	
   prospective	
   digit	
  primordia	
   in	
  the	
  forming	
  autopod.	
   In	
  the	
  absence	
  of	
  Smad4,	
  Sox9-­‐positive	
  chondrogenic	
  precursors	
  accumulate	
  proximally	
  (likely	
  at	
  the	
   level	
  of	
  the	
  prospective	
  stylopod)	
  while	
  the	
   distal	
   expression	
   is	
   disrupted.	
   This	
   could	
   be	
   attributed	
   to	
   a	
   cell-­‐autonomous	
  mesenchymal	
  defect	
  or	
  to	
  high	
  and	
  prolonged	
  AER-­‐FGF	
  signalling	
  in	
  distal	
  Smad4	
  mutant	
  limb	
  buds,	
  which	
  inhibits	
  differentiation	
  of	
  the	
  mesenchyme	
  (Benazet	
  and	
  Zeller,	
  2013).	
  These	
  results	
  indicate	
  that	
  SMAD4	
  could	
  be	
  part	
  of	
  the	
  novel	
  molecular	
  circuitry	
  that	
  had	
  to	
   evolve	
   during	
   formation	
   of	
   the	
   autopod	
   and	
   digits	
   in	
   tetrapods	
   (Woltering	
   and	
  Duboule,	
  2010).	
  The	
   impact	
   of	
   Smad4-­‐medited	
   signal	
   transduction	
   on	
   Sox9	
   expression	
   was	
   further	
  addressed	
  in	
  high-­‐density	
  mesenchymal	
  progenitor	
  cell	
  cultures,	
  which	
  provide	
  evidence	
  that	
   Smad4	
   is	
   necessary	
   to	
   sustain	
   SOX9	
   expression	
   downstream	
   BMP	
   (and	
   TGFβ)	
  receptors.	
   In	
   addition,	
   I	
   have	
   obtained	
   genetic	
   evidence	
   in	
   support	
   of	
   a	
   role	
   for	
   BMP	
  signalling	
   in	
   activation	
   of	
   Sox9	
   in	
   the	
   limb	
   bud	
   mesenchyme	
   at	
   very	
   early	
   stages.	
   My	
  genetic	
   evidence	
   corroborates	
   cell-­‐based	
   studies	
   that	
   show	
   that	
   Sox9	
   is	
   a	
   direct	
  transcriptional	
  target	
  of	
  both	
  canonical	
  and	
  non-­‐canonical	
  BMP	
  signal	
  transduction	
  (Gao	
  et	
  al.,	
  2013;	
  Pan	
  et	
  al.,	
  2008).	
  	
  Furthermore,	
  conditional	
  inactivation	
  of	
  Smad4	
  in	
  the	
  autopod	
  unveiled	
  its	
  differential	
  requirement	
   for	
   formation	
  of	
   anterior	
   and	
  posterior	
  digit	
  primordia.	
  The	
  mesenchymal	
  progenitors	
  giving	
  rise	
  to	
  the	
  posterior	
  digits	
  4/5	
  requires	
  canonical	
  BMP	
  signalling	
  for	
  a	
  shorter	
   time,	
   or	
   activate	
   BMP	
   signalling	
   earlier	
   than	
   the	
   anterior	
   compartment	
   as	
   a	
  possible	
   consequence	
   of	
   the	
   progressive	
   anterior	
   displacement	
   of	
   Grem1	
   expression	
  domain	
  (Michos	
  et	
  al.,	
  2004).	
  In	
  light	
  of	
  these	
  results,	
  the	
  loss	
  of	
  the	
  posterior	
  primordia	
  in	
   the	
   Bmp2;	
   Bmp4	
   mutant	
   mesenchyme	
   shows	
   that	
   BMP2	
   and	
   BMP4	
   mediate	
   up-­‐regulation	
  of	
  BMP	
  activity	
  in	
  the	
  posterior	
  limb	
  mesenchyme	
  prior	
  to	
  its	
  increase	
  in	
  the	
  anterior	
  mesenchyme	
   (Bandyopadhyay	
   et	
   al.,	
   2006).	
   In	
   addition,	
   this	
   study	
   shows	
   that	
  BMP7	
   is	
   required	
   to	
   specify	
   the	
   digit	
   primordia	
   in	
   the	
   anterior	
   limb	
  bud	
  mesenchyme.	
  Genetic	
  inactivation	
  of	
  Smad4	
  in	
  the	
  autopod	
  also	
  revealed	
  a	
  posterior-­‐to-­‐anterior	
  order	
  of	
  specification	
  of	
  digit	
  primordia,	
  which	
  apparently	
  contrast	
  with	
  the	
  results	
  obtained	
  by	
  temporal	
  conditional	
  inactivation	
  of	
  Shh	
  (Zhu	
  et	
  al.,	
  2008).	
  Zhu	
  and	
  colleagues	
  proposed	
  that	
  digit	
  determination	
  and	
  formation	
  follows	
  a	
  specific	
  sequence:	
  namely	
  4,	
  2,	
  5	
  and	
  3,	
  and	
   the	
  Shh-­‐independent	
  digit	
  1	
   appearing	
   last	
   (Zhu	
  et	
   al.,	
   2008).	
  These	
   results	
   can	
  be	
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reconciled	
  with	
   our	
   results	
   by	
   proposing	
   that	
   the	
   anterior	
   digit	
   2/3	
   and	
   the	
   posterior	
  digit	
   4/5	
   primordia	
   arise	
   from	
   single	
   Sox9-­‐positive	
   condensation	
   that	
   branches	
  subsequently	
  during	
  limb	
  bud	
  development.	
  	
  We	
  demonstrate	
  that	
  mesenchymal	
  Smad4	
  is	
  also	
  required	
  during	
  limb	
  bub	
  outgrowth	
  and	
   patterning	
   in	
   the	
   context	
   of	
   the	
   positive	
   feedback	
   loop	
   SHH/GREM1/AER-­‐FGF.	
  Despite	
   not	
   being	
   essential	
   for	
   the	
   establishment	
   of	
   the	
   limb	
   signalling	
   centers,	
  Smad4	
  modulates	
  AER-­‐FGF	
  and	
  Shh	
  expression.	
   Indeed,	
  upon	
  mesenchymal	
  removal	
  of	
  Smad4,	
  
Fgf8	
   is	
   up-­‐regulated	
   and	
   its	
   expression	
   is	
   prolonged,	
   while	
   Shh	
   expression	
   pattern	
   is	
  extended	
  proximally.	
  Notably,	
  similar	
  alterations	
  were	
  detected	
  following	
  inactivation	
  of	
  BMP	
   ligands	
   (Bandyopadhyay	
   et	
   al.,	
   2006;	
   Selever	
   et	
   al.,	
   2004),	
   indicating	
   that	
   SMAD4	
  transduces	
  the	
  low	
  levels	
  of	
  BMP	
  activity	
  during	
  limb	
  bud	
  outgrowth	
  and	
  patterning.	
  	
  The	
  roles	
  of	
  BMP	
  signalling	
  in	
  initiation	
  of	
  chondrogenesis	
  at	
  a	
  molecular	
  level	
  are	
  not	
  clear.	
  I	
  have	
  obtained	
  evidence	
  for	
  a	
  role	
  for	
  Smad4	
  in	
  regulating	
  the	
  small	
  GTPase	
  RhoC	
  (data	
  not	
  shown),	
  which	
  is	
  known	
  to	
  be	
  involved	
  in	
  cell	
  rearrangements	
  and	
  motility	
  by	
  acting	
  on	
  the	
  cytoskeleton	
  (Kitzing	
  et	
  al.,	
  2010).	
  Indeed,	
  RhoC	
  is	
  expressed	
  by	
  the	
  cells	
  of	
  the	
  perichondrium	
  and	
   is	
   supposed	
   to	
   inhibit	
   chondrogenesis	
   and	
  define	
   the	
  boundary	
  between	
   condensing	
   and	
   non-­‐condensing	
   tissues	
   (Montero	
   et	
   al.,	
   2007).	
   Moreover,	
  parallel	
  experiments	
  run	
   in	
   the	
   lab	
   indicate	
   that	
  expression	
  of	
  N-­‐cadherin	
   is	
  dependent	
  on	
   mesenchymal	
   Smad4.	
   Altogether,	
   these	
   data	
   point	
   at	
   a	
   possible	
   role	
   of	
   Smad4	
   in	
  rearranging	
   the	
   actin	
   cytoskeleton	
   during	
   initiation	
   of	
   chondrogenesis.	
   These	
  rearrangements	
   are	
   known	
   to	
   involve	
   β-­‐catenin	
   as	
   a	
   structural	
   component	
   and	
   as	
  transcriptional	
  modulator	
  (Modarresi	
  et	
  al.,	
  2005;	
  Ouyang	
  et	
  al.,	
  2013).	
  This	
  is	
  relevant	
  as	
  canonical	
   Wnt	
   signalling,	
   which	
   is	
   mediated	
   by	
   β-­‐catenin,	
   inhibits	
   chondrocyte	
  differentiation	
  (Rudnicki	
  and	
  Brown,	
  1997).	
  	
  
Smad4	
  inactivation	
  in	
  the	
  limb	
  mesenchyme	
  results	
  in	
  soft,	
  non-­‐organized	
  tissues	
  that	
  lack	
  bone	
  and	
  any	
  differentiated	
  structures.	
  Further	
  molecular	
  analysis	
  revealed	
  the	
  up-­‐regulation	
   and	
   wide-­‐spread	
   expression	
   of	
   markers	
   for	
   non-­‐chondrogenic	
   lineages.	
   In	
  particular,	
  Col	
   type	
   I,	
   its	
   downstream	
   target	
  Scx	
  (Cserjesi	
   et	
   al.,	
   1995;	
   Schweitzer	
   et	
   al.,	
  2001),	
  Fjx1	
  (Rock	
  et	
  al.,	
  2005)	
  and	
  Dcn	
  (Danielson	
  et	
  al.,	
  1997)	
  were	
  up-­‐regulated	
  and	
  co-­‐expressed	
   in	
   regions	
   that	
   would	
   normally	
   undergo	
   chondrogenesis.	
   This	
   is	
   consistent	
  with	
  the	
  results	
  obtained	
  by	
  Pizette	
  and	
  Niswander	
  following	
  misexpression	
  of	
  Noggin	
  in	
  the	
  chicken	
  wing	
  buds.	
  In	
  such	
  wing	
  buds	
  Gdf5,	
  which	
  marks	
  tendon	
  progenitors,	
  was	
  up-­‐regulated	
   in	
   regions	
   of	
   chondrogenic	
   condensations	
   (Pizette	
   and	
   Niswander,	
   2000).	
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Altogether,	
  these	
  results	
  point	
  to	
  a	
  role	
  of	
  SMAD4	
  in	
  restraining	
  non-­‐chondrogenic	
  versus	
  chondrogenic	
   cell	
   fates,	
   and	
   reveal	
   that	
   this	
   is	
   fundamental	
   prerequisite	
   to	
   initiate	
  chondrogenic	
  differentiation.	
  This	
  conclusion	
  is	
  of	
  particular	
  interest	
  since	
  experimental	
  evidence	
   indicates	
   that	
  BMP	
  activity	
   in	
   the	
   limb	
  bud	
  mesenchyme	
  down-­‐regulates	
  Wnt	
  signalling	
  in	
  the	
  ectoderm	
  to	
  prevent	
  tendon	
  and	
  connective	
  soft	
  tissue	
  differentiation	
  of	
  core	
  mesenchymal	
  cells	
  (Collette	
  et	
  al.,	
  2012;	
  Collette	
  et	
  al.,	
  2010;	
  Kamiya	
  et	
  al.,	
  2010;	
  ten	
  Berge	
  et	
  al.,	
  2008).	
  Together	
  these	
  results	
  suggest	
  that	
  the	
  modulation	
  of	
  BMP	
  and	
  WNT	
  activities	
  and	
  signal	
  transduction	
  define	
  chondrogenic	
  and	
  non-­‐chondrogenic	
  territories.	
  	
  Inactivation	
  of	
  SMAD4	
  in	
  the	
  limb	
  bud	
  mesenchyme	
  interferes	
  with	
  both	
  canonical	
  BMP	
  and	
   TGFβ	
   signal	
   transduction,	
   but	
   does	
   not	
   allow	
   discrimination	
   between	
   single	
  pathways.	
   However,	
   genetic	
   analysis	
   has	
   not	
   provided	
   evidence	
   for	
   essential	
   roles	
   of	
  TGFβ	
   signaling	
   in	
   onset	
   of	
   chondrogenesis.	
   Instead,	
   TGFβ	
   ligands	
   and	
   receptors	
   have	
  been	
   associated	
   with	
   the	
   organization	
   of	
   muscles	
   and	
   tendons,	
   which	
   in	
   turn	
   affects	
  organization	
  of	
  skeletal	
  elements	
  (Pryce	
  et	
  al.,	
  2009;	
  Sanford	
  et	
  al.,	
  1997).	
  Inactivation	
  of	
  
TGFβR2,	
   which	
   is	
   a	
   common	
   type	
   II	
   receptor	
   for	
   all	
   TGFβ	
   ligands,	
   results	
   in	
   dwarfism	
  (Spagnoli	
   et	
   al.,	
   2007),	
   but	
   the	
   underlying	
   alterations	
   are	
   unknown.	
   Inhibition	
   of	
   TGFβ	
  receptor	
   activity	
   in	
   mesenchymal	
   cell	
   cultures	
   causes	
   a	
   block	
   in	
   mesenchymal	
  condensations	
  and	
  COL	
  type	
  II	
  expression	
  similar	
  to	
  inhibition	
  of	
  BMP	
  receptors	
  activity	
  by	
  small	
  molecules	
  and	
  to	
  genetic	
  inactivation	
  of	
  Smad4.	
  Therefore,	
  shedding	
  light	
  on	
  the	
  spatio-­‐temporal	
  requirements	
  of	
  both	
  pathways	
  will	
  be	
  of	
  vital	
   importance	
  for	
  cartilage	
  and	
  bone	
  engineering	
  (see	
  e.g.	
  Jiang	
  et	
  al.,	
  2010;	
  Sanchez-­‐Adams	
  and	
  Athanasiou,	
  2012).	
  Experimental	
   evidence	
   suggests	
   that	
   TGFβ	
   may	
   prime	
   mesenchymal	
   cells	
   for	
   BMP-­‐mediated	
  induction	
  of	
  chondrogenesis	
  (see	
  e.g.	
  Karamboulas	
  et	
  al.,	
  2010;	
  Leonard	
  et	
  al.,	
  1991;	
  Roark	
  and	
  Greer,	
  1994).	
  	
  The	
   high	
   dynamic	
   modulation	
   of	
   BMP	
   activity	
   can	
   account	
   for	
   the	
   various	
   morpho-­‐regulatory	
   properties	
   of	
   BMP	
   signalling	
   pathway	
   throughout	
   limb	
   development.	
   BMP	
  activity	
   in	
  the	
   limb	
  is	
  high	
  during	
  establishment	
  of	
  the	
  AER,	
   low	
  during	
   limb	
  patterning	
  and	
   outgrowth,	
   and	
   is	
   increased	
   again	
   to	
   function	
   in	
   initiation	
   of	
   chondrogenesis	
   (see	
  Introduction).	
  Furthermore,	
  the	
  discrete	
  and	
  regular	
  fashion	
  by	
  which	
  skeletal	
  primordia	
  are	
  laid	
  down	
  along	
  the	
  A-­‐P	
  limb	
  axis	
  (Newman	
  and	
  Bhat,	
  2007)	
  and	
  the	
  tight	
  regulation	
  of	
   digit	
   identity	
   by	
  BMP	
   activity	
   (Suzuki	
   et	
   al.,	
   2008)	
   suggest	
   that	
   classical	
  morphogen	
  gradients	
   alone	
   cannot	
   explain	
   the	
   dynamic	
   modulation	
   of	
   BMP	
   signalling	
   activity.	
  Therefore,	
  a	
  real-­‐time	
  analysis	
  of	
  the	
  dynamics	
  of	
  BMP	
  activity	
  is	
  required	
  to	
  reveal	
  the	
  for	
  sure	
  highly	
  dynamic	
  exposure	
  of	
  progenitors	
  to	
  BMP	
  signalling.	
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9.	
  CONCLUSIONS	
  AND	
  OUTLOOK	
  
	
  The	
   present	
   study	
   on	
   the	
   multiple	
   roles	
   of	
   BMP	
   signalling	
   and	
   in	
   particular	
   SMAD4	
  requires	
  much	
  more	
  in-­‐depth	
  analysis.	
  Here	
  I	
  report	
  only	
  two	
  considerations:	
  	
  	
  1.	
  SMAD4-­‐mediated	
  BMP	
  signalling	
  is	
  fundamental	
  to	
  initiate	
  chondrogenesis,	
  as	
  it	
  has	
  been	
  established	
  in	
  several	
  cell-­‐based	
  studies,	
  see	
  e.g.	
  Barna	
  and	
  Niswander	
  (2007)	
  and	
  in	
   the	
   genetic	
   studies	
   during	
   my	
   PhD.	
   However,	
   the	
   mechanisms	
   that	
   underlie	
   the	
  initiation	
   of	
   chondrogenesis	
   by	
   cell	
   condensation	
   events	
   are	
   still	
   largely	
   unknown.	
  Evidence	
  suggests	
  that	
  SOX9	
  acts	
  downstream	
  of	
  BMP	
  signalling	
  to	
  mediate	
   its	
   function	
  in	
  initiating	
  chondrogenesis	
  by	
  the	
  up-­‐regulation	
  of	
  early	
  chondrogenic	
  markers	
  such	
  as	
  
Col	
   type	
   II	
   (reviewed	
   in	
   Hall	
   and	
   Miyake,	
   2000).	
   Indeed,	
   Sox9	
   inactivation	
   results	
   in	
  skeletal	
   agenesis	
   similar	
   to	
   Smad4	
   inactivation	
   (Akiyama	
   et	
   al.,	
   2002,	
   and	
  my	
   studies).	
  Some	
   studies	
   report	
   that	
   BMPs	
   can	
   also	
   directly	
   activate	
   early	
   chondrogenic	
   factors	
  (Haas	
  and	
  Tuan,	
  1999;	
  Inai	
  et	
  al.,	
  2013;	
  Morgan	
  et	
  al.,	
  2011).	
  Therefore	
  genetic	
  analysis	
  in	
  combination	
  with	
  high-­‐throughput	
  RNA/protein	
  profiling	
  is	
  necessary	
  to	
  gain	
  insight	
  into	
  the	
   complex	
   cell	
   and	
   tissue	
   rearrangements	
   that	
   occur	
   during	
   initiation	
   of	
  chondrogenesis.	
   In	
   addition,	
   direct	
   visualization	
   of	
   cell	
   behavior	
   during	
   formation	
   of	
  aggregates	
   has	
   to	
   be	
   used	
   to	
   investigate	
   the	
   early	
   steps	
   of	
   aggregation	
   of	
   chondrocytic	
  progenitors	
  in	
  combination	
  with	
  molecular	
  analysis	
  (Barna	
  and	
  Niswander,	
  2007).	
  	
  2.	
  The	
  present	
  study	
  also	
  opens	
  several	
  questions	
  on	
  how	
  and	
  when	
  digits	
  are	
  specified	
  and	
   determined	
   during	
   limb	
   bud	
   development.	
   As	
   discussed	
   in	
   the	
   previous	
   chapter,	
  discrete	
   temporal	
   requirement	
   of	
   Shh	
   for	
   patterning	
   unveils	
   an	
   order	
   of	
   digit	
  specification	
  (Zhu	
  et	
  al.,	
  2008)	
  that	
  differs	
  from	
  the	
  posterior-­‐to-­‐anterior	
  progression	
  of	
  specification	
  suggested	
  by	
  inactivation	
  of	
  Smad4	
  (my	
  studies).	
  Independently	
  of	
  the	
  order	
  of	
  digit	
  specification,	
  it	
  is	
  important	
  to	
  clarify	
  the	
  genetic	
  interactions	
  occurring	
  between	
  SHH	
   and	
   BMP	
   morpho-­‐regulatory	
   signals,	
   especially	
   in	
   the	
   light	
   of	
   their	
   dynamic	
  activities	
   with	
   respect	
   to	
   the	
   A-­‐P	
   limb	
   axis	
   formation	
   and	
   their	
   requirement	
   for	
   final	
  determination	
  and	
  shaping	
  of	
  digits	
  (Dahn	
  and	
  Fallon,	
  2000;	
  Suzuki	
  et	
  al.,	
  2008;	
  Suzuki	
  et	
  al.,	
  2004).	
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11.	
  APPENDIX	
  1	
  _	
  INACTIVATION	
  OF	
  SMAD4	
  AND	
  GREM1	
  IN	
  THE	
  AER	
  
	
  
	
  
Background	
  Ablation	
   of	
  BMP	
  activity	
   in	
   the	
   established	
  AER	
   results	
   in	
   a	
   variety	
   of	
   phenotypes	
   that	
  include	
   interdigital	
   webbing,	
   polydactyly,	
   phalanx	
   bifurcation	
   and	
   ectrodactyly	
   (Pajni-­‐Underwood	
  et	
  al.,	
  2007).	
  On	
  the	
  other	
  hand,	
  inactivation	
  of	
  Grem1	
  and	
  reduction	
  of	
  Bmp4	
  in	
   the	
  mesenchyme	
   restores	
   the	
   limb	
   skeleton	
   for	
   a	
   large	
  extent	
   (Benazet	
   et	
   al.,	
   2009),	
  indicating	
   that	
   GREM1	
   is	
   the	
   main	
   extracellular	
   antagonist	
   of	
   BMPs	
   in	
   the	
   limb	
   bud	
  mesenchyme.	
  Therefore,	
  we	
   sought	
   to	
  understand	
   if	
   reduction	
  of	
  BMP	
  activity	
   through	
  
Smad4	
  from	
   the	
  AER	
  could	
   compensate	
   for	
   the	
  at	
   least	
   the	
   sub-­‐ridge	
  mesenchymal	
   cell	
  death	
  phenotype	
  associated	
  with	
  inactivation	
  of	
  Grem1.	
  	
  
	
  
Results	
  To	
   this	
   aim,	
   we	
   inactivated	
   Smad4	
   (using	
   a	
  Msx2-­‐Cre	
   transgene)	
   in	
   a	
   Grem1	
   deficient	
  genetic	
   background	
   to	
   get	
   Grem1Δ/Δ;	
   Smad4Δ/ΔAER	
   embryos	
   (n=3,	
   see	
   Material	
   and	
  Methods).	
   We	
   found	
   that	
   the	
   compound	
   mutants	
   retain	
   the	
   interdigital	
   soft	
   tissue	
  webbing	
  to	
  the	
  extent	
  of	
  Smad4Δ/ΔAER	
  embryos	
  (Fig.	
  1A).	
  Grem1	
  deficient	
   forelimbs	
  have	
  three	
  rudimentary	
  digits,	
  while	
  Grem1Δ/Δ;	
  Smad4Δ/ΔAER	
  forelimbs	
  exhibit	
  between	
  3	
  and	
  4	
  digits	
  which	
  are	
  however	
  thickened	
  and	
   in	
  some	
  cases	
  bifurcated	
  (Fig.	
  1B,	
  compare	
  the	
  forelimbs	
  ‘FL’	
  in	
  the	
  lower	
  panels).	
  This	
  phenotype	
  is	
  indicative	
  of	
  a	
  minor	
  distal	
  rescue	
  with	
  respect	
  to	
  the	
  Grem1	
  loss-­‐of-­‐function.	
  In	
  addition,	
  2	
  of	
  3	
  hindlimbs	
  of	
  the	
  compound	
  mutant	
   embryos	
   showed	
   a	
   variable	
   phenotype	
   characterized	
   by	
   oligodactyly,	
  ectrodactyly	
   and	
   ectopic	
   sprouting	
   of	
   phalanges,	
   which	
   are	
   associated	
   with	
   the	
  
Smad4Δ/ΔAER	
  deficiency	
  (Fig.	
  1B,	
  hindlimb	
  ‘HL’	
  in	
  the	
  lower-­‐right	
  panels).	
  In	
  all	
  cases,	
  fore-­‐	
  and	
  hindlimb	
  buds	
  show	
  variable	
  degrees	
  of	
  bifurcations	
  of	
  the	
  distal	
  phalanges,	
  which	
  is	
  likely	
  due	
  to	
  excessive	
  AER-­‐FGF	
  signalling	
  (Pajni-­‐Underwood	
  et	
  al.,	
  2007).	
  The	
   fusion	
   of	
   the	
   zeugopodal	
   elements	
   in	
   forelimbs	
   of	
   Grem1Δ/Δ;	
   Smad4Δ/ΔAER	
   is	
  strikingly	
   similar	
   to	
   Grem1Δ/Δ	
   forelimbs.	
   In	
   contrast,	
   the	
   double	
   mutant	
   zeugopod	
   in	
  hindlimbs	
   is	
  more	
  affected	
  and	
  a	
  unique	
  ossification	
   forms	
  proximally	
   (arrowed	
   in	
  Fig.	
  1C).	
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Fig.	
   1.	
   (A)	
   Allele	
   series	
   of	
   compound	
   mutants	
   for	
   constitutive	
   Grem1	
   inactivation	
   and	
   AER-­‐
Smad4	
   inactivation	
   (using	
  Msx2-­‐CreTg).	
   E14.5	
   forelimbs	
   (FL,	
   upper	
   panels)	
   and	
   hindlimbs	
   (HL,	
  lower	
  panels)	
  are	
  pictured	
  on	
  dark	
  field.	
  Note	
  that	
  the	
  interdigital	
  webbing	
  is	
  retained	
  whenever	
  
Smad4	
   is	
   cleared	
   from	
   the	
  AER.	
   (B)	
   Skeletal	
   preparations	
   at	
   E18.5	
   are	
   stained	
  with	
  Alcian	
  Blue	
  (cartilage)	
  and	
  Alizarin	
  Red	
  (bone	
  matrix)	
  to	
  detect	
  alterations	
  in	
  digit	
  number	
  and	
  morphology	
  in	
  forelimbs	
  (FL)	
  and	
  hindlimbs	
  (HL).	
  Red	
  asterisks	
  mark	
  bifurcation	
  of	
  the	
  last	
  phalanges	
  typical	
  of	
  the	
   AER-­‐Smad4	
   removal;	
   blue	
   asterisks	
   point	
   at	
   ectopic	
   sprouting	
   of	
   phalanges;	
   black	
   arrows	
  indicate	
   a	
   ectrodactylous	
   phenotype.	
   	
   Double	
  Grem1;	
   AER-­‐Smad4	
   limbs	
   are	
   compared	
   to	
   stage-­‐matched	
  controls,	
  either	
  Wt	
  or	
  single	
  mutants	
  (Grem1Δ/Δ;	
  Smad4L/+	
  phenotype	
  is	
  comparable	
  with	
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a	
  single	
  Grem1Δ/Δ	
  mutant).	
  (C)	
  Skeletal	
  preparations	
  at	
  E18.5	
  of	
  zeugopod	
  are	
  stained	
  like	
  in	
  (B).	
  Both	
   FL	
   and	
   HL	
   are	
   pictured.	
   In	
   total,	
   3	
   double	
   mutant	
   embryos	
   were	
   collected.	
   1-­‐5:	
   digit/	
  metacarpal	
  identities.	
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12.	
  APPENDIX	
  2	
  _	
  ATTEMPTS	
  TO	
  GENERATE	
  A	
  BMP	
  SENSOR	
  MOUSE	
  	
  
	
  
Aim	
  of	
  the	
  project	
  and	
  background	
  The	
   establishment	
   of	
   a	
   BMP-­‐sensor	
   mouse	
   model	
   would	
   be	
   ideal	
   to	
   study	
   the	
   spatio-­‐temporal	
   dynamics	
   of	
   BMP	
   signaling.	
   For	
   the	
   analysis	
   during	
   limb	
   development,	
   a	
  reporter	
   that	
   is	
   rapidly	
   induced	
   and	
   degraded	
   would	
   be	
   important	
   for	
   detecting	
   the	
  postulated	
   variations	
   in	
   BMP	
   activity	
   during	
   initiation,	
   outgrowth	
   and	
   differentiation	
  during	
  limb	
  bud	
  development	
  (Benazet	
  et	
  al.,	
  2009).	
  The	
  BMP	
  sensor	
  models	
  generated	
  so	
   far	
  have	
  some	
  drawbacks	
   that	
   impair	
  either	
  sensitivity	
  or	
  dynamic	
  properties	
  of	
   the	
  readout	
  with	
  respect	
  to	
  the	
  original	
  signal.	
  	
  Mostly,	
  the	
  BMP-­‐responsive	
  element	
  (BRE;	
  Korchynskyi	
  and	
  ten	
  Dijke,	
  2002)	
  was	
  used	
  to	
  trace	
  BMP	
  signalling	
  activity.	
  The	
  BRE	
  is	
  a	
  minimal	
  enhancer	
  activated	
  by	
  pSMAD1	
  and	
  pSMAD5,	
  and	
  the	
  element	
  is	
  constituted	
  of	
  two	
  head-­‐to-­‐head	
  copies	
  of	
  the	
  regions	
  -­‐1105	
  bp	
  to	
  -­‐1080	
  bp	
  and	
  -­‐1052	
  bp	
  to	
  -­‐1032	
  bp	
  upstream	
  the	
  Id1	
  gene	
  transcriptional	
  start	
  site	
  (TSS;	
  Korchynskyi	
  and	
  ten	
  Dijke,	
  2002).	
  Id1	
  is	
  a	
  well-­‐characterized	
  BMP	
  target	
  gene	
  that	
  is	
  activated	
  by	
  both	
  BMP	
  and	
  TGFβ	
  signalling	
  (Hollnagel	
  et	
  al.,	
  1999;	
  Lopez-­‐Rovira	
  et	
  al.,	
  2002;	
   Ogata	
   et	
   al.,	
   1993;	
   Ying	
   et	
   al.,	
   2003).	
   The	
   CMVe-­‐(BRE)3-­‐MLP-­‐EGFP	
  mouse	
   line	
  generated	
   in	
   Christine	
   Mummery’s	
   laboratory	
   (Monteiro	
   et	
   al.,	
   2008)	
   consists	
   of	
  cytomegalovirus	
  immediate	
  early	
  promoter	
  (CMVe)	
  placed	
  upstream	
  three	
  copies	
  of	
  the	
  BRE	
   cassette	
   that	
   controls	
   the	
   expression.	
   The	
   cassette	
   is	
   followed	
   by	
   an	
   enhanced	
  version	
  of	
  the	
  green	
  fluorescent	
  protein	
  (GFP).	
  We	
  imported	
  this	
  mouse	
  strain	
  and	
  tested	
  it	
   for	
   sensing	
   BMP	
   signaling	
   in	
   limb	
   bud,	
   but	
   expression	
   that	
  mirrored	
   the	
   expression	
  pattern	
   of	
   the	
   BMP	
   signaling	
   targets	
  Msx2	
  and	
   Id1	
  was	
   not	
   detected	
  (Fig.	
   1A;	
   compare	
  with	
   the	
   expression	
   pattern	
   in	
   Fig.	
   3A).	
   This	
   result,	
   together	
   with	
   the	
   analysis	
   of	
  additional	
  transgenic	
  mouse	
  models	
  based	
  on	
  the	
  BRE	
  cassette	
  (Blank	
  et	
  al.,	
  2008;	
  Collery	
  and	
  Link,	
  2011)	
  suggested	
   that	
   the	
  BRE	
  minimal	
  enhancer	
  does	
  not	
  sense	
  BMP	
  activity	
  during	
  mouse	
  limb	
  bud	
  development.	
  Another	
   approach	
   is	
   based	
   on	
   inserting	
   a	
   reporter	
   into	
   the	
   endogenous	
   regulatory	
  sequences	
   responding	
   to	
   BMP	
   signal	
   transduction	
   (Bensoussan	
   et	
   al.,	
   2008;	
   Nam	
   and	
  Benezra,	
   2009;	
   Perry	
   et	
   al.,	
   2008).	
   We	
   imported	
   a	
   mouse	
   line	
   generated	
   by	
   Benoît	
  Robert’s	
   laboratory	
   (Bensoussan	
   et	
   al.,	
   2008).	
   In	
   these	
  mice	
   an	
   IRES-­‐GFP	
   transgene	
   is	
  placed	
   downstream	
   of	
   the	
   endogenous	
   Msx2	
   allele.	
   The	
   mouse	
   strain	
   faithfully	
  recapitulated	
  Msx2	
   expression	
   pattern	
   in	
   the	
   limb	
   bud	
   from	
   E10.5	
   onwards	
   (Fig.	
   1B).	
  Next,	
  beads	
  loaded	
  with	
  hrBMP4	
  were	
  implanted	
  into	
  limb	
  buds	
  to	
  assess	
  the	
  sensitivity	
  and	
   dynamic	
   regulation	
   of	
   the	
   GFP	
   transgene.	
   We	
   found	
   that	
   the	
   GFP	
   reporter	
   signal	
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could	
   not	
   be	
   detected	
   after	
   3-­‐4	
   hours	
   of	
   limb	
   culture,	
   whereas	
  Msx2	
   transcripts	
   were	
  already	
   activated.	
   Beads	
   were	
   implanted	
   in	
   different	
   location	
   to	
   assess	
   the	
   ectopic	
  activation	
  of	
  the	
  Msx2	
  target	
  gene	
  in	
  limb	
  buds	
  (Fig.	
  1B).	
  The	
  ectopic	
  GFP	
  induction	
  was	
  visible	
  about	
  6	
  hrs	
  after	
  bead	
   implantation,	
  when	
  Msx2	
  transcripts	
  already	
  begun	
   to	
  be	
  down-­‐regulated	
  again	
  (Fig.	
  1C,	
  left	
  panel).	
  After	
  22	
  hours	
  of	
  culture,	
  Msx2	
  transcripts	
  and	
  GFP	
  protein	
  were	
  mostly	
  cleared	
  around	
  the	
  bead	
  in	
  most	
  of	
  the	
  experimental	
  limb	
  bud	
  analysed	
   (n=7,	
   not	
   shown).	
   However,	
   when	
   the	
   hrBMP4-­‐loaded	
   beads	
  were	
   implanted	
  into	
   the	
   anterior	
   limb	
   bud	
   mesenchyme	
   (i.e.	
   into	
   the	
   region	
   corresponding	
   to	
   the	
  strongest	
  Msx2	
  expression),	
  GFP	
  was	
  detected	
  up	
  to	
  22	
  hrs	
  of	
  limb	
  culture	
  (Fig.	
  1C,	
  right	
  panel,	
  n=2).	
  This	
   result	
   suggests	
   that	
   the	
  GFP	
  protein	
   (about	
  20	
  hours,	
   see	
  Nagai	
  et	
  al.,	
  2002)	
  is	
  too	
  stable	
  to	
  allow	
  detection	
  of	
  rapid	
  dynamic	
  alterations	
  in	
  BMP	
  activity.	
  This	
  reveals	
  the	
  need	
  to	
  generate	
  a	
  novel	
  type	
  of	
  BMP	
  sensor	
  transgene.	
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Fig.	
  1	
  Existing	
  BMP-­‐sensor	
  mouse	
  
models	
   are	
   not	
   specific	
   or	
   have	
  
insufficient	
   dynamics	
   to	
   detect	
  
rapid	
   changes	
   in	
   BMP	
   activity	
   (A)	
  Epi-­‐fluorescence	
   images	
   in	
   the	
   GFP	
  channel	
   of	
   the	
   mouse	
   right	
   forelimb	
  at	
  E11.5	
   (left	
  panel)	
  and	
  E12.5	
   (right	
  panel)	
   of	
   the	
   BMP-­‐sensing	
   mouse	
  strain	
   generated	
   by	
   Monteiro	
   et	
   al.	
  (2008).	
   Note	
   that	
   GFP	
   outlines	
   the	
  vasculature.	
   GFP	
   signal	
   was	
  transposed	
   into	
   golden	
   color	
   using	
  the	
   Photoshop	
   Hue/Saturation	
   tool,	
  to	
  achieve	
  higher	
  signal-­‐to-­‐noise	
  ratio	
  in	
  printouts	
  (parameter:	
  Hue,	
  -­‐100).	
  
(B,C)	
   Bright-­‐field	
   in	
   situ	
   images	
  with	
   the	
   probes	
   indicated	
   (upper	
  panels)	
   and	
   the	
   corresponding	
   epi-­‐fluorescence	
   images	
   to	
   detect	
   GFP	
  expression	
   (lower	
   panels)	
   using	
   the	
  
Msx2-­‐GFP	
  mouse	
   strain	
   generated	
  by	
  Bensoussan	
   et	
   al.	
   (2008).	
   (B)	
   In	
   the	
  upper	
   panels,	
   heparin	
   beads	
   coated	
  with	
   0.1	
   mg/ml	
   hrBMP4	
   were	
  implanted	
   either	
   into	
   the	
   anterior-­‐distal	
   Msx2	
   expression	
   domain	
   (left	
  panel)	
   or	
   the	
   core	
   mesenchyme	
   (right	
   panel)	
   of	
   the	
   right	
   forelimbs.	
   Limb	
   bud	
   trunks	
   were	
  cultured	
   for	
   3-­‐4	
   hrs.	
   Note	
   that	
   ectopic	
  Msx2	
   expression	
   was	
   triggered	
   upon	
   bead	
   implantation	
  either	
  in	
  the	
  anterior	
  Msx2	
  expression	
  domain	
  (left-­‐upper	
  panel)	
  or	
  in	
  the	
  core	
  mesenchyme	
  in	
  a	
  domain	
  located	
  distally	
  to	
  the	
  bead	
  (right-­‐upper	
  panel;	
  see	
  arrowheads).	
  Left	
   limb	
  buds	
  serve	
  as	
  controls.	
  Lower	
  panels	
  show	
  that	
  GFP	
  corresponding	
  to	
  Msx2	
  induction	
  was	
  not	
  detectable	
  after	
  3-­‐4	
   hrs.	
   Arrowheads	
   point	
   to	
   the	
   same	
   region	
   in	
   both	
   panels.	
   (C)	
  Heparin	
   beads	
   loaded	
  with	
   0.1	
  mg/ml	
  hrBMP4	
  were	
  implanted	
  in	
  the	
  anterior-­‐distal	
  Msx2	
  expression	
  domain	
  into	
  right	
  forelimb	
  buds,	
  and	
  cultured	
  for	
  either	
  6-­‐7	
  hr	
  (left	
  panels)	
  or	
  22	
  hrs	
  (right	
  panels)	
  to	
  assess	
  changes	
  in	
  Msx2	
  expression	
   (upper	
   panel,	
   bright-­‐field	
   WISH	
   images)	
   and	
   GFP	
   fluorescence	
   (lower	
   panels).	
   Left	
  limbs	
   served	
   as	
   controls.	
   Black	
   arrowheads	
   point	
   to	
   the	
  Msx2	
   expression,	
   which	
   was	
   reduced	
  around	
  the	
  bead	
  by	
  6-­‐7	
  hr	
  and	
  cleared	
  around	
  22	
  hr	
  (upper	
  panels).	
  White	
  arrowheads	
  point	
  to	
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GFP	
   triggered	
   by	
   a	
   hrBMP4-­‐loaded	
   bead	
   at	
   both	
   6-­‐7	
   hr	
   and	
   22	
   hr	
   in	
   the	
   anterior	
  Msx2	
  domain	
  (lower	
  panels).	
  
	
  
	
  
Toward	
   BMP	
   sensor:	
   design	
   of	
   a	
   standard	
   vector	
   to	
   analyze	
   cis-­‐regulatory	
  
sequences	
  in	
  ES	
  cells	
  and	
  mice	
  In	
   order	
   to	
   generate	
   a	
   standard	
   vector	
   to	
   test	
   sequences	
   for	
   their	
   potential	
   enhancer	
  activity,	
   the	
   pIGNA	
   vector	
   was	
   generated	
   at	
   GeneArt®	
   (Life	
   Technologies,	
   Fig.	
   2A,	
  sequence	
   available	
   upon	
   request).	
   pIGNA	
   vector	
   contains	
   a	
   sequence	
   encoding	
   an	
  enhanced	
   version	
   of	
   the	
   yellow	
   fluorescent	
   protein	
   named	
   Venus.	
   Venus	
   has	
   reduced	
  sensitivity	
  for	
  chloride	
  ions	
  and	
  for	
  low	
  pH	
  and	
  is	
   induced	
  faster	
  than	
  the	
  standard	
  YFP	
  (Aulehla	
  et	
  al.,	
  2008;	
  Nagai	
  et	
  al.,	
  2002).	
  To	
  allow	
  a	
  better	
  quantification	
  of	
  fluorescence	
  signal	
   in	
  a	
   tissue	
  context,	
  a	
  Nuclear	
  Localization	
  Signal	
   (NLS;	
  sequence:	
  PKKKRKV)	
  was	
  added	
   downstream	
  Venus	
   Coding	
   Sequence	
   (CDS).	
   Also,	
   a	
   protein	
   degradation	
   domain	
  (PEST	
   sequence)	
  was	
  added	
  downstream	
   the	
  NLS	
   to	
   reduce	
   the	
  half-­‐life	
  of	
  Venus	
   from	
  ~20	
  hr	
   (Nagai	
   et	
   al.,	
   2002)	
   to	
   less	
   than	
  2	
  hr	
   (Aulehla	
   et	
   al.,	
   2008).	
  The	
  PEST	
   sequence	
  used	
   was	
   HGFPPAVAAQDDGTLPMSCAQESGMDRH,	
   and	
   the	
   three	
   underlined	
   alanine	
  residues	
   replace	
   three	
   glutamic	
   acid	
   residues	
   that	
   characterize	
   the	
   original	
   PEST	
  sequence	
   derived	
   from	
   mouse	
   ornithine	
   decarboxylase	
   (Li	
   et	
   al.,	
   1998).	
   A	
  polyadenylation	
   signal	
   (polyA)	
  derived	
   from	
   the	
  pCI-­‐neo	
  mammalian	
  expression	
  vector	
  (Promega)	
   was	
   synthetized	
   downstream	
   the	
   PEST	
   sequence.	
   Just	
   upstream	
   the	
   Venus	
  CDS,	
   a	
   chimeric	
   intron	
   cut-­‐and-­‐copied	
   from	
   the	
   pCI-­‐neo	
   vector	
   (Promega)	
   was	
  synthetized	
   in	
   order	
   to	
   facilitate	
   the	
   expression	
   of	
   the	
   downstream	
   reporter	
   gene	
   and	
  prevent	
   utilization	
   of	
   possible	
   cryptic	
   5’-­‐donor	
   splice	
   sites	
   within	
   the	
   reporter	
   (see	
  Promega	
   website;	
   Gross	
   et	
   al.,	
   1987;	
   Huang	
   and	
   Gorman,	
   1990).	
   The	
   sequence	
   block	
  spanning	
   from	
   the	
   chimeric	
   intron	
   to	
   the	
  polyA	
  was	
   flanked	
  by	
   two	
  Cre	
   recombination	
  sites	
   for	
   lox511	
   (upstream	
  Venus)	
   and	
   loxP	
   (downstream	
   the	
  polyA)	
   to	
   allow	
   targeting	
  the	
   conditional	
   Gt(Rosa)26Sor	
   locus	
   (Tchorz	
   et	
   al.,	
   2012)	
   by	
   Recombinase-­‐Mediated	
  Cassette	
   Exchange	
   (RMCE;	
   Schlake	
   and	
   Bode,	
   1994).	
   An	
   FRT	
   site	
   was	
   placed	
   just	
  upstream	
   the	
   loxP	
   site	
   to	
   allow	
   for	
   eventual	
   flippase-­‐driven	
   RMCE.	
   Unique	
   restriction	
  sites	
  (5’-­‐3’	
  order	
  ClaI,	
  KpnI,	
  ApaI,	
  HindIII,	
  NheI,	
  SalI,	
  PacI,	
  AatI)	
  were	
  placed	
  in	
  a	
  Multiple	
  Cloning	
  Site	
  (MCS)	
  downstream	
  the	
  lox511	
  site	
  and	
  upstream	
  the	
  Venus	
  CDS	
  to	
  insert	
  the	
  regulatory	
   sequences	
   of	
   interest.	
   Other	
   unique	
   restriction	
   sites	
   (FseI,	
   BclI	
   upstream	
  lox511	
   and	
   PmeI	
   downstream	
   loxP	
   site)	
   were	
   placed	
   outside	
   the	
   construct	
   to	
   allow	
  excision	
  of	
  the	
  entire	
  sequence	
  (Fig.	
  2A).	
  The	
  whole	
  construct	
  (1494bp)	
  was	
  cloned	
  into	
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the	
   pMA-­‐RQ	
   (ampR)	
   backbone	
   (GeneArt®)	
   and	
   propagated	
   in	
  E.	
   coli	
   K12	
   (dam+	
   dcm+	
  tonA	
  rec-­‐)	
  bacteria.	
  Neomycin	
  resistance	
  coding	
  gene	
  (NeoR)	
  was	
  subcloned	
  with	
  XbaI	
  from	
  the	
  pLoxpNeo-­‐2	
  vector	
   into	
  a	
  pBlueScript	
   II	
  KS(+)	
  vector	
   to	
  generate	
   the	
  pBSNeoR	
  vector.	
   In	
  order	
   to	
  maintain	
   the	
  NheI	
  restriction	
  site	
  unique	
   in	
   the	
  pIGNA	
  MCS,	
   the	
  NheI	
  site	
  upstream	
  the	
  pGK	
  promoter	
  driving	
   the	
   expression	
  of	
   the	
  Neo	
   resistance	
  was	
   eliminated	
  by	
  blunting	
  the	
  protruding	
  sequences	
  of	
   the	
  cut	
  restriction	
  site	
  with	
  a	
  T4	
  polymerase	
  (NEB).	
  A	
   full-­‐length	
  chicken	
  β-­‐globin	
  insulator	
  sequence	
  (Chung	
  et	
  al.,	
  1997)	
  was	
  subcloned	
  from	
  the	
  pXCHG3fwd	
   vector	
   (Dr.	
   Alexander	
   Aulehla)	
   into	
   a	
   blunted	
   EcoRI	
   restriction	
   site	
   in	
   the	
  pIGNA	
  vector,	
  just	
  upstream	
  the	
  FRT	
  recombination	
  site.	
  The	
  insulator	
  was	
  used	
  to	
  shield	
  the	
   transcriptional	
   activity	
   of	
   the	
   sensor	
   from	
   any	
   unwanted	
   activity	
   of	
   cis-­‐acting	
  regulatory	
  element	
  and	
  from	
  the	
  promoter	
  of	
  the	
  Gt(Rosa)26Sor	
  locus.	
  A	
  second	
  insulator	
  was	
  cloned	
  from	
  the	
  pXCHG3fwd	
  vector	
  into	
  a	
  ClaI-­‐Asp718	
  restriction	
  locus	
  downstream	
  the	
   lox511	
   site	
   into	
   the	
   pIGNA	
   vector.	
   Then,	
   the	
  NeoR	
   cassette	
  was	
   removed	
   from	
   the	
  pBSNeoR	
  vector	
  with	
  a	
  single	
  XbaI	
  restriction	
  digestion	
  and	
  cloned	
  into	
  the	
  pIGNA	
  vector	
  taking	
   advantage	
   of	
   the	
   single-­‐cutting	
   XbaI	
   site	
   present	
   in	
   the	
   sequence	
   of	
   the	
   FRT	
  recombination	
   site.	
   The	
   obtained	
   vector	
  was	
   named	
   pIGNA(2xins)NeoR	
   (Fig.	
   2B).	
   This	
  vector	
  was	
  supposed	
  to	
  be	
  an	
  easy-­‐to-­‐customize	
  shuttle	
  vector	
  for	
  analyzing	
  the	
  activity	
  of	
  cis-­‐regulatory	
  elements	
  by	
  inserting	
  them	
  into	
  the	
  Gt(Rosa)26Sor	
   locus	
  (Tchorz	
  et	
  al.,	
  2012).	
  	
  However,	
   three	
   targeting	
   attempts	
   were	
   performed	
   and	
   consistently	
   failed	
   to	
  contribute	
  antibiotic-­‐resistant	
  ES	
  cell	
  colonies.	
  Therefore,	
  another	
  ES	
  cell	
  line	
  carrying	
  a	
  replaceable	
  Gt(Rosa)26Sor	
  locus	
  was	
  adopted	
  from	
  Andrew	
  McMahon	
  laboratory	
  (Tsanov	
  et	
   al.,	
   2012),	
   and	
   the	
   targeting	
   vector	
   was	
   modified	
   accordingly	
   (see	
   the	
   following	
  sections).	
  	
  
	
   80	
  
	
  
Fig.	
   2	
   Schematics	
   of	
   intermediate,	
   targeting	
   vectors	
   and	
   RMCE-­‐mediated	
   recombination	
  
process	
   during	
   ES	
   cell	
   targeting.	
   (A)	
   pIGNA	
   vector	
   as	
   synthetized	
   at	
   GeneArt®.	
   Two	
   lox	
   sites	
  (lox511	
  and	
  loxP,	
  in	
  a	
  head-­‐to-­‐head	
  orientation)	
  enclose	
  a	
  multiple	
  cloning	
  site	
  (MCS),	
  a	
  chimeric	
  intron	
   from	
   the	
   pCI-­‐neo	
   vector	
   (Promega),	
   a	
   Venus	
   reporter	
   gene	
   endowed	
   with	
   a	
   nuclear	
  localization	
   signal,	
   a	
   degron	
   element	
   and	
   a	
   polyadenylation	
   signal	
   obtained	
   from	
   the	
   pCI-­‐Neo	
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vector	
   (Promega).	
   Two	
   NotI	
   restriction	
   sites	
   flank	
   the	
   Venus	
   reporter,	
   so	
   that	
   the	
   cassette	
  including	
   Venus-­‐NLS-­‐PEST	
   can	
   be	
   easily	
   customized.	
   An	
   FRT	
   site	
   including	
   a	
   unique	
   XbaI	
  restriction	
   site	
   allows	
   easy	
   insertion	
   of	
   neomycin	
   resistance	
   cassette	
   (NeoR)	
   from	
   an	
   in-­‐house	
  vector.	
  Unique	
  sites	
  are	
  placed	
  outside	
  the	
   lox	
  sites	
  to	
  allow	
  the	
  excision	
  of	
   the	
  whole	
  sequence.	
  
(B)	
   pIGNA(2xins)NeoR	
  as	
   an	
   easy-­‐fitting	
  platform	
   for	
   the	
   study	
  of	
  cis-­‐regulatory	
   elements.	
  Two	
  insulators	
   from	
  the	
  chicken	
  β-­‐globin	
  gene	
  (~1.2	
  kb)	
  and	
  a	
  NeoR	
  cassette	
   (~1.8	
  kb)	
  were	
  cloned	
  into	
   the	
   pIGNA	
   vector,	
   destroying	
   the	
   original	
   FRT	
   recombination	
   site.	
   (C)	
   pIGNA(2xins)NeoR	
  vector	
   was	
   customized	
   with	
   a	
   genomic	
   sequence	
   spanning	
   7874	
   bp	
   upstream	
   the	
   Id1	
   TSS	
   and	
  cloned	
   within	
   two	
   separate	
   blocks	
   upstream	
   the	
   chimeric	
   intron	
   sequence,	
   resulting	
   in	
   the	
  pIGNA(2xins)NeoRId1	
  vector	
  (see	
  Results	
  of	
  this	
  Appendix).	
  (D)	
  The	
  panel	
  shows	
  a	
  schematics	
  of	
  the	
   wild-­‐type	
   Gt(Rosa)26Sor	
   locus	
   (D,1.).	
   Below,	
   the	
   RMCE-­‐mediated	
   recombination	
   of	
   the	
  pXCHG3Id1	
   vector	
   (D,2.)	
   into	
   the	
   conditional	
   locus	
   (D,3.),	
   and	
   the	
   obtained	
   recombined	
   locus	
  
(D,4.).	
   Black	
   arrows	
   indicate	
   relative	
   position	
   and	
   orientation	
   of	
   the	
   primers	
   used	
   for	
   PCR	
  screening.	
   (E)	
   Schematics	
   of	
   the	
   Evolutionary	
   Conserved	
   Regions	
   (ECR)	
   obtained	
   at	
   the	
  ECRBrowser	
  (http://ecrbrowser.dcode.org)	
  on	
  the	
  cis-­‐regulatory	
  region	
  upstream	
   Id1	
  TSS	
  (~7.8	
  kb),	
   chosen	
   for	
  driving	
   the	
  reporter	
  expression.	
  Conserved	
  regions	
  are	
  displayed	
  on	
   the	
  vertical	
  axis	
  from	
  the	
  genomes	
  of	
  Zebrafish,	
  Frog,	
  Chicken,	
  Cow	
  and	
  Human	
  (from	
  the	
  top	
  to	
  the	
  bottom).	
  Conserved	
  regions	
  above	
  the	
  70%	
  of	
  similarity	
  were	
  colored	
   in	
  red.	
  Blue	
  bars	
  at	
  exonic	
  regions,	
  Salmon	
  at	
  intronic	
  regions,	
  Green	
  at	
  untranslated	
  region	
  on	
  the	
  Id1	
  gene.	
  Five	
  blocks	
  of	
  conserved	
  regions	
   were	
   identified	
   (named	
   a,	
   b,	
   c,	
   BRE-­‐containing	
   region,	
   mp	
   =	
   minimal	
   promoter).	
   MCS,	
  multiple	
   cloning	
   site;	
   Insul,	
   chicken	
   β	
   globin	
   insulator;	
   NeoR,	
   Neomycin	
   resistance	
   cassette;	
  
Id1_Enh,	
   Id1	
   enhancer	
   (from	
   -­‐7874	
   bp	
   to	
   -­‐720	
   bp	
   upstream	
   Id1	
   TSS);	
   Id1_Pro,	
   Id1	
   minimal	
  promoter	
  (from	
  -­‐720	
  bp	
  to	
  -­‐1	
  bp	
  upstream	
  Id1	
  TSS);	
  int,	
  chimeric	
  intron	
  from	
  pCI-­‐neo	
  mammalian	
  expression	
  vector	
  (Promega);	
  SA,	
  splice	
  acceptor.	
  
	
  
	
  
Choice	
  of	
  cis-­‐regulatory	
  region	
  to	
  construct	
  a	
  BMP	
  activity	
  sensor	
  The	
   best	
   characterized	
   BMP	
   target	
   genes	
   in	
   limb	
   buds	
   are	
   Id1,	
  Msx2	
   and	
   Grem1	
   (see	
  Introduction;	
   Fig.	
   3A).	
   Id1	
  and	
  Msx2	
   are	
   expressed	
   from	
  early	
   stages	
  onward	
   in	
   similar	
  patterns.	
   This	
   includes	
   a	
   domain	
   in	
   the	
   anterior	
   limb	
   bud	
  mesenchyme	
   and	
   a	
   smaller	
  domain	
   in	
   the	
   posterior	
   mesenchyme	
   connected	
   by	
   a	
   sub-­‐ectodermal	
   mesenchymal	
  domain	
   (see	
   Introduction	
   and	
   Fig.	
   3A).	
   The	
   Id1	
   expression	
   pattern	
   appeared	
   overall	
  broader	
  than	
  the	
  Msx2	
  domain.	
  Id1	
  transcripts	
  levels	
  were	
  higher	
  than	
  the	
  ones	
  of	
  Msx2	
  when	
  BMP	
  activity	
  was	
  high;	
  this	
  is	
  seen	
  best	
  at	
  early	
  (22-­‐28	
  somites)	
  and	
  late	
  stages	
  (38	
  somites	
  onwards)	
  (Fig.	
  3A;	
  Benazet	
  et	
  al.,	
  2009;	
  Lopez-­‐Rios	
  et	
  al.,	
  2012).	
  During	
  low	
  BMP	
  activity	
  (28	
  –	
  38	
  somites)	
  Id1	
  and	
  Msx2	
  transcript	
  levels	
  were	
  rather	
  similar.	
  In	
  order	
  to	
  evaluate	
   the	
   target	
   gene	
   that	
   best	
   recapitulates	
   loss	
   or	
   gain	
   of	
   BMP	
   activities,	
   the	
  mesenchymal	
  Smad4	
  and	
  Grem1	
  loss-­‐of-­‐function	
  were	
  used	
  for	
  analysis.	
  Results	
  showed	
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that	
  Id1	
  transcripts	
  were	
  lost	
  more	
  than	
  Msx2	
  in	
  Smad4	
  deficient	
  limb	
  buds	
  both	
  at	
  E10.5	
  and	
  E12.5,	
  pointing	
  to	
  a	
  more	
  specific	
  role	
  of	
  Id1	
  in	
  sensing	
  the	
  canonical	
  BMP	
  pathway	
  (Fig.	
  3B,C).	
  Up-­‐regulation	
  was	
  similar	
  for	
  both	
  Id1	
  and	
  Msx2	
  in	
  mouse	
  limb	
  buds	
  lacking	
  
Grem1	
  (Fig.	
   3B).	
   These	
   results	
   indicated	
   that	
   Id1	
  might	
   be	
   better	
   suited	
   as	
   readout	
   for	
  BMP	
  activity.	
  To	
  choose	
   the	
  cis-­‐regulatory	
  region	
   that	
  might	
  most	
   faithfully	
  mirror	
   the	
  dynamics	
  of	
  endogenous	
   Id1	
   expression	
   in	
   limb	
   buds,	
   we	
   focused	
   on	
   the	
   cis-­‐regulatory	
   regions	
  surrounding	
   the	
   BRE.	
   Since	
   the	
   BRE	
   alone	
   does	
   not	
   recapitulate	
   the	
   endogenous	
   Id1	
  expression	
  in	
  limb	
  buds	
  (Fig.	
  1A),	
  we	
  cloned	
  a	
  much	
  larger	
  fragment	
  of	
  the	
  endogenous	
  
Id1	
   promoter	
   into	
   the	
  pIGNA(2xins)NeoR	
  vector.	
  The	
   Id1	
  cis-­‐regulatory	
   region	
   selected	
  (Fig.	
  2E)	
  encompasses	
  7874	
  bp	
  upstream	
  the	
  Id1	
  TTS	
  and	
  encodes	
  two	
  regions	
  conserved	
  in	
  human,	
  cattle	
  and	
  chicken	
  genomes	
  (–4895	
  bp	
  to	
  -­‐4557	
  bp	
  and	
  -­‐1397	
  bp	
  to	
  -­‐785),	
  one	
  of	
  which	
  contains	
  the	
  well-­‐characterized	
  BRE	
  (Korchynskyi	
  and	
  ten	
  Dijke,	
  2002;	
  Fig.	
  2E,	
  regions	
   b	
   and	
   BRE-­‐containing	
   element).	
   The	
   minimal	
   promoter	
   (mp)	
   and	
   a	
   region	
  spanning	
  1606	
  bp	
  at	
  the	
  5’	
   limit	
  of	
  the	
  element	
  are	
  conserved	
  in	
  the	
  human	
  and	
  bovine	
  genome	
  (Fig.	
  2E,	
  regions	
  b	
  and	
  BRE-­‐containing	
  element).	
  In	
  addition,	
  a	
  short	
  third	
  region	
  ‘c’	
   (-­‐3560	
  bp	
   to	
   -­‐3422	
  bp)	
   is	
   conserved	
  between	
  mouse	
   and	
  human	
  genomes	
  only	
   (Fig	
  15E).	
   These	
   conserved	
   regions	
   were	
   identified	
   using	
   the	
   ECRBrowser	
   server	
  (http://ecrbrowser.dcode.org/)	
  at	
  a	
  threshold	
  of	
  70%	
  of	
  similarity.	
  	
  
	
  
	
  
Fig.	
   3	
   Assessment	
   of	
   Id1	
   and	
  Msx2	
   as	
   target	
   genes	
   of	
   BMP	
   signaling	
   through	
   the	
   canonical	
  pathway.	
  (A)	
  Time-­‐course	
  WISH	
  detection	
  of	
  Id1	
  transcripts	
  (upper	
  panels)	
  and	
  Msx2	
  transcripts	
  (lower	
  panels)	
  at	
  stages	
  ranging	
  from	
  22	
  to	
  43	
  somites;	
  dorsal	
  and	
  frontal	
  (AER)	
  points	
  of	
  view	
  of	
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the	
  expression	
  pattern	
  are	
  reported.	
  (B)	
  Id1	
   (upper	
  panels)	
  and	
  Msx2	
   (lower	
  panels)	
  transcripts	
  are	
  detected	
  by	
  WISH	
  in	
  wild-­‐type,	
  Smad4Δ/ΔM,	
  and	
  Grem1Δ/Δ	
  limbs	
  (from	
  left	
  to	
  right),	
  from	
  dorsal	
  and	
  frontal	
  (AER)	
  points	
  of	
  view	
  at	
  E10.5	
  (33-­‐35	
  somites;	
  n=2).	
  Results	
  showed	
  that	
  both	
  Id1	
  and	
  
Msx2	
  transcripts	
  levels	
  were	
  responding	
  to	
  the	
  amount	
  of	
  BMP	
  signaling	
  the	
  limb	
  was	
  exposed	
  to	
  in	
   the	
   different	
   genetic	
   backgrounds.	
  However,	
   Id1	
   transcripts	
   are	
   better	
   cleared	
   from	
   the	
   limb	
  bud	
   than	
   Msx2	
   transcripts	
   when	
   Smad4	
   is	
   removed	
   from	
   the	
   mesenchyme	
   in	
   the	
   Smad4Δ/ΔM	
  background.	
   (C)	
   As	
   in	
   panel	
   (B),	
   Id1	
   and	
  Msx2	
   expression	
   patterns	
   are	
   imaged	
   in	
   three	
   genetic	
  backgrounds.	
  Limbs	
  are	
  staged	
  E12.5;	
  only	
  dorsal	
  view	
  is	
  displayed	
  (n=2).	
  As	
  for	
   limbs	
  at	
  E10.5,	
  
Id1	
  transcripts	
  clearance	
  is	
  more	
  drastic	
  in	
  the	
  Smad4Δ/ΔM	
  background	
  than	
  for	
  Msx2	
  transcripts.	
  s,	
  somites.	
  	
  	
  
Cloning	
  steps	
  for	
  the	
  targeting	
  vector	
  The	
   chosen	
   mouse	
   Id1	
   cis-­‐regulatory	
   region	
   was	
   assembled	
   from	
   a	
   bacterial	
   artificial	
  chromosome	
   (BAC),	
   sequenced	
   to	
   exclude	
   alterations	
   and	
   cloned	
   into	
   the	
  pIGNA(2xins)NeoRmp	
  vector	
  to	
  generate	
  the	
  pIGNA(2xins)NeoRId1	
  targeting	
  vector	
  (Fig.	
  2C).	
  In	
  order	
  to	
  target	
  the	
  Gt(Rosa)26Sor	
   locus	
  in	
  V6.5	
  ES	
  cells	
  (Tsanov	
  et	
  al.,	
  2012),	
  the	
  backbone	
  and	
  the	
  recombination	
  sites	
  of	
  the	
  pIGNA(2xins)NeoRId1	
  vector	
  were	
  inserted	
  into	
  a	
  shuttle	
  vector	
  provided	
  by	
  McMahon	
  Lab,	
  which	
  was	
  a	
  prerequisite	
   to	
  obtain	
  the	
  targeting	
  vector	
  pXCHG3Id1	
  (~17.1	
  Kb).	
  	
  
	
  
RMCE-­‐mediated	
  insertion	
  into	
  the	
  Gt(Rosa)26Sor	
  locus	
  pXCHG3Id1	
  vector	
  was	
  electroporated	
  in	
  V6.5	
  ES	
  cells	
  (Eggan	
  et	
  al.,	
  2001;	
  Tsanov	
  et	
  al.,	
  2012)	
   carrying	
   a	
   customized	
   Gt(Rosa)26Sor	
   locus,	
   which	
   should	
   provide	
   a	
   permissive	
  environment	
  for	
  transcription	
  (Turan	
  et	
  al.,	
  2011;	
  Zambrowicz	
  et	
  al.,	
  1997).	
  The	
  intronic	
  region	
  between	
  exons	
  1	
  and	
  2	
  was	
  replaced	
  with	
  two	
  sequences	
  that	
  encode	
  a	
  Puromycin	
  resistance	
  and	
  a	
  FLP	
  recombinase,	
  flanked	
  by	
  F3	
  and	
  FRT	
  recombination	
  sites.	
  Upstream	
  the	
  F3	
  site,	
  a	
  splice	
  acceptor	
  and	
  an	
  ATG	
  translation	
  starting	
  codon	
  were	
  placed	
  to	
  allow	
  for	
   a	
   selection	
   cassette	
   to	
  be	
   expressed	
  by	
   the	
   endogenous	
  Gt(Rosa)26Sor	
  promoter;	
   in	
  addition,	
   a	
   full-­‐length	
   chicken	
   β-­‐globin	
   insulator	
   was	
   cloned	
   downstream	
   the	
   FRT	
   site	
  (Fig.	
   2D).	
   The	
   resulting	
   customized	
   and	
  RMCE	
   compatible	
   ES	
   cells	
  were	
   called	
   FLPoC2	
  (Tsanov	
  et	
  al.,	
  2012).	
  These	
  cells	
  were	
  used	
  for	
  targeting.	
  A	
  vial	
  of	
  FLPoC2	
  cells	
  at	
  passage	
  15	
  was	
  thawed	
  11	
  days	
  before	
  targeting	
  on	
  a	
  monolayer	
  of	
  mitomycin-­‐treated	
  EMFI.	
  Cells	
  were	
  kept	
  in	
  culture	
  and	
  passaged	
  on	
  a	
  new	
  mitomycin-­‐treated	
  EMFI	
  monolayer	
  every	
  two	
  days,	
  whenever	
  ES	
  cell	
  reached	
  75-­‐80	
  %	
  confluency.	
  On	
  the	
  day	
  of	
  targeting	
  8	
  x	
  10	
  cm	
  dishes	
  of	
  ES	
  cell	
  on	
  EMFI	
  were	
  treated	
  with	
  trypsin	
  as	
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for	
  passaging	
  and	
  pre-­‐plated	
  for	
  12	
  min	
  to	
  let	
  most	
  of	
  the	
  EMFI	
  cells	
  to	
  attach	
  to	
  the	
  plate	
  surface.	
  Cells	
  were	
  pulled	
  into	
  two	
  50	
  ml	
  falcon	
  tubes;	
  10	
  μl	
  were	
  saved	
  for	
  counting	
  cells	
  and	
  the	
  rest	
  was	
  centrifuged	
  at	
  2000	
  rpm	
  for	
  5	
  min	
  and	
  the	
  pellet	
  was	
  re-­‐suspended	
  in	
  2.6	
  ml	
  of	
  pre-­‐warmed	
  PBS	
  without	
  calcium	
  and	
  magnesium	
  (GIBCO).	
  The	
  content	
  of	
  the	
  two	
   falcon	
   tubes	
  was	
  pulled	
   to	
   get	
   a	
   total	
   volume	
  of	
  5.2	
  ml	
   and	
  a	
   cell	
   concentration	
  of	
  18.75	
  x	
  106	
  cells/ml.	
  pXCHG3Id1	
  targeting	
  vector	
  to	
  a	
  final	
  concentration	
  of	
  1	
  μg/μl	
  in	
  a	
  total	
   of	
   35	
   μl	
   of	
   water	
   (GIBCO)	
   was	
   added	
   to	
   two	
   cuvettes	
   (Biorad	
   Gene	
   Pulser	
   165-­‐2088).	
  One	
  cuvette	
  carried	
  35	
  μl	
  of	
  water	
  alone	
  and	
  was	
  used	
  as	
  negative	
  ‘water’	
  control.	
  800	
  μl	
  of	
   cell	
   suspension	
   in	
  PBS	
  was	
  added	
   to	
  each	
  cuvette	
  and	
   the	
  content	
  was	
  gently	
  mixed.	
  Electroporation	
  was	
  achieved	
  with	
  475	
  μF	
  of	
  capacitance	
  and	
  0.24	
  KV	
  of	
  voltage	
  on	
   a	
  BioRad	
  Gene	
  Pulser	
   II.	
   Cuvettes	
  were	
   incubated	
  20	
  min	
   on	
   ice	
   and	
   the	
   content	
   of	
  each	
  cuvette	
  was	
  resuspended	
  in	
  9	
  ml	
  of	
  pre-­‐warmed	
  ES	
  cell	
  medium	
  (see	
  Material	
  and	
  Methods).	
  The	
  content	
  of	
  the	
  two	
  experimental	
  cuvettes	
  was	
  pulled	
  and	
  plated	
  1:10	
  on	
  10	
  x	
  10	
  cm	
  gelatin-­‐coated	
  dishes	
  and	
  1:5	
  on	
  5	
  x	
  10	
  cm	
  gelatin-­‐coated	
  dishes.	
  ‘Water’	
  control	
  was	
  plated	
  1:10	
  on	
  2	
  x	
  10	
  cm	
  dishes	
  and	
  1:5	
  on	
  2	
  x	
  10	
  cm	
  dishes.	
  800	
  μl	
  of	
  cells	
  in	
  PBS	
  were	
  not	
  electroporated;	
  they	
  were	
  re-­‐suspended	
  in	
  4.5	
  ml	
  ES	
  cell	
  medium	
  and	
  plated	
  the	
  same	
  way	
  as	
  the	
  ‘water’	
  control.	
  	
  The	
   second	
   day	
   after	
   targeting,	
   ES	
   cell	
   were	
   cultured	
   in	
   the	
   presence	
   of	
   G418	
   (Life	
  Technologies)	
   at	
   a	
   concentration	
   of	
   200	
   μg/ml	
   (Tsanov	
   et	
   al.,	
   2012).	
   Medium	
   was	
  changed	
   every	
   day.	
   On	
   the	
   fourth	
   day	
   from	
   targeting,	
   all	
   plates	
   showed	
   massive	
   cell	
  death.	
  On	
   the	
   sixth	
  day	
   from	
   targeting,	
  ES	
   cell	
   clones	
  appeared.	
  No	
  ES	
   cell	
   clones	
  were	
  visible	
  on	
  the	
  control	
  dishes	
  containing	
  the	
  ‘water’	
  control	
  cells.	
  Nine	
  days	
  after	
  electroporation,	
  14	
  clones	
  on	
  the	
  experimental	
  dishes	
  were	
  picked	
  with	
  a	
  p200	
  Gilson	
  pipette	
  and	
  single	
  colonies	
  were	
  moved	
  into	
  a	
  48-­‐well	
  plate	
  containing	
  EMFI	
  cells	
  and	
  ES	
  cell	
  medium	
  without	
  selection.	
  The	
  medium	
  was	
  changed	
  every	
  day.	
  ES	
  cell	
  clones	
  were	
  either	
  tryplated	
  or	
  passaged	
  1:3	
  into	
  a	
  progressively	
   larger	
  plate	
  (24-­‐,	
  6-­‐well	
  plate,	
  6	
  cm	
  plate,	
  10	
  cm	
  plate).	
  When	
  cells	
  were	
  into	
  a	
  24-­‐well	
  plates,	
  were	
  also	
  passaged	
  on	
  a	
  gelatin-­‐coated	
  plate	
  for	
  DNA	
  retrieval	
  for	
  Southern	
  Blot	
  analysis	
  (not	
  shown).	
  The	
  rest	
  of	
  the	
  pellet	
  was	
  used	
  for	
  PCR	
  screening.	
  ES	
  cell	
  clones	
  were	
  frozen	
  in	
  three	
  vials	
  when	
  they	
  displayed	
  75-­‐80	
  %	
  confluency	
  either	
  from	
  a	
  6	
  cm	
  or	
  a	
  10	
  cm	
  dish.	
  12	
  out	
  of	
  14	
  clones	
  were	
  successfully	
  expanded	
  and	
  frozen.	
  All	
  12	
  ES	
  cell	
  clones	
  were	
  screened	
  by	
  PCR	
  and	
  all	
  of	
  them	
  showed	
  correct	
  integration	
  at	
   the	
   F3	
   recombination	
   site	
   and	
   the	
   presence	
   of	
   an	
   internal	
   transgene	
   sequence	
  spanning	
   the	
   Id1	
   minimal	
   promoter	
   and	
   the	
   Venus	
   coding	
   sequence.	
   The	
   frequency	
   of	
  recombinant	
  colonies	
  was	
  about	
  half	
  the	
  one	
  reported	
  by	
  Tsanov	
  et	
  al.	
  2012	
  (~1	
  colony	
  per	
  106	
  cells).	
  This	
   is	
   likely	
  due	
   to	
   the	
  relatively	
   large	
  size	
  of	
   the	
   targeting	
  vector	
   (~17	
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kb).	
   Out	
   of	
   12	
   ES	
   cell	
   clones,	
   7	
   were	
   of	
   mixed	
   composition	
   and	
   were	
   excluded	
   from	
  further	
   analysis.	
   The	
   other	
   5	
  ES	
   cell	
   clones	
   (whose	
   screening	
   by	
  PCR	
   is	
   showed	
   in	
   Fig.	
  4A),	
  were	
  expanded	
  and	
  used	
   for	
  blastocyst	
   injection.	
   Screening	
   conditions	
  and	
  primer	
  sequences	
  are	
  reported	
  in	
  Table	
  1.	
  	
  
Table	
   1.	
   PCR	
   screening	
   strategy.	
  From	
  the	
   top	
   to	
   the	
  bottom,	
  efficient	
   recombination	
  of	
   the	
  conditional	
   Gt(Rosa)26Sor	
   locus	
   in	
   FLPoC2	
   cells	
   was	
   tested	
   by	
   amplification	
   over	
   the	
   F3	
  recombination	
   site,	
   by	
   checking	
   the	
   presence	
   of	
   the	
   transgene,	
   of	
   the	
   conditional	
   locus	
   (for	
  incomplete	
   recombination),	
   and	
   the	
   wild-­‐type	
   allele.	
   Primer	
   sequences	
   are	
   reported	
   and	
   their	
  position	
   in	
   the	
   recombined	
   locus	
   is	
   depicted	
   in	
   the	
   schematics	
   in	
   Figure	
   15D.	
   A	
   standard	
   PCR	
  amplification	
  protocol	
  was	
  used,	
  with	
  1	
  minute	
  of	
  elongation	
  at	
  72°C.	
  Annealing	
  temperature	
  and	
  cycle	
  number	
  are	
  reported	
  for	
  each	
  reaction.	
  	
  	
  
Analysis	
  of	
  ES	
  cell	
  clones	
  Potential	
   and	
  dynamics	
   of	
   Venus	
   expression	
   in	
   the	
   different	
   ES	
   cell	
   clones	
  were	
   tested	
  initially	
   in	
   embryoid	
   bodies	
   (EB).	
   In	
   order	
   to	
   assess	
   which	
   EB	
   differentiation	
   stage	
  exhibited	
   the	
   highest	
   expression	
   of	
   Id1,	
   R1	
   cells	
   were	
   differentiated	
   into	
   EBs	
   and	
  harvested	
  at	
  different	
  time	
  points	
  (5,	
  8,	
  12,	
  16	
  days)	
  for	
  a	
  PCR	
  analysis.	
  The	
  levels	
  of	
  Id1	
  and	
  Msx2	
   expression	
  were	
   quantified	
   in	
   comparison	
   to	
  Hand2,	
   whose	
   expression	
   rises	
  progressively	
  during	
  EB	
  differentiation	
  (PhD	
  thesis	
  by	
  Marco	
  Osterwalder).	
  This	
  analysis	
  showed	
   that	
   the	
   Id1	
   transcriptional	
   activity	
   peaked	
   between	
   day	
   8	
   and	
   12	
   of	
  differentiation,	
  whereas	
  Msx2	
  transcripts	
  remained	
  constant	
  (Fig.	
  4B).	
  This	
  analysis	
  was	
  used	
   for	
   further	
  EB-­‐based	
  experiments,	
  which	
  were	
   then	
  conducted	
  either	
  at	
  day	
  10	
  or	
  day	
   12	
   of	
   differentiation.	
   Venus	
   fluorescence	
   and	
   anti-­‐GFP	
   antibody	
   staining	
   were	
  assessed	
   in	
   clone	
   1A1	
   (Fig.	
   4C,D;	
   n=3)	
   and	
   on	
   other	
   clones	
   (1A3,	
   1A6,	
   1C2;	
   data	
   not	
  shown).	
  Ubiquitous	
  Venus	
  expression	
  driven	
  by	
  the	
  histone	
  H2B	
  promoter	
  in	
  the	
  context	
  of	
   the	
   Smad4	
   conditional	
   locus	
   served	
   as	
   a	
   positive	
   control	
   (Osterwalder	
   et	
   al.,	
   2010),	
  whereas	
  parental	
  FLPoC2	
  cells	
  as	
  negative	
  controls	
  (Fig.	
  4C,D,	
  right-­‐most	
  pictures).	
  This	
  analysis	
  showed	
   that	
   the	
  activity	
  of	
   Id1-­‐Venus	
  in	
  clone	
  1A1	
  correlates	
  well	
  with	
   the	
   Id1	
  transcript	
   levels	
   upon	
   short-­‐time	
   (7	
   hr)	
   stimulation	
   with	
   hrBMP4	
   protein	
   (Fig.	
   4E,	
   F).	
  
Target	
  amplicon	
   Forward	
  primer	
   Reverse	
  primer	
   Annealing	
  temp.	
   Cycle	
  number	
  
Rec.	
  F3	
  site	
  (F8-­‐R1)	
   5'-­‐	
  CATGATGGATACTTTCTCGG	
  -­‐3'	
   5'-­‐	
  GTGATCTGCAACTCCAGTC	
  -­‐3'	
   56°C	
   31	
  
Transgene	
  (F11-­‐R8)	
   5'-­‐	
  GGACACGCTGAACTTGTGG	
  -­‐3'	
   5'-­‐	
  GTCCTGAGTCACTGGCCAAC	
  -­‐3'	
   57°C	
   30	
  
Cond.	
  Locus	
  (F5-­‐R5)	
   5'-­‐	
  CTCAGAAAGCTGGTCATCAG	
  -­‐3'	
   5'-­‐	
  CATCACCGACATCGTGTC	
  -­‐3'	
   58°C	
   32	
  
Wt	
  allele	
  (F1-­‐R1)	
   5'-­‐	
  GGATATGAAGTACTGGGCTCT	
  -­‐3'	
   5'-­‐	
  GTGATCTGCAACTCCAGTC	
  -­‐3'	
   58°C	
   36	
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Unexpectedly,	
  Id1	
  was	
  not	
  permanently	
  induced	
  by	
  hrBMP4	
  treatment,	
  but	
  rather	
  varied	
  overtime	
  (Fig	
  16F;	
  n=1).	
  This	
  experiment	
  was	
  repeated	
  with	
  similar	
  results	
  using	
  clone	
  1A3	
  (n=1;	
  data	
  not	
  shown).	
  These	
  results	
  indicate	
  that	
  the	
  Id1-­‐Venus	
  reporter	
  construct	
  is	
  able	
  to	
  sense	
  changes	
  in	
  BMP	
  activity	
  with	
  good	
  temporal	
  resolution	
  (below	
  1	
  hr).	
  	
  	
  	
  
	
  
	
  
Fig.	
   4	
   (A)	
   PCR	
   screening	
   of	
   selected	
  non-­‐mixed	
  ES	
   cell	
   clones.	
  DNA	
   samples	
   from	
  1A8	
  mixed	
  clone,	
  FLPoC2	
  parental	
  ES	
  cells	
  and	
  EMFI	
  cells	
  were	
  used	
  as	
  controls.	
  From	
  the	
  top	
  to	
  the	
  bottom,	
  the	
   PCR	
   reactions	
   were	
   used	
   to	
   test:	
   effective	
   recombination	
   over	
   the	
   F3	
   recombination	
   site;	
  presence	
  of	
   the	
   transgene;	
  presence	
  of	
   the	
  conditional	
  Gt(Rosa)26Sor	
   locus	
   (from	
  FLPoC2	
  cells);	
  presence	
   of	
   	
   the	
   wild-­‐type	
   Gt(Rosa)26Sor	
   locus.	
   The	
   PCR	
   screening	
   reveals	
   5	
   successfully	
   and	
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completely	
  targeted	
  clones,	
  heterozygous	
  for	
  the	
  Id1-­‐Venus	
  transgene	
  in	
  the	
  Gt(Rosa)26Sor	
  locus.	
  
(B)	
   Id1,	
   Msx2,	
   Hand2	
   transcripts	
   were	
   quantified	
   by	
   RT-­‐qPCR	
   on	
   embryonic	
   bodies	
   (EBs)	
  generated	
  from	
  R1	
  ES	
  cells	
  at	
  day	
  5,	
  8,	
  12,	
  16	
  of	
  differentiation.	
  Time	
  point	
  0	
  (days)	
  is	
  equivalent	
  to	
   non-­‐differentiated	
   ES	
   cell.	
   Values	
   are	
   reported	
   as	
   normalized	
   fold	
   expression	
   ±	
   SD	
   (bars)	
  calculated	
  on	
  the	
  experiment	
  replicates.	
  The	
  experiment	
  was	
  performed	
  one	
  time.	
  Samples,	
  either	
  as	
   EB	
   pellets	
   or	
   purified	
   RNA	
   samples	
   were	
   provided	
   by	
   Dr.	
   Marco	
   Osterwalder.	
   (C)	
   Confocal	
  fluorescence	
   images	
   (63x,	
   oil	
   immersion	
   objective)	
   of	
   EB	
   at	
   day	
   10	
   of	
   differentiation.	
   EBs	
  were	
  obtained	
   from	
   clone	
   1A1	
   ES	
   cell;	
   H2B-­‐Venus	
   ES	
   cell	
   (Osterwalder	
   et	
   al.,	
   2010)	
   were	
   used	
   as	
  positive	
   control	
   and	
   FLPoC2	
   parental	
   ES	
   cell	
   were	
   used	
   as	
   negative	
   control	
   (from	
   left	
   to	
   right,	
  respectively).	
  For	
  the	
  left-­‐most	
  panel,	
  three	
  sections	
  from	
  different	
  fields-­‐of-­‐view	
  were	
  juxtaposed	
  to	
  indicate	
  the	
  variation	
  in	
  fluorescence	
  intensity	
  encountered	
  in	
  the	
  samples.	
  EBs	
  from	
  clone	
  1A1	
  were	
  treated	
  with	
  10	
  ng/ml	
  hrBMP4	
  for	
  4	
  hours	
  before	
  cell	
  harvesting	
  to	
  trigger	
  Venus	
  expression.	
  
(D)	
  Confocal	
  fluorescence	
  images	
  (20x)	
  detecting	
  Venus	
  protein	
  by	
  use	
  of	
  the	
  cross-­‐reacting	
  anti-­‐GFP	
  antibody	
  in	
  EBs.	
  From	
  left	
  to	
  right:	
  EBs	
  at	
  day	
  12	
  of	
  differentiation	
  obtained	
  from	
  1A1	
  ES	
  cell;	
  H2B-­‐Venus	
  cells	
  (2	
  days	
  in	
  culture	
  on	
  gelatin-­‐coated	
  dish);	
  parental	
  FLPoC2	
  cells	
  (also	
  2	
  days	
  in	
  culture	
  on	
  gelatin-­‐coated	
  dish).	
  Two	
  segments	
  from	
  different	
  fields-­‐of-­‐view	
  were	
  juxtaposed	
  in	
  the	
  left-­‐most	
  image	
  to	
  display	
  the	
  variety	
  in	
  fluorescent	
  intensity	
  among	
  differently	
  committed	
  groups	
  of	
  cells.	
  (E)	
  RT-­‐qPCR	
  quantification	
  of	
  Id1	
  (upper	
  panel)	
  and	
  Venus	
  (lower	
  panel)	
  transcripts	
  from	
  differentiated	
  EBs	
  at	
  day	
  10	
   from	
  clone	
  1A1,	
  either	
   treated	
  with	
  hrBMP4	
  (10ng/ml)	
  at	
  different	
  time-­‐points	
  before	
  harvesting	
  (1	
  to	
  7	
  hr	
  –	
  on	
  the	
  horizontal	
  axis	
  -­‐)	
  –	
  green	
  color	
  -­‐	
  or	
  non-­‐treated	
  related	
   controls	
  –	
  violet	
   color-­‐.	
  (F)	
  Plot	
  of	
   the	
  differences	
  between	
   the	
   Id1	
   and	
  Venus	
  transcript	
  levels	
   (blue	
   and	
   red	
   line/dots,	
   respectively)	
   of	
   hrBMP4-­‐treated	
   versus	
   non-­‐treated	
   samples	
  reported	
   in	
   panel	
   (E).	
   The	
   green	
   dots	
   labeled	
   as	
   ‘nt’=	
   ‘non-­‐treated’	
   samples	
   do	
   not	
   represent	
   a	
  difference,	
  but	
  the	
  absolute	
  expression	
  value	
  of	
  the	
  transcripts	
  at	
  t=0.	
  (G)	
  RT-­‐qPCR	
  quantification	
  of	
   Id1	
   and	
  Venus	
   transcripts	
   from	
  EBs	
  at	
  day	
  10	
  of	
  differentiation,	
   derived	
   from	
  FLPoC2	
  ES	
   cell	
  (left	
  plot)	
  and	
  H2B-­‐Venus	
  ES	
  cell	
  (right	
  plot)	
  (used	
  as	
  negative	
  and	
  positive	
  controls,	
  respectively,	
  for	
  the	
  experiment	
  in	
  panels	
  (E)	
  and	
  (F)).	
  	
  
Blastocyst	
  injection	
  Blastocyst	
   injection	
   procedure	
   was	
   outsourced	
   at	
   the	
   Transgenic	
   mouse	
   facility	
   at	
   the	
  Biozentrum	
   (Basel),	
   directed	
   by	
   Daniela	
   Klewe-­‐Nebenius.	
   1A1,	
   1A3,	
   1A5,	
   1A6	
   ES	
   cell	
  clones	
  were	
  injected	
  in	
  Balb/cxBalb/c,	
  or	
  C57Bl/6	
  J	
  -­‐Tyr<c-­‐2j>/j	
  x	
  C57Bl/6	
  J	
  -­‐Tyr<c-­‐2j>/j,	
  or	
  C57Bl/6	
   J	
   x	
  C57Bl/6	
   J	
  blastocysts.	
  Out	
  of	
  43	
   injection	
  attempts,	
  4	
   chimeras	
  between	
  20%	
  and	
  50%	
  chimerism	
  (based	
  on	
  coat	
  color	
  assessment)	
  were	
  obtained.	
  No	
  germ-­‐line	
  transmission	
  was	
  however	
  obtained.	
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13.	
  APPENDIX	
  3	
  _	
  ESTABLISHMENT	
  OF	
  THE	
  AGGREGATION	
  CHIMERA	
  TECHNIQUE	
  
	
  
	
  
Introduction	
  and	
  aim	
  of	
  the	
  project	
  The	
   necessity	
   of	
   dissecting	
   cis-­‐regulatory	
   landscapes	
   to	
   understand	
   developmental	
  processes	
   at	
   a	
   molecular	
   level	
   has	
   become	
   important	
   (see	
   for	
   instance	
   Andrey	
   et	
   al.,	
  2013;	
  Attanasio	
  et	
  al.,	
  2013).	
  To	
  respond	
  to	
  this	
  need,	
  we	
  sought	
  to	
  establish	
  a	
   fast	
  and	
  robust	
  technique	
  to	
  get	
  time-­‐	
  and	
  cost-­‐effective	
  readouts	
  of	
  the	
  activity	
  of	
  cis-­‐regulatory	
  regions	
  of	
  interest.	
  Homologous	
  recombination	
  is	
  the	
  standard	
  way	
  to	
  obtain	
  site-­‐specific	
  integration	
  of	
  single-­‐copy	
  transgenes	
  (Capecchi,	
  1989).	
  Once	
  suitable	
  recombinase	
  target	
  sites	
  are	
  inserted	
  into	
  the	
  genome	
  by	
  homologous	
  recombination,	
  specific	
  targeting	
  into	
  the	
  same	
  locus	
  can	
  be	
  repeatedly	
  achieved	
  by	
  Recombinase-­‐Mediated	
  Cassette	
  Exchange	
  (RMCE)	
   or	
   dual	
   RMCE	
   (dRMCE)	
   (see	
  Osterwalder	
   et	
   al.,	
   2010;	
   Turan	
   et	
   al.,	
   2013).	
   The	
  correctly	
  engineered	
  ES	
  cells	
  are	
  either	
   transferred	
   into	
  blastocoel	
  cavity	
  or	
  aggregated	
  with	
   8-­‐cell	
   stage	
   embryos	
   (Wood	
   et	
   al.,	
   1993a)	
   and	
   then	
   injected	
   into	
   pseudopregnant	
  mothers	
  (reviewed	
  in	
  Tanaka	
  et	
  al.,	
  2009).	
  On	
  these	
  bases,	
  we	
  sought	
  to	
   implement	
  the	
  ES	
  cell	
  aggregation	
  chimera	
  technique	
  previously	
  established	
  (Wood	
  et	
  al.,	
  1993b),	
  with	
  the	
  technical	
  support	
  of	
  Alexander	
  Auhlela	
  (EBML,	
  Heidelberg)	
  and	
  Jean-­‐Francois	
  Spetz	
  (FMI,	
  Basel).	
  	
  
	
  
Fig.	
  1	
  Generation	
  of	
  aggregation	
  chimeras.	
  (A)	
  Morula-­‐stage	
  embryos	
  are	
  flushed	
  out	
  of	
  the	
  uterus	
  of	
  donor	
  mothers	
  at	
  E2.5.	
  In	
  the	
  left	
  panel,	
  a	
  good	
  embryo	
  with	
  its	
  cells	
  surrounded	
  by	
  the	
  
zona	
  pellucida	
  (a	
  glycoprotein	
  membrane).	
   In	
   the	
  right	
  panel,	
  a	
  bad	
  embryo	
  appears	
   translucent	
  cell	
  debris	
  can	
  be	
  seen.	
  These	
  embryos	
  were	
  discarded.	
  (B)	
  The	
  Zona	
  pellucida	
  was	
  removed	
  by	
  digestion	
  with	
  Tyrode’s	
  acid.	
  Zona	
  pellucida-­‐free	
  embryos	
  appear	
  at	
  morula	
  stage	
   (C)	
  Left	
  panel:	
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part	
  of	
  an	
  aggregation	
  drop	
  is	
  depicted.	
  Phase	
  contrast	
  is	
  overlapped	
  with	
  red-­‐florescence	
  to	
  show	
  the	
  dsRed	
  of	
  the	
  G4dsRed	
  ES	
  cells.	
  The	
  black	
  arrowhead	
  points	
  at	
  a	
  morula	
  stage	
  embryos	
  in	
  the	
  aggregation	
   drop.	
   After	
   aggregation,	
   morulas	
   are	
   cleaned	
   from	
   excess	
   ES	
   cells.	
   Right	
   panel:	
  G4dsRed	
  ES	
  cells	
  are	
  aggregated	
  with	
  a	
  morula.	
  (D)	
  After	
  aggregation,	
  ON	
  incubation	
  allows	
  the	
  morulas	
   to	
   develop	
   into	
   blastocysts	
   and	
  ES	
   cells	
   are	
   incorporated	
   into	
   the	
   inner	
   cell	
  mass	
   (red	
  fluorescence)	
  giving	
  rise	
  to	
  the	
  embryos	
  proper.	
  	
  	
  
The	
  aggregation	
  procedure	
  	
  
ES	
  cell	
  handling	
  ES	
  cells	
  are	
  treated	
  according	
  to	
  the	
  general	
  protocol	
  (see	
  Material	
  and	
  Methods).	
  On	
  the	
  day	
   of	
   aggregation,	
   at	
   least	
   one	
   6	
   cm	
   dish	
   of	
   ES	
   cell	
   cultured	
   on	
   a	
   monolayer	
   of	
  mitomycin-­‐treated	
  EMFI	
  cells	
  must	
  be	
  ready	
  for	
  passage.	
  The	
  ES	
  cells	
  on	
  this	
  dish	
  will	
  be	
  partly	
  passaged	
  1:3	
  and	
  partly	
  used	
  for	
  aggregation.	
  ES	
  cells	
  destined	
  for	
  aggregation	
  are	
  resupended	
  in	
  freshly	
  prepared	
  aggregation	
  medium	
  (18	
  ml	
  DMEM	
  4,5	
  g/L	
  Glucose	
  [the	
  same	
  one	
  used	
   for	
  ES	
   cell],	
   66	
  mg	
  Ca-­‐lactate	
   [Sigma	
  Cat.	
   21185]).	
  Mix	
  well	
   to	
   dissolve.	
  Add	
   2	
   ml	
   FCS	
   [Gibco]	
   and	
   filter	
   solution	
   with	
   a	
   0.22	
   μm	
   filter)	
   to	
   achieve	
   a	
   final	
  concentration	
  between	
  1.1	
  and	
  1.3	
  x	
  106	
  cells/ml.	
  To	
  make	
  the	
  aggregation	
  plate,	
  cells	
  are	
  pipetted	
  as	
  drops	
  of	
  ~35	
  μl	
  into	
  a	
  10	
  cm	
  Petri	
  dish	
  and	
  drops	
  are	
  covered	
  with	
  mineral	
  oil.	
  The	
  aggregation	
  plate	
  is	
  pre-­‐equilibrated	
  at	
  37°C,	
  5%	
  CO2	
  for	
  at	
  least	
  20	
  min.	
  The	
  ES	
  cells	
  we	
  have	
  used	
  for	
  aggregation	
  are:	
  R1	
  (Nagy	
  et	
  al.,	
  1993),	
  FLPoC2-­‐targeted	
  ES	
   cells	
   clone	
   1A3	
   (see	
   Appendix	
   1),	
   H2B-­‐Venus	
   ES	
   cells	
   (Osterwalder	
   et	
   al.,	
   2010),	
  G4dsRed	
   (Vintersten	
   et	
   al.,	
   2004).	
   ‘G4dsRed’	
   is	
   a	
   129S6/B6-­‐F1	
   ES	
   cell	
   line	
   carrying	
   a	
  transgene	
  encoding	
  the	
  dsRed	
  fluorescent	
  protein,	
  and	
  was	
  used	
  to	
  maintain	
  aggregation	
  with	
  non-­‐fluorescent	
  host	
  embryos	
  (Fig.	
  1).	
  
	
  
	
  
Superovulation	
  of	
  donor	
  females	
  Female	
  NMRI	
  mice	
  of	
  3	
  to	
  5	
  weeks	
  of	
  age	
  are	
  injected	
  intraperitoneally	
  (25G	
  needle)	
  on	
  day	
   0	
  with	
   5	
   I.U.	
   PMSG	
   (Pregnant	
  Mare	
   Serum	
  Gonadotropin	
   -­‐	
  Pregnyl	
   from	
  Organon).	
  The	
  PMSG	
  powder	
  is	
  reconstituted	
  in	
  sterile	
  PBS	
  w/o	
  calcium	
  and	
  magnesium	
  from	
  Gibco	
  in	
   1ml	
   aliquots	
   to	
   a	
   final	
   concentration	
   of	
   50	
   I.U./ml	
   and	
   stored	
   at	
   -­‐20°C	
   in	
   the	
   dark.	
  Gonadotropin	
  working	
  aliquots	
  are	
  kept	
  at	
  the	
  above	
  conditions	
  for	
  at	
  least	
  2	
  months,	
  or	
  until	
  decrease	
  in	
  the	
  efficiency	
  is	
  detected.	
  On	
  day	
  2	
  the	
  mice	
  are	
  injected	
  with	
  5	
  I.U.	
  hCG	
  (Folligon	
   from	
   Intervet).	
   hCG	
   powder	
   is	
   reconstituted	
   in	
   sterile	
   PBS	
   to	
   a	
   final	
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concentration	
  of	
  500	
  I.U./ml,	
  and	
  stored	
  at	
  -­‐20°C	
  in	
  100μl	
  aliquots	
  in	
  the	
  dark.	
  Just	
  before	
  use,	
  add	
  900	
  μl	
  sterile	
  PBS	
  to	
  dilute	
  hCG	
  to	
  50	
  I.U./ml.	
  Both	
  injections	
  are	
  performed	
  at	
  1:30	
  pm	
  on	
  day	
  0	
   and	
  day	
  2.	
  After	
   injection	
  of	
   hCG,	
   the	
  primed	
   female	
  mice	
   are	
   set	
   to	
  mate	
  with	
  proven	
  stud	
  males.	
  	
  	
   	
  
Material	
  for	
  collecting	
  and	
  processing	
  embryos	
  
• Dissecting	
  microscope	
  
• Forceps:	
  one	
  bent,	
  one	
  straight	
  
• Warming	
  plate	
  set	
  at	
  37°C	
  close	
  to	
  the	
  microscope	
  
• M2	
  medium	
  (prepared	
  following	
  the	
  recipe	
  _	
  see	
  below)	
  
• KSOM	
  medium	
  (MR-­‐106-­‐D	
  from	
  Millipore)	
  
• Mouth	
  pipette	
  (A5177-­‐5EA	
  from	
  Sigma)	
  
• Pulled	
   capillaries	
   (7087	
  45	
   from	
  BlauBrand);	
   the	
  aspiring	
  hole	
  diameter	
   should	
  be	
  between	
  110	
  and	
  140	
  μm	
  
• Needle	
   (304000	
   from	
   BD	
   Microlance,	
   30G)	
   blunted	
   by	
   scratching	
   the	
   tip	
   over	
  sand	
  paper	
  
• 1	
  ml	
  syringes	
  for	
  flushing	
  and	
  2	
  ml	
  for	
  making	
  drops	
  
• Cell	
  Petri	
  dishes	
  (10	
  cm	
  and	
  3.5	
  cm);	
  
• Mineral	
  oil	
  (M5310	
  from	
  Sigma	
  –	
  test	
  every	
  bottle	
  before	
  use	
  –	
  keep	
  at	
  RT	
  in	
  the	
  dark)	
  
• Tyrode’s	
  solution	
  (T1788	
  from	
  Sigma	
  –	
  aliquot	
  in	
  2ml	
  tubes	
  and	
  store	
  at	
   	
   	
  -­‐20°).	
  Alternatively,	
  prepare	
  the	
  solution	
  as	
  follows	
  (for	
  500ml):	
  	
   NaCl	
   	
   4	
  g	
  KCl	
   	
   0.1	
  g	
  CaCl2.2H2O	
   0.13	
  g	
  MgCl2.6H2O	
   0.05	
  g	
  Glucose	
   0.5	
  g	
  (PVP)-­‐40	
   2	
  g	
  	
  Dissolve	
  powders	
   in	
  about	
  450	
  ml	
  of	
  water.	
  Adjust	
   to	
  pH	
  2.5	
  with	
  1M	
  HCl.	
  Top	
  up	
   to	
  500	
  ml.	
  Sterilize	
  by	
  filtration	
  with	
  0.22	
  μm	
  stericup	
  from	
  Millipore,	
  aliquot	
  and	
  store	
  at	
  -­‐20°C.	
  	
  Thawed	
  aliquots	
  can	
  be	
  frozen	
  once.	
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Notes	
  about	
  embryos	
  handling	
  1.	
  Mouth	
  pipetting	
  is	
  advised;	
  2.	
  To	
  better	
  visualize	
  embryos,	
  use	
   light	
   from	
  below	
  and	
  play	
  with	
   the	
  dark	
   field	
   to	
  get	
  the	
  best	
  observation	
  point.	
  When	
  moving	
  the	
  embryos	
  from	
  one	
  drop	
  to	
  the	
  other,	
  use	
  a	
  low	
   magnification,	
   such	
   as	
   you	
   just	
   see	
   dots	
   in	
   place	
   of	
   cells.	
   When	
   observing	
   the	
  embryos,	
  use	
  a	
  high	
  magnification	
  (like	
  for	
  digestion	
  of	
  the	
  zona	
  pellucida);	
  	
  	
  
Embryo	
  collection	
  On	
  E2.5	
  (experimental	
  day	
  5)	
  embryos	
  at	
  morula	
  stage	
  (8-­‐16	
  blastomeres)	
  are	
  collected	
  (Fig.	
  1A).	
  M2	
  medium	
  (for	
  handling	
  embryos	
  outside	
  the	
  incubator)	
  must	
  be	
  prepared	
  in	
  advance	
  (about	
  20	
  ml	
  per	
  experiment);	
  it	
  must	
  pre-­‐equilibrated	
  at	
  37°C	
  and	
  5%	
  CO2.	
  	
  Procedure:	
  	
  1.	
  Pre-­‐warm	
  the	
  loaded	
  flushing	
  and	
  drop-­‐making	
  syringes	
  together	
  with	
  some	
  10	
  cm	
  and	
  3.5	
  cm	
  Petri	
  dishes	
  on	
  the	
  warming	
  plate;	
  2.	
  Kill	
  superovulated	
  and	
  plugged	
  females	
  at	
  E2.5	
  and	
  collect	
  the	
  oviduct	
  with	
  about	
  5	
  mm	
  of	
  uterus	
  piece	
  attached	
  (the	
  oviduct	
  must	
  be	
  dissociated	
  from	
  the	
  ovary,	
  use	
  thin	
  scissor	
   to	
   this	
   aim).	
   Remove	
   as	
   much	
   fat	
   as	
   you	
   can.	
   Oviduct/uteri	
   fragments	
   are	
  collected	
  in	
  a	
  3.5	
  cm	
  Petri	
  dish	
  filled	
  with	
  pre-­‐warmed	
  M2	
  medium;	
  3.	
  Embryo	
  flushing:	
  place	
  a	
  oviduct/uterus	
  fragment	
  in	
  a	
  small	
  drop	
  of	
  M2	
  medium	
  in	
  a	
  10	
   cm	
   Petri	
   dish,	
   so	
   that	
   the	
   piece	
   does	
   not	
   float	
   but	
   is	
   hydrated.	
   At	
   this	
   stage	
   of	
  development,	
  embryos	
  are	
  morulas	
  settled	
  in	
  between	
  the	
  ovary	
  and	
  the	
  distal	
  part	
  of	
  the	
  uterus.	
  Two	
  alternative	
  techniques	
  can	
  be	
  used	
  to	
  collect	
  embryos:	
  4.	
   Use	
   a	
   M2-­‐loaded	
   1-­‐ml	
   syringe	
   with	
   a	
   blunted	
   30G	
   needle	
   to	
   flush	
   the	
   medium	
  through	
  the	
  ampulla	
  (the	
  distal-­‐most	
  part	
  of	
  the	
  oviduct)	
  while	
  holding	
  the	
  ampulla	
  and	
  the	
   needle	
   inside	
   it	
   with	
   forceps,	
   in	
   order	
   to	
   prevent	
   medium	
   reflux.	
   Embryos	
   are	
  flushed	
  out	
  at	
  the	
  end	
  of	
  the	
  uterus.	
  5.	
  Separate	
   the	
  oviduct	
   from	
  the	
  uterus	
  and	
  unravel	
   the	
  distal	
  part	
  of	
   the	
  uterus	
  with	
  forceps,	
  to	
  increase	
  the	
  opening.	
  Flush	
  the	
  embryos	
  out	
  of	
  the	
  uterus	
  with	
  a	
  M2-­‐loaded	
  1-­‐ml	
  syringe,	
  while	
  clumping	
   the	
  uterus	
  extremity	
  and	
   the	
  needle	
   inside	
   it	
  with	
  blunt	
  forceps,	
  in	
  order	
  to	
  avoid	
  fluid	
  reflux.	
  6.	
  Collect	
   the	
  embryos	
  and	
  transfer	
   them	
  to	
  a	
  clean	
  drop,	
  preferably	
  on	
  a	
  3.5cm	
  Petri	
  dish	
  that	
  is	
  kept	
  on	
  the	
  warming	
  plate.	
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7.	
  Process	
  all	
  the	
  pieces.	
  8.	
  Select	
  good	
  embryos:	
  good	
  embryos	
  appear	
  opaque	
  in	
  dark	
  field.	
  Blastomeres	
  fill	
  the	
  space	
  and	
  are	
  surrounded	
  by	
  the	
  zona	
  pellucida.	
  9.	
  Keep	
  embryos	
  and	
  tissue	
  pieces	
  in	
  M2	
  medium	
  on	
  the	
  37°C	
  plate	
  whenever	
  are	
  not	
  handling	
  them	
  and	
  while	
  preparing	
  the	
  ES	
  cell	
  for	
  aggregation.	
  Make	
  sure	
  medium	
  does	
  not	
  evaporate.	
  	
  	
  
Removal	
  of	
  the	
  zona	
  pellucida	
  Note:	
   remember	
   to	
   use	
   a	
   previously	
   coated	
   glass	
   needle	
   for	
   these	
   and	
   all	
   next	
   steps,	
  otherwise	
  embryos	
  will	
  stick	
  to	
  the	
  glass.	
  For	
  this	
  reason,	
  use	
  only	
  bacterial	
  Petri	
  dishes	
  and	
  NOT	
  cell	
  culture	
  dishes.	
  	
  1.	
  Take	
  a	
  10	
  cm	
  Petri	
  dish	
  and	
  dispose	
  4	
  drops	
  of	
  M2	
  at	
  four	
  opposite	
  points	
  at	
  the	
  border	
  of	
  the	
  plate.	
  Place	
  a	
  drop	
  of	
  Tyrode’s	
  acid	
  in	
  the	
  center	
  of	
  the	
  dish,	
  so	
  that	
  each	
  drop	
  is	
  not	
  touching	
  the	
  others.	
  All	
  solutions	
  must	
  be	
  pre-­‐equilibrated	
  at	
  37°C,	
  5%	
  CO2;	
  2.	
  Rinse	
  the	
  collected	
  embryos	
  in	
  one	
  M2	
  drop;	
  3.	
  Move	
   about	
   20	
   embryos	
   per	
   time	
   into	
   the	
   drop	
   of	
   Tyrode’s	
   acid;	
   closely	
   look	
   at	
   the	
  
zona	
  pellucida	
  to	
  disappear;	
  4.	
   As	
   soon	
   as	
   the	
   zona	
  pellucida	
   is	
  removed,	
   rinse	
   the	
   embryos	
   in	
   the	
   remaining	
   three	
  drops	
  of	
  medium.	
  See	
  Fig.	
  1B	
  	
  
	
  
ES	
  cells-­‐embryos	
  aggregation	
  1.	
  Place	
  from	
  5	
  to	
  15	
  embryos	
  per	
  drop	
  on	
  the	
  aggregation	
  plate,	
  where	
  ES	
  cell	
  must	
  have	
  formed	
  a	
  monolayer.	
  2.	
   Incubate	
   the	
   aggregation	
   plate	
   (ES	
   cells	
   and	
   embryos)	
   at	
   37°C	
   5%	
   CO2	
   during	
  aggregation	
  (1-­‐2	
  hrs).	
  3.	
   In	
   the	
  meantime,	
  prepare	
  the	
  dish	
   for	
  ON	
  culture:	
  place	
  several	
  35	
  μl	
  drops	
  of	
  KSOM	
  medium	
  on	
  a	
  10cm	
  petri	
  dish	
  and	
  cover	
  the	
  drops	
  with	
  mineral	
  oil.	
  Equilibrate	
  the	
  plate	
  for	
  at	
  least	
  15	
  min	
  at	
  37°C	
  5%	
  CO2	
  before	
  use.	
  4.	
  After	
  aggregation	
  period,	
  gently	
  pipette	
  the	
  embryos	
  up	
  and	
  down	
  to	
  detach	
  them	
  from	
  underlying	
  layer	
  of	
  ES	
  cell.	
  5.	
  Move	
   the	
   embryos	
   to	
   one	
   drop	
   of	
   KSOM	
   and	
   clean	
   them	
   from	
   excess	
   of	
   ES	
   cells	
   by	
  gently	
  pipetting	
  up-­‐and-­‐down.	
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6.	
   Transfer	
   the	
   embryos	
   to	
   fresh	
   KSOM	
   drop.	
   Pay	
   attention	
   not	
   to	
   put	
   more	
   than	
   3-­‐4	
  embryos	
   per	
   drop	
   and	
   place	
   them	
   distant	
   from	
   one	
   another	
   to	
   avoid	
   embryo-­‐embryo	
  aggregation.	
  7.	
  Incubate	
  the	
  aggregation	
  plate	
  ON	
  at	
  37°C	
  5%	
  CO2.	
  See	
  Fig.	
  1C,D.	
  	
  
	
  
Solutions	
  for	
  culturing	
  embryos	
  M2	
  medium:	
  11	
   stock	
   solutions	
   are	
   prepared	
   and	
   stored	
   at	
   -­‐20°C,	
   ready-­‐made	
   for	
   quick	
   medium	
  preparation:	
  	
  Stock	
  number	
   Solution	
   	
   	
   	
   	
   Grams	
  per	
  100ml	
  0	
   	
   	
   10x	
  NaCl	
  (Merck	
  1064041000)	
   	
   	
   6.4g	
  1	
   	
   	
   100x	
  NaHCO3	
   (Merck	
  1063290500)	
   	
   	
   3.49g	
  2	
   	
   	
   100x	
  Na-­‐Pyruvate	
  (Merck	
  1066190050)	
   	
   0.36g	
  3	
   	
   	
   100x	
  Streptomyc.	
  Sulf.	
  (Sigma	
  56501)	
  	
   	
   0.5g	
  4	
   	
   	
   100x	
  KH2PO4	
  (Merck	
  1048731000)	
   	
   	
   1.62g	
  5	
   	
   	
   100x	
  Ca-­‐Lactate.3H2O	
  (Sigma	
  44388)	
  	
   	
   4.65g	
  6	
   	
   	
   100x	
  KCl	
  (Merck	
  1049361000)	
   	
   	
   3.56g	
  7	
   	
   	
   100x	
  MgSO4.7H2O	
  (Merck	
  1058860500)	
   	
   2.94g	
  8	
   	
   	
   100x	
  Glucose	
  	
   (Sigma	
  G8270)	
  	
   	
   	
   10g	
  9	
   	
   	
   10x	
  HEPES	
  (Sigma	
  54457)	
   	
   	
   	
   see	
  below	
  10	
   	
   	
   100x	
  K-­‐PenG	
   (Sigma	
  P7794)	
  	
   	
   	
   0.75g	
  	
  Stocks	
  number	
  3	
  and	
  10	
  have	
  a	
  shelf	
  life	
  of	
  about	
  12	
  months.	
  	
  Hepes	
  solution:	
  dissolve	
  24.85	
  g	
  of	
  HEPES	
  in	
  400	
  ml	
  of	
  Aqua	
  ad	
  inject	
  (Braun/Aichele	
  Medico,	
  Cat.	
   530108)	
   in	
   a	
   sterile	
  plastic	
  bottle.	
   Prepare	
  25	
  ml	
  of	
  2	
  N	
  NaOH	
   in	
  Aqua	
  ad	
  inject	
   and	
   adjust	
  HEPES	
   solution	
   to	
   pH	
  7.4	
   (with	
   about	
   20	
  ml	
   2	
  N	
  NaOH).	
  Add	
  1	
  ml	
   of	
  Phenol	
   Red	
   (Sigma	
   P0290),	
   filter	
   sterilize	
   (with	
   0.22	
   μm	
   stericup	
   from	
   Millipore,	
   Cat.	
  SGMPU02RE)	
  and	
  store	
  10.5	
  ml	
  aliquots	
  at	
  -­‐20°C.	
  When	
  preparing	
  the	
  working	
  medium,	
  add	
   the	
   appropriate	
   amount	
   of	
   each	
   stock	
   solution	
   and	
   bring	
   to	
   volume	
  with	
   Aqua	
   ad	
  inject.	
  Filter	
   sterilize	
   (with	
  0.22	
  μm	
  stericup	
   from	
  Millipore	
  Cat.	
   SGMPU02RE),	
  add	
  400	
  mg	
  BSA	
  (Sigma	
  Cat.	
  A3311)	
  per	
  100	
  ml	
  of	
  medium	
  in	
  sterile	
  conditions	
  and	
  let	
  it	
  dissolve.	
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Shelf	
  life	
  for	
  this	
  medium	
  is	
  2	
  weeks	
  at	
  4°C.	
  Medium	
  can	
  be	
  frozen	
  before	
  adding	
  BSA	
  for	
  long-­‐term	
  storage.	
  Aqua	
  ad	
  inject	
  can	
  also	
  be	
  frozen.	
  	
   	
  
Preparation	
  for	
  transfer	
  Transfers	
   are	
   generally	
   performed	
   around	
   2	
   pm	
   of	
   the	
   day	
   after	
   aggregation.	
   At	
   this	
  point,	
   embryos	
   should	
   be	
   at	
  morula	
   or	
   blastocyst	
   stages.	
   Contribution	
   of	
   ES	
   cell	
   to	
   the	
  inner	
   cell	
  mass	
   should	
  be	
  partial,	
   since	
   too	
  high	
  percentage	
  of	
  ES	
   cell	
  may	
   lead	
   to	
  not-­‐viable	
   mice	
   or	
   not-­‐fertile	
   chimeras.	
   Before	
   transfer,	
   the	
   embryos	
   are	
   rinsed	
   by	
   serial	
  passage	
   through	
  4	
  drops	
  of	
  M2	
  pre-­‐equilibrated	
  medium	
   in	
  a	
  10	
  cm	
  petri	
  dish,	
  using	
  4	
  different	
   glass	
   needles;	
   each	
   needle	
   has	
   to	
   be	
   coated	
  with	
  medium	
   for	
   at	
   least	
   10	
  min	
  before	
  starting.	
  	
  	
  
Embryo	
  transfer	
  
(done	
  by	
  Javier	
  Lopez-­‐Rios)	
  	
  
MATERIAL	
  FOR	
  EMBRYO	
  TRANSFER	
  
• FST	
  14381-­‐43	
  (also	
  Moria	
  8143A):	
  Moria	
  Bonn	
  Scissors	
  
• FST	
  11151-­‐10	
  (curved	
  fine	
  forceps,	
  serrated)	
  
• FST	
  11154-­‐10	
  (curved	
  tissue	
  forceps	
  1x2)	
  
• FST	
  18374-­‐44	
  (Moria	
  Seraphine	
  Bulldog	
  clamp	
  MC44)	
  
• FST	
  18025-­‐10	
  (Suturing	
  forceps;	
  used	
  to	
  hold	
  the	
  upper	
  part	
  of	
  the	
  uterus	
  before	
  punching	
  a	
  hole	
  with	
  the	
  30G	
  needle)	
  	
  
ANESTHESIA	
  FOR	
  EMBRYO	
  TRANSFER	
  Ketamine/xylazine/acepromazine	
   anesthesia	
   cocktail	
   to	
   be	
   administer	
   by	
   i.p	
   injection	
  (10	
  ml):	
  
	
  
• Ketamine	
  (100	
  mg/ml)	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   1.0	
  ml	
  
• Xylazine	
  (20	
  mg/ml)	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   1.0	
  ml	
  
• Acepromazine	
  (10	
  mg/ml)	
  	
  	
  	
  	
   0.3	
  ml	
  
• Sterile	
  water	
  or	
  saline	
  	
  	
  	
  	
  	
  	
  	
   7.7	
  ml	
  	
  Store	
  the	
  mix	
  at	
  4°C	
  for	
  a	
  maximum	
  of	
  two	
  weeks	
  (it	
  can	
  also	
  be	
  frozen).	
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Mouse	
  body	
  weight	
  	
   Volume	
  cocktail	
  (for	
  surgery)	
  20	
  g	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   	
  0.13	
  ml	
  25	
  g	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   	
  0.16	
  ml	
  30	
  g	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   	
  0.20	
  ml	
  35	
  g	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   	
  0.23	
  ml	
  	
  
	
  
EMBRYO	
  TRANSFER	
  PROCEDURE	
  1.	
  Three	
  days	
  before	
  the	
  transfer,	
  set	
  1-­‐2	
  NMRI	
  females	
  (6-­‐8	
  weeks	
  of	
  age;	
  older	
  females	
  will	
   be	
  more	
   difficult	
   to	
   use	
   for	
   embryo	
   transfer	
   as	
   they	
   accumulate	
   fat)	
   in	
   plug-­‐check	
  with	
  vasectomized	
  males	
  (proven	
  to	
  be	
  sterile).	
  Plug	
  check	
  the	
  next	
  morning	
  and	
  stop	
  the	
  mating.	
  Non-­‐plugged	
  females	
  can	
  be	
  reused,	
  while	
  pseudopregnant	
  animals	
  that	
  are	
  not	
  transferred	
  can	
  be	
  used	
  again	
  in	
  two	
  weeks	
  of	
  rest.	
  2.	
  Keep	
  surgical	
   instruments	
  sterile	
  (clean	
  them	
  with	
  Ethanol	
  70%;	
  heat-­‐sterilize	
  for	
  10	
  seconds	
  at	
  >200°C).	
  3.	
  Anesthetize	
  the	
  mouse.	
  	
  4.	
  Shave	
  the	
  mouse	
  on	
  both	
  sides	
  between	
  the	
  hindlimb	
  and	
  last	
  rib.	
  Put	
  protective	
  gel	
  on	
  both	
  eyes.	
  5.	
  Clean	
  the	
  skin	
  with	
  70%	
  EtOH	
  and	
  cellulose	
  pads	
  in	
  the	
  direction	
  of	
  the	
  hair.	
  6.	
  Use	
  the	
  curved	
  tissue	
  forceps	
  1x2	
  to	
  clip	
  the	
  skin	
  and	
  the	
  Moria	
  Bonn	
  Scissors	
  to	
  cut,	
  make	
   an	
   incision	
   of	
   around	
   5	
  mm	
   in	
   the	
   skin,	
   in	
   the	
   region	
  where	
   the	
   ovary	
   is	
   (small	
  depression	
  on	
  the	
  side).	
  7.	
  Use	
  the	
  same	
  tools	
  as	
  above	
  to	
  detach	
  the	
  skin	
  from	
  the	
  peritoneum	
  on	
  both	
  sides	
  of	
  the	
  wound.	
  8.	
  Clean	
  the	
  wound	
  again	
  with	
  cellulose	
  pads	
  soaked	
  in	
  70%	
  EtOH	
  in	
  the	
  direction	
  of	
  the	
  hair.	
  9.	
   Under	
   the	
  microscope,	
   locate	
   the	
   ovary	
   by	
  moving	
   the	
  wound	
   like	
   a	
  window.	
   Fat	
   is	
  white,	
  while	
  the	
  ovary	
  is	
  orange	
  and	
  can	
  be	
  found	
  close	
  to	
  the	
  kidney	
  (dark	
  red).	
  10.	
  Using	
  the	
  same	
  tools,	
  pinch	
  and	
  cut	
  the	
  peritoneal	
  wall.	
  Make	
  a	
  small	
  cut,	
   introduce	
  the	
  tip	
  of	
  the	
  closed	
  scissors	
  through	
  it	
  and	
  open	
  the	
  scissors	
  to	
  widen	
  the	
  opening.	
  This	
  helps	
  to	
  prevent	
  bleeding.	
  If	
  bleeding	
  occurs,	
  it	
  can	
  be	
  stopped	
  with	
  absorption	
  pads.	
  11.	
  Using	
  the	
  serrated	
  and	
  1x2	
  curved	
  fine	
  forceps	
  search	
  for	
  the	
  ovary	
  and	
  pull	
  it	
  out	
  by	
  the	
  fat,	
  taking	
  care	
  not	
  to	
  touch	
  the	
  ovary,	
  oviduct	
  or	
  uterus.	
  Use	
  a	
  seraphine	
  clamp	
  on	
  the	
  fat	
   to	
   keep	
   the	
   uterus	
   out	
   of	
   the	
   body	
   wall	
   and	
   in	
   the	
   right	
   orientation	
   for	
   injection,	
  always	
  trying	
  to	
  avoid	
  excessive	
  tension	
  on	
  the	
  uterus.	
  12.	
  Load	
  8	
  (max.	
  10)	
  embryos	
  into	
  the	
  glass	
  transfer	
  capillary	
  in	
  the	
  minimum	
  amount	
  of	
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media	
   and	
   make	
   sure	
   that	
   two	
   air	
   bubbles	
   are	
   placed	
   after	
   the	
   embryos,	
   allowing	
   to	
  monitor	
  a	
  successful	
  transfer.	
  13.	
  Turn	
  the	
  mouse	
  so	
  that	
  the	
  uterus	
  can	
  be	
  accessed	
  with	
  the	
  needle	
  in	
  parallel.	
  Ideally,	
  hold	
  a	
  30G	
  needle/syringe	
  and	
  the	
  transfer	
  capillary	
  in	
  the	
  same	
  hand,	
  while	
  holding	
  the	
  uterus	
  with	
  suturing	
  forceps.	
  Make	
  a	
  hole	
  with	
  the	
  30G	
  needle	
  and	
  immediately	
  insert	
  the	
  glass	
  capillary	
  and	
  blow	
  the	
  embryos	
  into	
  the	
  uterus	
  by	
  making	
  sure	
  the	
  bubbles	
  are	
  gone	
  from	
  the	
  capillary.	
  	
  14.	
  Place	
  the	
  uterus	
  back	
  into	
  the	
  body	
  cavity	
  by	
  holding	
  the	
  wall	
  of	
  the	
  peritoneum	
  with	
  the	
  1x2	
   forceps;	
   release	
   the	
   seraphine	
   clamp	
   and	
  use	
   the	
   serrated	
   fine	
   curved	
   forceps.	
  Hold	
  the	
  sides	
  of	
  the	
  peritoneum.	
  15.	
  Put	
  back	
  the	
  sides	
  of	
  the	
  skin	
  wound	
  so	
  that	
  the	
  inner	
  sides	
  are	
  touching	
  and	
  you	
  see	
  the	
  borders	
  of	
  the	
  wound.	
  Close	
  it	
  using	
  two	
  suture	
  clips.	
  16.	
  Repeat	
  the	
  whole	
  procedure	
  on	
  the	
  other	
  side.	
  One	
  female	
  can	
  be	
  transferred	
  on	
  both	
  sides	
  in	
  around	
  20	
  minutes.	
  17.	
  Place	
  the	
  mouse	
  in	
  its	
  cage,	
  cover	
  with	
  tissue	
  and	
  put	
  under	
  a	
  heating	
  lamp	
  (or	
  onto	
  heating	
  plate)	
  until	
   it	
  regains	
  consciousness	
  (around	
  30-­‐40	
  minutes	
  after	
  the	
  end	
  of	
  the	
  procedure).	
  Provide	
  mouse	
  with	
  analgesics	
  at	
  free	
  will.	
  18.	
   10	
   days	
   after	
   surgery,	
   remove	
   the	
   clips.	
   Weight	
   increase	
   is	
   a	
   reliable	
   sign	
   of	
  pregnancy.	
  	
  	
  
Results	
  All	
  the	
  transferred	
  pregnant	
  females	
  were	
  allowed	
  to	
  deliver;	
  no	
  embryos	
  were	
  collected	
  during	
   pregnancy.	
   Trial	
   experiments	
   with	
   flushed	
   and	
   re-­‐implanted	
   embryos	
   (without	
  aggregation	
  step)	
  provided	
  7	
  and	
  18	
  pups	
  from	
  embryos	
  without	
  and	
  with	
  tyrode’s	
  acid	
  treatment,	
  respectively,	
  out	
  of	
  a	
  total	
  60	
  embryos	
  transferred.	
  From	
  G4dsRed	
  ES	
  cells	
  we	
  obtained	
   5	
   chimeras	
   –	
   3	
   males	
   and	
   2	
   females	
   -­‐	
   (10%,	
   30%,	
   50%,	
   95%,	
   100%	
   of	
  chimerism	
  based	
  on	
  the	
  agouti	
  coat	
  color)	
  out	
  of	
  24	
  pups	
  from	
  35	
  mice	
  transferred.	
  Chimeras	
   and	
   F1	
   pups	
   were	
   both	
   phenotyped	
   by	
   detection	
   of	
   fluorescence	
   in	
   the	
   red	
  channel	
  and	
  genotyped	
  by	
  PCR	
  (Fig.	
  2).	
  From	
  the	
  FLPoC2-­‐targeted	
  ES	
  cells	
  clone	
  1A3	
  2	
  male	
  chimeras	
  (both	
  10%	
  of	
  chimerism)	
  were	
  obtained	
  in	
  a	
  litter	
  of	
  4	
  pups	
  out	
  of	
  10	
  mice	
  transferred.	
  Germline	
  transmission	
  has	
  been	
  achieved	
  with	
  the	
  highest	
  chimeric	
  grade.	
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Fig.	
   2	
   Screening	
   for	
   the	
   dsRed	
   allele.	
  Chimeras	
  and	
  F1	
  pups	
  obtained	
  from	
  the	
  transfer	
  of	
   embryos	
   aggregated	
  with	
   G4dsRed	
   cells	
  were	
  screened	
   by	
   PCR	
   and	
   by	
   detection	
   of	
   the	
   dsRed	
  ubiquitous	
  fluorescence	
  directly	
  in	
  the	
  ear	
  biopsy.	
  PCR	
  screening	
  was	
  carried	
  out	
  using	
  the	
  protocol	
  provided	
  by	
  Jackson	
  Laboratory.	
  (A)	
  From	
  left	
  to	
  right,	
   PCR	
   screening	
   of	
   chimera	
   no.	
   1	
   (95%	
  chimerism	
   from	
   coat	
   color);	
   F1	
   pup	
   with	
   black	
  coat	
   obtained	
   from	
   chimera	
   no.	
   1	
   was	
   found	
  negative	
   for	
   the	
   dsRed-­‐expressing	
   transgene;	
   a	
  wild-­‐type	
   NMRI	
   biopsy	
   was	
   used	
   as	
   negative	
  control;	
   a	
   biopsy	
   taken	
   from	
   a	
  mouse	
   known	
   to	
  carry	
  the	
  dsRed	
  transgene	
  was	
  used	
  as	
  a	
  positive	
  control;	
   DNA	
   extracted	
   from	
   G4dsRed	
   ES	
   cells	
  (‘dsRed‘	
   in	
   the	
   figure)	
   was	
   used	
   as	
   positive	
  control;	
   DNA	
   extracted	
   from	
   EMFI	
   cells	
   was	
   used	
   as	
   negative	
   control.	
   (B)	
   Epi-­‐fluorescent	
   and	
  bright-­‐field	
  overlapped	
  images	
  show	
  the	
  fluorescent	
  ear	
  biopsy	
  taken	
  from	
  chimera	
  no.	
  1	
  (in	
  the	
  center),	
  in	
  comparison	
  with	
  a	
  negative	
  control	
  from	
  a	
  wild-­‐type	
  NMRI	
  mouse	
  (on	
  the	
  left)	
  and	
  the	
  non-­‐fluorescent	
  ear	
  piece	
  taken	
  from	
  F1	
  pup	
  no.	
  3	
  (on	
  the	
  right).	
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